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Abstract 
Abstract 
Zellkultursysteme mit Krebszelllinien werden seit Langem zur Untersuchung der Interakti-
on zwischen Pathogenen und ihren Wirtszellen eingesetzt. Diese Systeme eignen sich 
aufgrund der reduzierten Komplexität für die Analyse einzelner Faktoren, spiegeln jedoch 
nicht den Zustand primärer Zellen oder die komplexe Gewebestruktur wieder. Um die 
Beschränkungen zu umgehen, wurden in dieser Arbeit neue Modelle etabliert auf der 
Grundlage von reversibel immortalisierten humanen Primärzellen und ex vivo Kultur von 
intaktem humanem Eileitergewebe. Infektionen mit dem humanpathogenen Bakterium 
Chlamydia trachomatis, welches chronische Schmerzen oder Unfruchtbarkeit auslösen 
kann, wurden in diesen Modellen untersucht. Reversible Immortalisierung wurde mit pri-
mären human Eileiterzellen (FT Zellen) und humanen Nabelschnurzellen (HUVEC) 
durchgeführt. Das System basiert auf lentiviralem Gentransfer und dem Cre-lox-System. 
HUVEC Zellen wurden mit Kombinationen der Onkoproteine hTERT, SV40T und Bmi1 
immortalisiert. Immortalisierung von FT Zellen wurde mit SV40T und Bmi1 erreicht. Eine 
Analyse der FT Zelllinien zeigte Veränderungen des Karyotyps durch die Immortalisie-
rung. Bemerkenswerterweise konnten die Stammzellmarker CD44 und Oct4 in FT Zellen 
nachgewiesen werden. Ex vivo Gewebekultur humaner Eileiter wurde als stabiles Infekti-
onsmodel für Chlamydia trachomatis etabliert. Mittels hochauflösender Konfokal-
mikroskopie wurde gezeigt, dass die Infektion mit C. trachomatis tiefgreifende Verände-
rungen im Epithel der Mukosa auslöst und zum Verlust der Zelladhäsion und Zellpolarität 
führt. Ein erhöhter Anteil apoptotischer Zellen wurde nach Infektion mit Serovar D beo-
bachtet, einem klinischen Isolat des Genitaltraktes. Dieses Ergebnis steht im Gegensatz 
zu Infektionen mit dem Laborstamm Serovar L2. Phänotypische Veränderungen in nicht 
infizierten Zellen weisen auf die Existenz parakriner Signalwege während der akuten In-
fektion und Veränderung der epithelialen Homeostase hin. 
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Abstract 
Abstract 
Cell culture systems with cancer-derived cell lines have long been used to study the 
interaction between pathogens and their host cells. Due to reduced complexity these 
systems are convenient for the analysis of single factors; however, they do not represent 
the condition of primary cells or the complex tissue structure. To circumvent these 
limitations new models were established in this study on the basis of reversibly 
immortalized human primary cells and ex vivo culture of intact human fallopian tube 
tissue. Infections with the human pathogenic bacterium Chlamydia trachomatis, which 
can lead to chronic pain or infertility, were analyzed in these models. Reversible 
immortalization was applied to primary human fallopian tube (FT) cells and human 
umbilical vein cells (HUVEC). This system is based on lentiviral gene transfer and the 
Cre-lox-system. HUVEC cells were immortalized with a combination of two of the 
oncoproteins hTERT, SV40T and Bmi1. Immortalization of FT cells was achieved with 
SV40T and Bmi1. Analysis of FT cell lines revealed changes of the karyotype induced by 
immortalization. Remarkably, the stem cell markers CD44 and Oct4 were detected in FT 
cells. Ex vivo tissue culture of human fallopian tubes was established as stable and 
reliable infection model for Chlamydia trachomatis. Via high resolution confocal analysis 
the infection with C. trachomatis was discovered to trigger profound changes in the 
epithelial mucosa, causing loss of cell adhesion and polarity. Interestingly, an increase in 
the rate of apoptotic cells was observed after infection with serovar D, a clinical genital 
tract isolate. This finding is in contrast to infections with serovar L2, a laboratory strain. 
Phenotypic changes in non-infected cells suggest the existence of paracrine signalling 
during acute infection and change in epithelial homeostasis. 
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Zusammenfassung 
Zusammenfassung 
Zellkultursysteme werden seit Langem zur Untersuchung der Interaktion zwischen Pa-
thogenen und ihren lebenden Wirtszellen eingesetzt. Krebszelllinien und immortalisierte 
Zelllinien sind aufgrund der reduzierten Komplexität der Systeme geeignet für die Analyse 
einzelner Faktoren. Diese Zellen spiegeln jedoch nicht den Zustand primärer Zellen wie-
der, und die direkte und routinierte Arbeit mit Primärzellen ist oft kompliziert aufgrund der 
limitierten Proliferation und Verfügbarkeit der Zellen. Des Weiteren unterscheiden sich 
diese Modelsysteme von der Infektionssituation in vivo, in der mehrere Zelltypen inter-
agieren und die Zellen in die komplexe Gewebestruktur eingebettet sind.  
Daher werden neue Modelsysteme auf der Grundlage von Primärgewebe benötigt, um 
diese komplexe Situation besser nachzustellen. Um die Beschränkungen der herkömm-
lich verwendeten Zellkulturen zu umgehen, wurden in dieser Arbeit neue Modelle etabliert 
auf der Grundlage von 1. isolierten reversibel immortalisierten humanen Primärzellen, 
und 2. ex vivo Kultur von intaktem humanem Eileitergewebe. Infektionen mit dem hu-
manpathogenen Bakterium Chlamydia trachomatis, welches chronische Schmerzen oder 
Unfruchtbarkeit auslösen kann, wurden in diesen Modellen untersucht. 
Reversible Immortalisierung, d.h. Immortalisierung von Zellen mit der Möglichkeit, die 
Immortalisierungskonstrukte später aus dem Genom herauszuschneiden, wurde mit pri-
mären human Eileiterzellen (FT Zellen) und humanen Nabelschnurzellen (HUVEC) 
durchgeführt. Das System basiert auf lentiviralem Gentransfer und dem Cre-lox-System. 
Die HUVEC Zellen wurden mit einer Kombination aus zwei der Onkoproteine hTERT, 
SV40T und Bmi1 oder nur SV40T immortalisiert. Insgesamt wurden 21 FT Zelllinien her-
gestellt, welche die Onkoproteine SV40T und Bmi1 enthielten. Eine Analyse der FT Zellli-
nien zeigte Veränderungen des Karyotyps durch die Immortalisierung auf. Bemerkens-
werterweise konnten die Stammzell- und mesenchymalen Marker CD44, Oct4 und N-
Cadherin in FT Zellen nachgewiesen werden.  
In dieser Arbeit konnte die ex vivo Gewebekultur humaner Eileiter erfolgreich etabliert 
werden und erwies sich als stabiles und verlässliches Infektionsmodel für Chlamydia tra-
chomatis. Dies ist die erste Studie, die eine detaillierte Analyse subzellulärer Marker wäh-
rend des Verlaufs der Chlamydieninfektion direkt in humanem Gewebe mittels Immunflu-
oreszenz beschreibt.  
Unter Verwendung hochauflösender Konfokalmikroskopie fanden wir heraus, dass die 
Infektion mit C. trachomatis tiefgreifende Veränderungen im Epithel der Mukosa auslöst 
und zu einem Verlust der Zelladhäsion und Zellpolarität führt. Interessanterweise wurde 
außerdem ein Anstieg des Anteils apoptotischer Zellen nach Infektion mit dem Serovar D 
beobachtet. Das Serovar D ist weit verbreitet unter klinischen Isolaten des Genitaltraktes. 
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Dieses Ergebnis steht im Gegensatz zu Infektionen mit dem Serovar L2, einem weit ver-
breiteten Laborstamm. Phänotypische Veränderungen in nicht infizierten Zellen könnten 
bedeutend für die durch Chlamydien verursachten Symptome sein und zum Verständnis 
dieser beitragen, da sie auf die Existenz parakriner Signalwege während der akuten In-
fektion und Veränderung der epithelialen Homeostase hinweisen.  
Summary 
Summary 
Cell culture systems have long been used to study the interaction between pathogens 
and their living host cells. Cancer-derived cell lines and immortalized cells are convenient 
for the analysis of single factors due to reduced complexity of the systems. These cells, 
however, do not represent the condition of primary cells, and the direct and routine work 
with primary cells often is complicated due to the cells’ limited proliferation and 
acquisition. In addition, all of these model systems differ from the infection situation in 
vivo, where multiple cell types interact and the cells are embedded in the complex tissue 
structure.  
Therefore, new primary tissue based model systems are needed to better mimic this 
complex situation. To circumvent the limitations of traditionally used cell cultures, new 
models were established in this study on the basis of (1) isolated reversibly immortalized 
human primary cells, and (2) ex vivo culture of intact human fallopian tube tissue. 
Infections with the human pathogenic bacterium Chlamydia trachomatis, which can lead 
to chronic pain or infertility, were analyzed in these models.   
Reversible immortalization, i.e. immortalization of cells with the possibility to excise the 
immortalizing constructs later from the genome, was applied to primary human fallopian 
tube (FT) cells and human umbilical vein cells (HUVEC). This system is based on 
lentiviral gene transfer and the Cre-lox-system. HUVEC cells were immortalized with a 
combination of two of the oncoproteins hTERT, SV40T and Bmi1 or SV40T alone. In total 
21 FT cell lines were generated containing SV40T and Bmi1 oncoproteins. Analysis of FT 
cell lines revealed changes of the karyotype induced by immortalization. Remarkably, the 
stem cell and mesenchymal markers CD44, Oct4 and N-cadherin were detected in FT 
cells.   
Ex vivo tissue culture of human fallopian tubes was successfully established in this study 
and shown to be a stable and reliable infection model for Chlamydia trachomatis. This is 
the first study presenting detailed analysis of subcellular markers by immunofluorescence 
during the course of chlamydial infection directly in human tissue.  
By using high resolution confocal analysis we discovered that infection with C. 
trachomatis triggers profound changes in the epithelial mucosa, causing loss of cell 
adhesion and polarity. Interestingly, an increase in the rate of apoptotic cells was 
observed, too, after infection with serovar D, which is prevalent among clinical genital 
tract isolates. This finding is in contrast to infections with serovar L2, a widely used 
laboratory strain. Phenotypic changes in non-infected cells could be significant for and 
contribute to the understanding of Chlamydia-induced pathology, as they suggest the 
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existence of a paracrine signalling during acute infection and change in epithelial 
homeostasis. 
Introduction 
1 Introduction 
1.1 Chlamydiae 
Chlamydiae are non-motile Gram-negative bacteria. In the past, chlamydiae were thought 
to be protozoans due to the presence in a typical intracellular vacuole. As the pathogens 
are obligate intracellular and small (approximately 300 nm for the infectious form), they 
were later regarded as large viruses. In the 1960’s, chlamydiae were finally identified as 
bacteria (Schachter and Caldwell, 1980; Moulder, 1966; Gear,, et al., 1963). Chlamydiae 
are distributed world-wide and infect humans and animals (see chapter 1.2).  
 
1.1.1 Taxonomy of chlamydiae 
The taxonomy of the order Chlamydiales was redefined approximately 10 years ago 
based on phylogenetic analysis of the 16S and 23S rRNA genes in addition to genetic 
and phenotypic information (Bush and Everett, 2001; Horn,, et al., 2000; Everett, et al., 
1999). The order now contains four families: Chlamydiaceae, Parachlamydiaceae, 
Waddliaceae and Simkaniaceae. The formerly single genus Chlamydia of the family 
Chlamydiaceae was divided into the two genera Chlamydia and Chlamydophila (Fig. 1.1). 
However, the proposal was not universally accepted (Stephens, et al., 2009).  
Among the Chlamydiaceae are human pathogens as well as animal-infecting species. 
Chlamydia trachomatis and Chlamydophila pneumoniae are human pathogens causing 
ocular and urogenital diseases as well as pneumonia (see below). In contrast to members 
of the Chlamydiaceae, bacteria of the families Parachlamydiaceae and Simkaniaceae  
 
 
Fig. 1.1: Taxonomy of the family Chlamydiaceae and indication of typical hosts. The new 
taxonomy of the family Chlamydiaceae within the order Chlamydiales. Typical hosts are indicated 
at the right side; human pathogenic strains are highlighted. The length of lines does not 
correspond to actual evolutionary distance. After: Bush and Everett, 2001; Everett, et al., 1999. 
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reside within amoebae. However, their involvement in human infections has been 
discussed (Heinz, et al., 2007; Friedman, et al., 2003; Horn, et al., 2000). 
 
1.1.2 Developmental cycle of chlamydiae 
The obligate intracellular bacteria of the family Chlamydiaceae all reside within a 
membrane-bound vacuole, termed the chlamydial inclusion, inside the host cell. 
Chlamydiae possess a unique biphasic life cycle, changing between two morphological 
distinct stages (Fig. 1.2). These are an infectious but metabolically inactive form 
(elementary body, EB), which never divides, and a replicating non-infective form 
(reticulate body, RB). The EBs have condensed DNA and are approximately 0.3 µm in 
size. EBs are released from infected host cells at the end of the cycle and infect new 
cells, in which they transform into RBs with a diameter of approximately 1 µm and 
multiply. Chlamydiae usually infect cells that are not actively phagocytic (Moulder, 1991; 
Matsumoto, 1973; Hammerschlag, 2002; Abdelrahman and Belland, 2005).  
As chlamydiae are obligate intracellular pathogens, entry into mucosal epithelial cells is 
necessary for survival and replication. Attachment of the infectious EBs to the host cells 
involves electrostatic binding (Stephens, et al., 2001; Su, et al., 1996). Chlamydiae use 
multiple possible routes of entry. Reports include phagocytosis, clathrin- and lipid 
microdomain-dependent entry (Hybiske and Stephens, 2007; Dautry-Varsat, et al., 2005; 
Abdelrahman and Belland, 2005). EBs are equipped with a functional type III secretion 
system delivering effectors into the host cell, which facilitate bacterial entry (Abdelrahman 
and Belland, 2005; Clifton, et al., 2004).  
The bacteria stay within the membrane-bound phagosome, which is termed the 
chlamydial inclusion. EB differentiation into the growing form (RB) is accompanied by 
enlargement and loss of infectivity. Chromosome decondensation and transcription take 
place. Early genes include genes involved in inclusion modification and nutrient 
acquisition, e.g. lipids from the host’s Golgi vesicles. Within two hours after entry, the 
inclusion locates to the perinuclear region and remains close to the Golgi apparatus. 
Chlamydiae actively modify the inclusion membrane to protect their replicative niche and 
evade the host endocytic pathway, which would lead to fusion with lysosomes 
(Abdelrahman and Belland, 2005; Hammerschlag, 2002; Hackstadt, et al., 1996).  
RBs grow rapidly and replicate through binary fission during the middle of the replication 
cycle. 24 – 48h post infection RBs differentiate asynchronously back into EBs. 48 – 72h 
post infection bacteria leave the host cell via cell lysis or exocytosis of the whole inclusion 
(Abdelrahman and Belland, 2005; Hammerschlag, 2002). 
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Fig. 1.2: Developmental cycle of chlamydiae. Schematic representation of the chlamydial 
developmental cycle within host cells (yellow). For description see text. EB: elementary body (red); 
RB: reticulate body (blue); AB: aberrant body (grey); N: nucleus (brown). After: Hammerschlag, 
2002. 
 
All chlamydial species are able to cause persistent infections, which are prolonged and in 
which the pathogen is not eliminated. Persistent infection can be triggered by antibiotics, 
cytokines, or nutrient limitation (Harper, et al., 2000; Beatty, et al., 1994; Abdelrahman 
and Belland, 2005). Under these conditions, the developmental cycle is interrupted and 
RBs transform into an enlarged aberrant form (aberrant body, AB) with reduced metabolic 
activity. Persistent ABs often are unsusceptible to antibiotics. Chlamydiae can persist in 
the host for months to years. This results in continued damage to the host. Persistence 
can redevelop into open disease, when the limiting conditions change (Abdelrahman and 
Belland, 2005; Hammerschlag, 2002).  
 
1.2 Chlamydial diseases 
Chlamydiae can infect mucosal tissues of humans, mammals and birds causing infections 
of the eyes, the respiratory and urogenital tract. In addition, chlamydiae have been 
associated with chronic diseases such as arthritis and atherosclerosis (Gérard, et al., 
2010; Vainas, et al., 2009).  
Importantly, chlamydiae are the leading cause of infectious blindness worldwide and of 
the most common bacterial sexually transmitted diseases (STD). In Germany, in average 
6 % of patients were infected with chlamydiae as observed in a six year surveillance 
study (Robert Koch Institute, 2010; 
http://www.rki.de/cln_160/nn_1759378/DE/Content/Infekt/EpidBull/Archiv/2010/03/Tabelle
.html?__nnn=true). Therefore, analysis of chlamydial pathogenesis is of great medical 
importance. 
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1.2.1 Medical importance of Chlamydia trachomatis 
Chlamydia trachomatis is classified into three groups of serovars (A-C, D-K and L1-L3) 
according to the different diseases they cause. The serovars A – C are the agents of the 
ocular disease trachoma, an infection of the conjunctiva and inner side of eyelids, 
eventually causing the eyelids to turn inwards. The eyelashes scratch the cornea, which 
leads to visual impairment and results in permanent blindness. Trachoma is the most 
frequent infectious cause of blindness worldwide and is endemic in over 50 countries, 
predominantly Africa, Middle East and Asia. Approximately 1.3 million people are blinded 
by trachoma, which makes 3.6 % of total blindness worldwide. In some parts of 
developing countries, over 90 % of the population is infected (Burton and Mabey, 2009; 
Resnikoff, et al., 2004; WHO, 
http://www.who.int/vaccine_research/diseases/soa_std/en/index1.html). Chlamydia 
trachomatis ocular serovars have additionally been associated with the chronic disease 
arthritis (Gérard, et al., 2010).  
C. trachomatis of the second group, serovars D – K, causes urogenital tract infections in 
woman and men and is associated with the most common STD. There are around 90 
million new cases of infections per year worldwide with 4-5 million new cases alone in the 
USA (WHO, http://www.who.int/vaccine_research/diseases/soa_std/en/index1.html). A 
high portion of infections stays asymptomatic and thus often untreated. Symptomatic 
patients present with vaginal discharge or pelvic pain. Infections in woman include 
cervicitis, salpingitis (inflammation of fallopian tube), and pelvic inflammatory disease 
(PID) (Ridgway, 1986; Hare, 1983). Tissue damage and scarring occur, whose causing 
mechanisms are not fully understood, and sequelae include tubal occlusion, ectopic 
pregnancy and infertility (Darville and Hiltke, 2010; Hare, 1983). Infections in men can 
result in urethritis and prostatitis (Ridgway, 1986).  
The systemic disease lymphogranuloma venereum (LGV) is caused by C. trachomatis 
serovars L1 – L3 and is more common in tropical countries. Unlike other forms of 
chlamydial infection, in LGV lymph tissue is invaded rather than only epithelial cells. 
Bacteria enter through primary lesions, e.g. in the vagina or penis, and cause swelling of 
lymph nodes. Infections can lead to necrotic lesions and scarring, rectal stricture and 
elephantiasis (thickening of legs or genitals) (Ridgway, 1986; Schachter and Osoba, 
1983). 
 
1.2.2 Infections by other chlamydial strains 
Chlamydophila pneumoniae, formerly known as Chlamydia pneumoniae, is a human 
pathogen and primarily infects the mucosal epithelium of the respiratory tract causing 
pneumonia. Symptoms range from mild, self-limiting disease to severe forms. C. 
 - 11 - 
Introduction 
pneumoniae is also associated with the chronic diseases arthritis and atherosclerosis 
(Burillo and Bouza, 2010; Gérard, et al., 2010; Blasi, et al., 2009).  
The other species of the Chlamydiaceae infect animals (compare Fig. 1.1) but have the 
potential of zoonotic infections. Especially Chlamydophila psittaci, which naturally resides 
in birds, can cause pneumonia in humans. The disease in humans is called psittacosis or 
ornithosis (Gregory and Schaffner, 1997). Other bacteria of this family are agents of 
infertility and abortion, which in sheep, goats, cattle and swine are caused by 
Chlamydophila abortus, Chlamydophila pecorum and Chlamydia suis (Mohamad and 
Rodolakis, 2010; Nietfeld, 2001; Hoelzle, et al., 2000). Chlamydia muridarum is an agent 
of pneumonia and infertility in mice (Swenson and Schachter, 1984; Woodland, et al., 
1983), while Chlamydophila felis and Chlamydophila caviae are associated with 
conjunctivitis in cats and guinea pigs, respectively (Hartmann, et al., 2010; Helps, et al., 
2005; Lutz-Wohlgroth, et al., 2006). 
 
1.2.3 Effects of chlamydiae on fallopian tubes   
Infection with chlamydiae is closely linked to the pathology of fallopian tubes. The highest 
risk for tubal pathology was observed in women with antibodies against C. trachomatis in 
combination with increased levels of a marker for inflammation (C-reactive protein), thus 
being a marker for persistent infection (Land and den Hartog, 2006). Antibody levels 
against Chlamydia are quantitatively related to the severity of fallopian tube damage in 
infertile women (El Hakim, et al., 2010).  
Chlamydia contributes to tubal pathology in several aspects. Chlamydial infections exert a 
cytotoxic effect on fallopian tube epithelial cells and cause tissue destruction, including 
loss of microvilli, rapture of cells and cell junctions (Cooper, et al., 1990; Hvid, et al., 
2007). The immune response following the infection is believed to lead to tissue scarring.  
Pelvic inflammatory disease (PID) is an inflammation of the genital tract ranging from the 
cervix to the fallopian tubes and ovaries. PID is caused by infection, mostly a sexually 
transmitted infection, with bacteria such as Chlamydia trachomatis or Neisseria 
gonorrhoeae (Soper, 2010). Therefore, repeated chlamydial infections are a risk factor for 
PID. Importantly, PID is linked to inflammation of fallopian tubes, which can result in 
scarring and thus chronic pelvic pain, infertility and ectopic pregnancy (Soper, 2010). 
Over 98% of all ectopic pregnancies, i.e. pregnancies outside of the uterus, are located in 
the fallopian tubes. Previous PID and damage of the fallopian tubes (e.g. by infection with 
Chlamydia trachomatis) belong to the main risk factors of ectopic pregnancy and tubal 
factor infertility (Shaw, et al., 2010; Shao, et al., 2010).  
Persistent infections by C. trachomatis are prevalent in the fallopian tube, despite 
antibiotic treatment. In addition to PID, subclinical salpingitis is very common. Today, 
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women frequently delay the wish to get pregnant in the Western world, which often 
prolongs the time until fertility problems are detected (Mårdh, 2004).  
The transport of the human egg and embryo through fallopian tubes to the uterus 
involves ciliary beating, muscle contraction and flow of tubal secretions. Ciliary activity 
seems to be central for the transport (Lyons, et al., 2006). Occlusion of the fallopian tubes 
is thought to eventually inhibit egg transport. Alterations of cilia activity or muscle 
contraction in the fallopian tube are thought to contribute to ectopic pregnancy and 
infertility by interfering with egg transport as well (Shao, et al., 2010). Inflammation, as it 
follows chlamydial infection, is associated with deciliation (Lyons, et al., 2006). 
Additionally, damage of mainly ciliated epithelial cells was reported (Hvid, et al., 2007). 
Furthermore, muscular activity can be influenced by chlamydiae, too, as infection with 
Chlamydia muridarum disrupted spontaneous contractions of fallopian tubes in a mouse 
model (Dixon, et al., 2009).  
In addition, the infection with C. trachomatis was recently reported to increase expression 
of a cell surface receptor (prokineticin receptor 2) in human fallopian tubes that is 
increased in fallopian tubes from women with ectopic pregnancy. Thereby, the infection 
could generate a microenvironment susceptible for ectopic implantation (Shaw, et al., 
2011).  
Many ovarian and peritoneal carcinomas originate in the fallopian tubes (Seidman, et al., 
2010). Chronic inflammation was shown to be associated with carcinogenesis in some 
tissues and a source for chronic inflammation of the fallopian tubes is infection with 
Chlamydia trachomatis. The probability of having ovarian cancer was reported to be 
increased in women with high antibody levels against chlamydial elementary bodies 
(Ness, et al., 2003). Based on the study by Ness, et al., Carvalho and Carvalho (2008) 
hypothesized that fallopian tube infection with C. trachomatis and associated chronic 
inflammation may be involved in fallopian tube carcinogenesis that is thought to 
contribute to some ovarian cancers. 
 
1.3 Chlamydiae and apoptosis 
One of the hallmarks of chlamydial infection observed in cell culture is inhibition of 
apoptosis, presumably to assure intracellular replication. Therefore, chlamydial strains 
were compared in this study regarding their influence on apoptosis.  
Apoptosis is a form of programmed cell death. The controlled deletion of cells is an 
important mechanism of cell turnover in tissue homeostasis and during embryonic 
development. Apoptosis is characterized by distinct morphological changes within the 
cell: condensation of the nucleus, cell shrinkage, nuclear fragmentation, and budding of 
apoptotic vesicles from the cell surface. These apoptotic bodies contain all nuclear and 
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cytoplasmic components with the organelles being tightly packed but intact. No cellular 
components are released into the extracellular environment. Apoptotic bodies are 
phagocytosed by macrophages, parenchymal cells or epithelial cells, and degraded (Kerr, 
et al., 1972; Monks, et al., 2005). 
 
1.3.1 Apoptotic pathways 
Different pathways of apoptosis induction are known. Mainly the intrinsic pathway via 
mitochondria and the extrinsic pathway triggered by extracellular signals via a cell surface 
receptor are involved. In addition, apoptosis can be initiated by cytotoxic T-cells. Various 
effector proteins, activators and inhibitors of apoptosis are known. The balance between 
pro- and anti-apoptotic proteins within the cell can determine the cell’s fate (Sharma and 
Rudel, 2009).  
The key effector proteins of apoptosis are cysteine-dependent aspartate-specific 
proteases (caspases). These proteases are produced as inactive zymogens and 
activated by autocatalysis or cleavage by other caspases. In response to pro-apoptotic 
signals the caspase cascade is activated, including the key effector caspase-3, and 
irreversibly leads to cell death. Cell disassembly by caspases is achieved through 
inactivation of inhibitors of apoptosis (e.g. Bcl-2 proteins), cleavage of cell structures (e.g. 
the nuclear lamina or cytoskeleton components such as cytokeratin-18) and deregulation 
of protein activity by cleavage (Schutte, et al., 2004; Thornberry and Lazebnik, 1998; 
Cohen, 1997).  
Another cellular component involved in the apoptotic pathways is the mitochondria. 
Permeabilization of the mitochondrial membrane is a pro-apoptotic step and releases 
cytochrome c for the downstream activation of the caspase cascade. The pro-apoptotic 
BH3-only proteins lead to this permeabilization (Sharma and Rudel, 2009; Adams and 
Corey, 1998).  
As caspase activation irreversibly leads to cell death, it must be strictly regulated. The 
inhibitor of apoptosis proteins (IAPs) are able to directly bind and inhibit some of the 
caspases (Huang, et al., 2001; Deveraux, et al., 1997). Proteins of the Bcl-2 family 
promote cell survival by interacting with and inhibiting proteins required for 
permeabilization of the mitochondrial membranes (Adams and Corey, 1998). 
 
1.3.2 Influence of chlamydiae on apoptosis 
Apoptosis plays a role in protection against pathogens. It eliminates the infected cell and 
as all intracellular content of the dying cell is present in the apoptotic bodies, microbial 
antigens are transported to uninfected antigen-presenting cells. Obligate intracellular 
pathogens, such as Chlamydia and Rickettsia, therefore need to block apoptosis in order 
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to replicate inside the host cell and to circumvent immune recognition (Böhme and Rudel, 
2009; Sharma and Rudel, 2009).  
Chlamydiae are widely described to inhibit apoptosis within their host cells (Böhme, et al., 
2010; Häcker, et al., 2006; Rajalingam, et al., 2001). Apoptosis resistance has been 
reported for all major chlamydial species, including Chlamydophila pneumoniae and 
Chlamydia trachomatis (Sharma and Rudel, 2009). An initial study showed that only 
infected cells were protected (Rajalingam, et al., 2001).  
Chlamydiae were shown to block the mitochondrial permeabilization and cytochrom c 
release by degrading the pro-apoptotic BH3-only proteins. This in turn inhibits the 
activation of the downstream caspases, including caspase-3 (Pirbhai, et al., 2006; Ying, 
et al., 2005; Fischer, et al., 2004; Fan, et al., 1998). Additionally, anti-apoptotic proteins of 
the Bcl-2 family (e.g. Mcl-1) are upregulated (Hess, et al., 2001). Chlamydiae also 
interfere with the apoptosis pathways downstream of mitochondria. Some inhibitor of 
apoptosis proteins (IAPs) are upregulated in cells infected with chlamydiae, other IAPs 
are stabilized, leading to inhibition of caspase-3 (Rajalingam, et al., 2006; Hess, et al., 
2001).  
In case of Chlamydia trachomatis, studies were mainly performed with the serovar L2, 
which is a widely used laboratory strain, or in some studies with ocular serovars (Böhme, 
et al., 2010; Rajalingam, et al., 2006; Ying, et al., 2005; Fischer, et al., 2004; Fan, et al., 
1998). Apoptosis resistance of cells infected with Clamydiae is thought to play a role in 
establishing long-term interactions and persistence, which is associated with chronic 
infections (Byrne and Ojcius, 2004).  
Chlamydiae were described to act pro-apoptotically in the late stages of the infection 
cycle prior to escape from the host cells. In addition, some reports describe cell death 
induced by chlamydiae, which was, however, later characterized to be different from 
apoptosis (Sharma and Rudel, 2009; Byrne and Ojcius, 2004). 
 
1.4 Primary cells and tissue 
Chlamydiae infect the urogenital tract and can cause infertility in woman (see chapter 
1.2). Various model systems exist to study these infections. However, they can not 
completely simulate the complex situation of the primary tissue within organs and might 
lack important factors present in vivo. As primary cells and tissue of the human fallopian 
tube (FT) are targets of chlamydial infection, primary FT cells and FT ex vivo tissue 
culture were used in this study.  
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1.4.1 Anatomy of the female genital tract 
The female reproductive tract contains pairs of ovary and fallopian tube (also named 
oviduct or tuba uterina). The ovary containing the egg cells is in close proximity to the 
fallopian tube, which connects to the uterus and performs the task of transporting the egg 
into it (Fig. 1.3).  
 
 
Fig. 1.3: Anatomy of the human female genital tract. The fallopian tube connects the ovary with 
the uterus. The ovary is held in place by the utero-ovarian ligament. The cervix protrudes into the 
vagina. The fallopian tube consists of four segments, which differ in width and extent of mucosal 
folds: the infundibulum, the ampulla, the isthmus and the pars uterina. For further description see 
text. 
 
The fallopian tube comprises distinct regions varying in their structure. The infundibulum 
is a cone-like structure with fimbriae and an opening towards the ovary. It absorbs the 
egg. The ampulla is the longest part of the tube and the one with the largest lumen. The 
mucous inner layer, the mucosa, forms multiple folds in the ampullary region (Fig. 1.4). 
The following part, the isthmus, is located close to the uterus and has a narrowed lumen 
(Fig. 1.5). The mucosal folds are reduced, and muscle layers are thicker than in the 
previous parts. The opening into the uterus lumen runs inside the uterus wall and is 
named pars uterina (or pars uterina tubae uterinae). The endometrium is the mucosa 
(see below) of the uterus. The neck of the uterus, the cervix, protrudes into the vagina 
(Nasu and Narahara, 2010; Saksouk and Johnson, 2004; Bucher and Wartenberg, 1997). 
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Fig. 1.4: Transversal section through the ampullary region of a fallopian tube. Ampullary 
region of a 20-year-old woman. Extensive mucosal folds protrude into the lumen of the tube; the 
tubal musculature contains blood vessels; subperitoneal musculature surrounds the tube and is 
encircled by the tunica serosa (lining of the abdominal cavity). Drawing of hematoxillin-eosin 
staining. From Bucher and Wartenberg, 1997. 
 
 
Fig. 1.5: Transversal section through the isthmus of a fallopian tube. Isthmic region near 
the uterus of a 44-year-old woman. Simple columnar epithelium lines the lumen of the tube; 
the extent of mucosal folds is reduced; circular and longitudinal musculature, the two 
layers of tubal musculature, form thick layers. Drawing of hematoxillin-eosin staining. From 
Bucher and Wartenberg, 1997. 
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1.4.2 Epithelia and endothelia 
Epithelia are the cell layers lining all surfaces of the body. This includes the inner surfaces 
of organs, the internal body cavities and the mammalian skin. Epithelial cells are in close 
proximity to each other and form a closed cell layer. The basement membrane, a thin 
fibrous layer beneath the epithelial cells, anchors the basal side of the epithelium to the 
underlying connective tissue. The apical side of the cells faces the lumen of an organ, a 
body cavity or the environment (in case of skin). In addition, a specialised type of 
epithelium exits, named endothelium, which lines the inner surfaces of blood and lymph 
vessels (Bucher and Wartenberg, 1997).  
Classification of epithelia is based on cell shape and number of layers. Single-layer 
epithelium is termed simple, whereas epithelium consisting of two or more cell layers is 
named stratified. According to the height of cells in the top layer, epithelia are classified 
as columnar (with cells taller than wide), cuboidal (with cube-like shaped cells) or 
squamous (with flattened cells) (Bucher and Wartenberg, 1997).  
The mucosa of the human fallopian tube consists of a single-layer columnar epithelium 
and the connective tissue underneath (lamina propria; also named lamina propria 
mucosae) (Fig. 1.6). Ciliated as well as non-ciliated cells are present in the epithelial layer 
(Bucher and Wartenberg, 1997). The cytoskeletal intermediate filaments cytokeratin-8 
and cytokeratin-18 are typically found in simple epithelium (Moll, 1993). 
 
 
Fig. 1.6: Mucosa of the human fallopian tube. The mucosa of the human fallopian tube consists 
of a single-layer columnar epithelium (with ciliated and non-ciliated cells) and the lamina propria 
underneath. Drawing of hematoxillin-eosin staining. From Bucher and Wartenberg, 1997. 
 
Polarized epithelial cells 
In the body, epithelial layers form a tight barrier. The cells are polarized possessing 
distinct membrane compartments with differential composition: the apical membrane (AM) 
and the baso-lateral membrane (BLM) (Fig. 1.7). Tight junctions (TJ) are the protein 
complexes responsible for barrier function. They consist among others of proteins of the 
claudin-family as well as occludin and ZO-proteins (Furuse, 2010; Marshall, et al., 2009; 
Radisky, 2005).  
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Adherens junctions mediate cell-cell-adhesion via homophilic interactions of cadherins 
(Fig. 1.7). These possess a transmembrane and a surface part. Cadherin-mediated 
contacts depend on Ca2+ interacting with the extracellular domains. E-cadherin is the form 
predominantly found in epithelial cells and VE-cadherin was described as vascular 
endothelial cadherin. The intracellular catenins connect the junctions to the actin 
cytoskeleton (Meng and Takeichi, 2009; Radisky, 2005).  
Additional proteins mediating adherence between cells are the homophilic 
transmembrane proteins EpCAM (epithelial cell adhesion molecule, CD326), which is 
specifically expressed in epithelial cells, and PECAM-1 (platelet/endothelial cell adhesion 
molecule 1, CD31) in endothelial cells (Baeuerle and Gires, 2007; Woodfin, et al., 2007). 
EpCAM was also described to interact directly with the tight junction protein claudin-7 as 
well as to antagonize cell contacts established by cadherins (Ladwein, et al., 2005; 
Litvinov, et al., 1997). The contact between the basal membrane of the epithelial cells and 
the basement membrane is mediated by a group of transmembrane proteins, the 
integrins (Radisky, 2005).  
 
 
Fig. 1.7: Tight and adherens junctions in polarized epithelial cells. For description see text. 
AJ: adherens junction; AM: apical membrane (grey); BLM: baso-lateral membrane (dark red); BM: 
basement membrane (black); N: nucleus (brown); TJ: tight junction. 
 
1.5 Immortalization of primary cells 
Isolated primary cells have a confined life span and depending on the cell type do not 
grow in cell culture in many cases. In order to generate a stock of cells growing 
continuously, cellular characteristics have to be changed. However, the least aggressive 
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approach should be used to acquire least changes in the cells. Immortalization of primary 
cells has been developed as widely-used tool. 
 
1.5.1 Immortalization and transformation 
Targeted immortalization of cells is assumed to lead to more reliable results than using 
transformed cells, as immortalization is intended to retain properties of primary cells. 
Immortalized cells possess infinite life span. Unlike transformed cells, however, other 
features of primary cells can be kept. This includes anchorage-dependent non-invasive 
growth and contact inhibition of growth. In addition, targeted immortalization aims to avoid 
tumorigenicity of cells.  
In contrast, transformation is a process, by which cells acquire infinite life span and 
anchorage-independent and invasive growth. Contacts change between cells and 
adhesion to substrate or basement membrane is disrupted. The transformed cells loose 
contact inhibition of growth and tumor formation can occur. Carcinogenic transformation 
leads to the unlimited, often invasive growth of cancer cells as well as tumor formation, 
tissue invasion and metastases. In addition, cancer cells evade apoptosis, are self-
sufficient in growth signals and insensitive to anti-growth signals. Cancer tissue sustains 
angiogenesis (Lin, et al., 2011; Lapierre, et al., 2011; Hanahan and Weinberg, 2000).  
Transformation is a multistep process that is believed to require alterations in at least 
three cellular pathways. Key tumor suppressors (such as p53 and Rb) need to be 
inactivated, cell proliferation has to be activated and cell aging connected to chromosome 
replication has to be prevented (Sun, et al., 2005; Hahn, et al., 1999).  
The tumor suppressor p53 is a transcription factor acting as master regulator, as it 
influences the expression of an array of genes. Some of these genes are involved in DNA 
damage repair pathways and induction of cell cycle arrest. p53 is activated by cellular 
stress (Menendez, et al., 2010). Other well known tumor suppressors are the 
retinoblastoma proteins (Rb), which inhibit DNA replication in resting cells. These proteins 
bind transcription factors that are needed for the activation of the DNA replication (Levine, 
2009). 
Ras proteins are involved in the regulation and activation of cell proliferation. These small 
GTPases are part of the signal transduction from cell surface receptors to several 
pathways within the cells, including the mitogen activated protein kinase (MAPK) 
pathway. Mutations can lead to permanently activated Ras, resulting in activation of cell 
proliferation and survival (Frémin and Meloche, 2010). Furthermore, Mizumoto, et al. 
(2006) demonstrated that immortalized non-tumorigenic cells with activated telomerase 
and inactivated Rb were rendered invasive and thus tumorigenic upon introduction of an 
active Ras mutant.  
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Activation of the human telomerase, which is not active in most cells of the body, can 
prevent cell aging. In absence of the telomerase activity, the telomeres at the end of the 
chromosomes are shortened during DNA replication. This process has been connected to 
cellular senescence. The activation of telomerase results in the elongation of telomeres 
and therefore antagonizes cell aging (see chapter 1.5.2). 
 
Oncogenes discovered in cancers can induce cell growth. Therefore, these oncogenes 
were used for targeted immortalization of cells. In the literature, the simultaneous usage 
of two oncogenes together is often described.  
In order to have more relevant models for the investigation of chamydial infection, cell 
lines were generated within this study. The oncoproteins used to immortalize cells in this 
study are hTERT, SV40T and Bmi1. The characteristics of these oncoproteins are 
summarized in table 1.1 and described in detail below, including their cellular functions, 
occurrence and usage for immortalization of primary cells (chapters 1.5.2, 1.5.3, and 
1.5.4). Lentivirus-mediated gene transfer of oncogenes was used in this study for the 
targeted immortalization, which is described in detail below (chapter 1.6).  
 
Tab. 1.1: Functions and reported usage of hTERT, SV40T and Bmi1. For references, see text. 
Oncoprotein Function Immortalized human cells 
hTERT  
 
(human telomerase 
reverse 
transcriptase) 
- catalytic subunit of human 
telomerase  
- elongation of telomeric repeats at 
end of chromosomes 
- prevention of progressive telomere 
shortening, a factor of senescence 
- urothelial cells 
- meibomian gland epithelial 
cells 
- esophageal epithelial cells 
- liver endothelial cells 
- muscle satellite cells 
SV40T  
 
(Simian Virus 40  
large tumor antigen) 
- inactivation of retinoblastoma 
proteins, which leads to activation 
of transcription factors and entry 
into S phase of cell cycle  
- inactivation of p53 tumor 
suppressor  
- protein necessary for the viral DNA 
replication and transcription 
- renal epithelial cells 
- mammary epithelial cells 
- bile duct epithelial cells 
- endothelial progenitor cells 
- liver endothelial cells 
- hepatocytes 
Bmi1  
 
(B lymphoma Mo-
MLV insertion region 
1) 
- transcriptional repressor  
- repression of the ink4a-locus with 
the tumor suppressor genes p16 
and p19Arf (human homolog: 
p14Arf)  
- a polycomb ring finger protein 
- required for self-renewal of adult 
stem cells 
- bronchial epithelial cells 
- nasopharyngeal epithelial 
cells 
- mammary gland epithelial 
cells 
- mammary epithelial cells 
- olfactory ensheathing glia 
- muscle satellite cells 
- hepatocytes 
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1.5.2 hTERT 
The human telomerase reverse transcriptase (hTERT) is the catalytic subunit of the 
telomerase. This enzyme elongates the telomeres at the end of the chromosomes 
through addition of a repeating pattern of six nucleotides (TTAGGG) (Morin, 1989).  
Telomerase is a ribonucleoprotein complex consiting of RNA and protein components, 
which are both required for activity. The telomerase has reverse transcriptase activity and 
uses the RNA as template. This enzyme is able to elongate the single stranded DNA of 
the telomeres which end with a 3’ DNA overhang (Greider and Blackburn, 1987; Shippen-
Lentz and Blackburn, 1990; Blackburn, et al., 1989).  
Generally, telomerase is repressed in somatic cells. This leads to telomere shortening 
during aging of cells (Harley, et al., 1990). Thus, telomere expression is a factor of cellular 
senescence. Deregulation of telomerase expression may play a role in oncogenesis as 
telomerase is reactivated in most advanced cancers (Artandi and DePinho, 2010). 
Telomerase activity was detected in approx. 87 % of ovarian epithelial cancers and 
hTERT was significantly stronger expressed in renal cell carcinoma compared to the 
adjacent tissues (Zhang F, et al., 2008; Wu, et al., 2008). hTERT expression is also 
upregulated in cervical and gastric cancer (Xi, et al., 2005; Jong, et al., 1999; Gigek at al., 
2009). 
As hTERT expression is rate-limiting for telomerase activity, inserting the hTERT 
oncogene into primary cells has been widely used for cellular immortalization. Successful 
immortalization was reported e.g. for human urothelial cells, human meibomian gland 
epithelial cells, a human esophageal epithelial cell line, human liver endothelial cells and 
human muscle satellite cells (Chapman, et al., 2008; Liu, et al., 2010; Cheung, et al., 
2010; Matsumura, et al., 2004; Cudré-Mauroux, et al., 2003). Usage of hTERT led to cell 
lines with long-term genotypic and phenotypic stability, nearly-diploid and non-tumorigenic 
cells, with only sometimes genetic and genomic alterations found (Cudré-Mauroux, et al., 
2003; Cheung, et al., 2010). 
 
1.5.3 SV40T 
The Simian Virus 40 large tumor antigen (SV40T) is a viral protein from Simian Virus 40, 
a non-enveloped dsDNA virus of the polyomavirus group. SV40T is expressed early in the 
viral lifecycle. It binds to the viral origin of replication and is required for the initiation of 
replication and for transcription of the viral DNA (Fanning and Zhao, 2009).  
In the host cells, SV40T additionally binds to and inactivates the retinoblastoma (Rb) 
proteins. This interaction eliminates Rb-E2F repressive complexes and activates 
transcription factors including E2F and thereby finally leads to entry of the cells into the 
cell cycle phase of DNA synthesis (S phase). This is necessary for the virus to replicate 
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its own DNA. SV40T also binds to and inactivates the p53 tumor suppressor (Levine 
2009; Cantalupo, et al., 2009; Sáenz-Robles, et al., 2007). In addition, SV40T can inhibit 
apoptosis (Yu and Alwine, 2002).  
The SV40T mediated gene regulation was shown to be primarily exerted through and 
dependent on the binding to Rb proteins (Rathi, et al., 2009). SV40T induces tumors in 
animals and can transform many types of cells in culture (Butel and Lednicky, 1999). 
Among these are human renal epithelial cells, human mammary epithelial cells, human 
cholangiocytes, which are epithelial cells of the bile duct, as well as human endothelial 
progenitor cells, human liver endothelial cells and human hepatocytes (Kowolik et al, 
2004; Garbe, et al., 1999; Maruyama, et al., 2004; Qiu, et al., 2006; Matsumura, et al., 
2004; Nguyen, et al., 2005).  
SV40T was reported to be very efficient for growth induction of cells, but led to 
chromosomal aberrations and strong phenotypic changes (Cudré-Mauroux, et al., 2003). 
SV40T induced chromosomal instability was reported to induce a variety of chromosomal 
aberrations, the most frequently observed being dicentric chromosomes (chromosomes 
with two centromeres) and also tetraploidy (Hein, et al., 2009; Ray, et al., 1992). 
 
1.5.4 Bmi1 
The B lymphoma Moloney Murine Leukemia Virus insertion region 1 (Bmi1) was first 
identified as an oncogene that is involved in the formation of mouse lymphomas (van 
Lohuizen, et al., 1991). A homologous gene exists in humans. Bmi1 has a regulatory role 
in cell cycle and senescence and is a transcriptional repressor. It targets the ink4a-locus, 
which encodes the tumor suppressors p16 and p19Arf (murine protein; p14Arf is the 
human homolog). Therefore, Bmi1 expression leads to the downregulation of the ink4a-
locus (Jacobs, et al., 1999).  
The mechanisms of Bmi1 action involve epigenetic silencing via histone modifications. As 
a member of the polycomb repressive complex 1 (PRC1) Bmi1 is located at the ink4a-
locus together with other polycomb group proteins in young proliferating cells. The locus 
is silenced through histone H3 methylation. In contrast, in senescent cells a histone 
demethylase is expressed and recruited. The polycomb proteins dissociate from the 
locus, which then is transcriptionally active. The repression exerted by Bmi1 requires 
direct association with the locus (Agherbi, et al., 2009; Bracken, et al., 2007). Additionally, 
Bmi1 expression was reported to induce hTERT activity in immortalized cell lines (Song, 
et al., 2006; Dimri, et al., 2002).  
Bmi1 deficient mouse embryonic fibroblasts are impaired in the progression into S phase 
of the cell cycle and prematurely enter senescence (Jacobs, et al., 1999). Bmi1 is 
required for the self-renewal of adult haematopoietic stem cells and plays an important 
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role for the regulation of proliferation of stem and progenitor cells (Park, et al., 2003; 
Lessard and Sauvageau, 2003).  
Bmi1 is upregulated in many cancers, e.g. ovarian cancer and gastric cancer and its 
misregulation has also been implicated in the development of some types of lung cancer 
(Yang, et al., 2010; Zhang, et al., 2008; Zhang, et al., 2010; Vonlanthen, et al., 2001). 
Strong Bmi1 expression could be correlated with advanced tumor stages or shortened 
patient survival in ovarian and gastric cancers (Yang, et al., 2010; Zhang, et al., 2010).  
Bmi1 was described for the immortalization of various cells including human bronchial 
epithelial cell lines, human nasopharyngeal epithelial cells, human mammary gland 
epithelial cells and human mammary epithelial cells (Fulcher, et al., 2009; Song, et al., 
2006; Haga, et al., 2007; Dimri, et al., 2002). In addition, Bmi1 was used for generation of 
cell lines of human olfactory ensheathing glia, human muscle satellite cells and human 
hepatocytes. Overexpression of Bmi1 was also reported to immortalize fibroblasts 
(García-Escudero, et al., 2010; Cudré-Mauroux, et al., 2003; Nguyen, et al., 2005; 
Jacobs, et al., 1999).  Immortalization of human muscle satellite cells with Bmi1 together 
with hTERT led to a cell line with long-term genotypic and phenotypic stability (Cudré-
Mauroux, et al., 2003). 
 
1.6 Lentiviruses 
In this study, we wanted to use lentivirus-mediated transfer of oncogenes for the 
immortalization of primary cells to generate new cell lines. The lentiviral plasmid system 
used in this work is based on HIV-1. Therefore, structure and replication of the lentivirus 
HIV-1 are introduced.  
Lentiviruses belong to the family of retroviruses, which mainly infect vertebrates and 
cause various symptoms, including tumors and immunodeficiencies. Retroviruses contain 
an RNA-genome and were named after their enzyme “reverse transcriptase”, which can 
transcribe RNA into double-stranded DNA. The human immunodeficiency virus (HIV) is a 
human pathogenic lentivirus (Modrow, et al., 2010). 
 
1.6.1 Structure of lentiviruses 
Lentiviral particles consist of a capsid surrounded by a coating membrane, which is 
derived from the cytoplasma membrane of the host cell. The structure of HIV-1 is shown 
as example (Fig. 1.8). The viral glycoproteins (the external glycoprotein gp120 and the 
transmembrane protein gp41) are associated with the coating membrane. The matrix 
proteins are associated with the inner side of the coating membrane and form a net-like 
protein layer. The viral capsid, also termed the viral core, is located inside the viral 
particle. Its outer layer is formed by the capsid proteins. The capsid contains two identical  
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Fig. 1.8: Structure of HIV-1. For description see text. After: Ganser-Pornillos, et al., 2008; 
Modrow, et al., 2010. 
 
copies of a single-stranded RNA genome. The nucleocapsid proteins form a complex with 
the RNA genome. In addition, the viral enzymes integrase, reverse transcriptase and 
protease are located within the capsid (Ganser-Pornillos, et al., 2008; Modrow, et al., 
2010).  
The genomes of all retroviruses code for three major precursor protein products: Gag 
(group specific antigens – matrix, capsid, and nucleocapsid), Pol (enzymatic activities) 
and Env (envelope glycoproteins). The 5’- and 3’-ends of the coding region are flanked by 
regulatory sequences required for reverse transcription as well as integration into the 
host’s genome (Modrow, et al., 2010). 
 
1.6.2 Replication cycle of lentiviruses 
The extracellular glycoprotein mediates adsorption of the viral particle to the host cell. In 
case of HIV-1, gp120 binds to CD4, which is expressed on the cell surface of immune 
cells such as T helper cells and macrophages (Modrow, et al., 2010).  
The viral and cell membranes fuse. The capsid and its content are the parts of the virus 
that are released into the cytoplasm of new host cells upon infection. The capsid uncoats 
to release its content and reverse transcription of the viral RNA into double-stranded DNA 
takes place (a complex mechanism reviewed in Haseltine, 1991). The proviral DNA is 
trafficked to the nucleus and integrates into the host cell’s genome by action of the viral 
integrase. The integrated virus is called provirus (Ganser-Pornillos, et al., 2008; Modrow, 
et al., 2010).  
The integrated provirus carries identical sequences at the ends, which are generated 
during reverse transcription of the viral RNA into double-stranded DNA. These sequences 
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are termed long terminal repeats (LTR) and flank the viral genes in the same orientation 
at both sides (Modrow, et al., 2010).  
The proviral DNA is transcribed in the host nucleus and translated in the cytoplasm. New 
copies of the viral RNA genome as well as the viral proteins are generated. The protein 
and RNA components assemble at the cytoplasma membrane and form immature viral 
particles budding from the cell (Modrow, et al., 2010). The structural proteins of the HIV-1 
virus are derived from the Gag-polyprotein, which is cleaved during virus assembly by the 
viral protease. The newly cleaved proteins rearrange to form the mature infective virus 
particle (Ganser-Pornillos, et al., 2008). 
 
1.6.3 Lentiviruses as vectors for genetic transfer 
Various viral vector systems are used to transfer genetic material into target cells. 
Lentiviral vectors, oncoretroviral vectors, adeno-associated virus (AAV) vectors and 
adenovirus vectors are used for the development of treatment for hereditary disorders. 
Advantages and disadvantages of the different vector systems for gene transfer are 
summarized in table 1.2 (O’Connor and Crystal, 2006). 
In this study, a lentiviral system was used. Among the advantages of lentivector systems 
are integration of the transferred genetic material into the chromosome of the target cells, 
a requirement for long term gene expression, and a relatively large capacity (8-10 kb). In 
contrast to conventional retroviral vectors (oncoretroviruses), which can only transduce 
dividing cells, lentiviruses can infect dividing as well as non-dividing cells. Additionally, the 
genetic information expressing viral structural proteins is not transferred, thus these viral 
proteins are not made in the host and attack of vector-transduced cells by the immune 
 
Tab. 1.2: Advantages and disadvantages of viral gene transfer systems. For references, see 
text. 
Viral system Advantages Disadvantages 
Lentiviral 
vector 
- long term expression: gene 
integration 
- transduction of non-dividing cells 
- risk of insertional mutagenesis 
- human pathogens 
Onco-
retroviral 
vector 
- long term expression: gene 
integration 
- non-human origin 
- only transduction of dividing cells 
- risk of insertional mutagenesis 
AAV vector - non-pathogenic 
- transduction of non-dividing cells 
- no mandatory integration 
- limited transgene size 
Adenovirus 
vector 
- high cloning capacity - transient expression 
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system is unlikely. However, as lentiviral vectors integrate into the target genome, there is 
a risk of insertional mutagenesis. Lentiviruses are human pathogens, requiring additional 
safety considerations leading to replication-incompetent viral particles (see below) 
(O’Connor and Crystal, 2006; Salmon and Trono, 2006; http://tronolab.epfl.ch/).  
The lentiviral vector system used in this study is derived from HIV-1 genome and was 
generated in the laboratory of Didier Trono. For safety reasons the formation of 
replication-competent viral particles has to be prevented. Therefore, all required 
sequences are distributed on as many independent units as possible. Unneeded 
regulatory or coding sequences are deleted from the viral genome. In the system used 
here the information for the viral enzymes and inner structural proteins, the envelope 
protein and the genetic information of the target genes, which will be transferred, is 
separated on three plasmids. Replication-competent viral particles could only occur by 
multiple recombinations. The system is designed in the way that only the target genes 
and flanking regulatory sequences enter the infected cells, without any genetic 
information for the viral  enzymes and structural proteins. Thus, the infectious particles 
can integrate once into the host genome, but not replicate (Salmon and Trono, 2006).  
The HIV-1 envelope protein can be exchanged in this system with the analogous protein 
of another virus. The exchange is called pseudotyping and alters the tropism of the viral 
particle. Frequently, the envelope glycoprotein G-protein of vesicular stomatitis virus 
(VSV-G) is used due to its high stability and broad tropism. VSV-G binds to membrane 
phospholipids ubiquitously expressed in mammalian cells (Salmon and Trono, 2006; 
Mastromarino, et al., 1987).  
Lentivectors are not only used for gene therapy, but also for immortalization of primary 
cells. They are especially useful, because isolated primary cell populations do not always 
grow and the lentivectors are able to transduce specific genes into non-dividing as well as 
dividing cells (Fulcher, et al., 2009; Nguyen, et al., 2005; Cudré-Mauroux, et al., 2003; 
Salmon, et al., 2000).  
The lentiviral plasmid is transcribed and integrated in the same way as described for 
lentiviruses (see above). The plasmid encoding the target gene to be transferred is 
transfected into producer cells and transcribed into the genomic viral RNA (Fig. 1.9). 
Together with the structural and enzymatic components generated from two additionally 
transfected plasmids this RNA forms the lentivector particles. Once the lentivector 
particles infected new target cells, reverse transcription takes place inside the target cells 
and the provirus integrates (Salmon, et al., 2000).  
We used a specialized lentiviral system containing the Cre-lox-system. Thereby, this 
lentiviral system comprises the possibility to excise the integrated target gene from the 
host chromosomes. For this purpose, a lox-sequence is located on the lentiviral plasmid. 
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The lox-sequence is a DNA element recognized by the recombinase Cre. As the 
sequence at one end of the genomic viral RNA gets duplicated during reverse 
transcription, the two lox-sequences flank the integrated target gene (Fig. 1.9). Cre 
mediates recombination between these sites leaving a viral LTR sequence in the host 
genome. The Cre-lox-system was reported to function efficiently (Kowolik, et al., 2004; 
Salmon, et al., 2000; Westerman and Leboulch, 1996).  
During excision of the transferred construct by Cre, the viral thymidine kinase of Herpes 
Simplex Virus type 1 (HSV-1 TK) is used as suicide gene for negative selection. HSV-1 
TK converts a nucleoside analogon (e.g. ganciclovir) to phosphorylated nucleotides. Their 
incorporation into the DNA blocks replication. Thus, cells still carrying the construct are 
sensitive to ganciclovir and die (Salmon, et al., 2000; Caruso, 1996). 
 
 
 
Fig. 1.9: Schematic diagram of the lentivector replication cycle. For description see text. LTR: 
long terminal repeat; R: regulatory elements; TK: HSV-1 thymidine kinase; lox: lox-sequence. After: 
Salmon, et al., 2000. 
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1.7 Objective 
Infections caused by chlamydiae can induce several severe diseases in the human 
population, including blindness, infertility and pneumonia. So far, the widely used infection 
models comprise cancer-derived cell lines in culture. These simplified models are useful 
for analysis of single factors in host-pathogen-interaction, but neither represent the 
primary state of a cell nor the complex infection situation in vivo involving multiple cell 
types.  
The aim of this work was to establish new model systems based on human primary cells 
and tissue culture to investigate chlamydial infections in a context approximating the in 
vivo situation. Primary human cells should be subjected to reversible immortalization by 
lentivirus-mediated gene transfer in order to generate stable cell stocks. At the same time, 
reversion of the immortalizing factor would allow to work in cells similar to the primary 
cells. Epithelial cells from the fallopian tube and endothelial cells from the umbilical vein 
can serve as model systems for chlamydiae. As neither a reversibly immortalized 
fallopian tube cell line nor commercially available primary fallopian tube cells existed, 
establishing of cell isolation and culture should be part of this work prior to immortalization 
of the primary cells.  
As no cell culture model system simulates the complex structure of primary tissues, a 
second model should be established by directly using ex vivo fallopian tube tissue culture. 
The tissue culture should be implemented for analysis of the course of infection with 
Chlamydia trachomatis including changes occurring within the infected epithelium. In 
addition, Chlamydia trachomatis serovars causing diverse diseases should be analyzed 
for differences in their effects on the host cells. 
Materials and methods 
2 Materials and methods 
2.1 Materials 
2.1.1 Primary tissue 
Primary healthy human fallopian tube (FT) tissue was obtained from the Clinics for 
Obstetrics and Gynecology, Campus Virchow-Klinikum and Campus Mitte, at Charité 
University Hospital, Berlin, Germany, kindly provided by Dr. Christina Fotopoulou and Dr. 
Kati Hasenbein, with given consent of patients. Material transfer and experimental usage 
were approved by the ethics commission of the Charité University Hospital (application 
no. EA1/002/07).  
Human umbilical cords were obtained shortly after childbirth from Clinics for Obstetrics 
and Gynecology, Campus Virchow-Klinikum and Campus Charité Mitte, at Charité 
University Hospital, Berlin, Germany, kindly provided by Dr. Silke Michaelis (presently 
Campus Benjamin Franklin) and Dr. Gabriele Gossing after given consent of patients. 
 
2.1.2 Cell lines and primary cells 
Tab. 2.1: Description of cell lines and primary cells. 
Cells  Source and media 
End1 cells End1/E6E7, human epithelial endocervical cells, originated from primary 
cells via HPV16 E6E7 immortalization (ATCC, no. CRL-2615), cultivated in 
DMEM medium 
FT cells human fallopian tube cells, primary and immortalized cells (this study), 
cultivated in MEM-Earl`s medium 
Hela229 cells human epithelial cells, originated from cervix carcinoma (ATCC, no. CCL-
2.1), cultivated in RPMI-1640 medium 
Hela05 cells human epithelial cells, originated from cervix carcinoma (DSMZ, no. ACC57; 
obtained from ATCC, no. CCL-2), cultivated in RPMI-1640 medium 
HUVEC cells human umbilical vein endothelial cells, primary and immortalized cells (this 
study), cultivated in ECGM medium 
T84 cells human colon epithelial cells, derived from lung metastasis of colon cancer 
(ATCC, no. CCL-248), cultivated in DMEM/Ham’s F12 medium  
TMNK-1 cells human liver endothelial cell line, immortalized via hTERT and SV40T 
(Matsumura, et al., 2004), cultivated in DMEM medium, kindly provided by 
Dr. Naoya Kobayashi (Okayama University, Japan) 
293T cells human embryonic kidney cells (HEK 293T, ATCC, no. CRL-11268), 
cultivated in DMEM II medium 
 
2.1.3 Bacteria 
Chlamydia trachomatis Lymphogranuloma venereum (LGV) serovar L2 (ATCC, VR-902B) 
Chlamydia trachomatis serovar D (ATCC, VR-885)  
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2.1.4 Cell culture media, supplements and buffers 
Tab. 2.2: Basal media. 
Medium Description  
RPMI-1640 with HEPES (Gibco-Invitrogen, no. 52400-041), supplemented with 2 
mM L-glutamine 
DMEM Dulbecco`s minimal essential medium (Gibco-Invitrogen, no. 10938-
025), supplemented with 2 mM L-glutamine and 1 mM Na-pyruvate  
DMEM II DMEM as above, but without Na-pyruvate  
DMEM/Ham`s F12 DMEM and Ham`s F12 mixed 1:1 (Gibco-Invitrogen, no. 31330-038) 
MEM-Earl`s Minimal essential medium with Earl`s salts (Gibco-Invitrogen, no. 
31095-029), supplemented with 2 mM L-glutamine and 20 mM HEPES 
ECGM Endothelial cell growth medium (PromoCell, basal medium no. C-
22210, supplement pack no. C-39210), supplemented with 20 mM 
HEPES 
 
Growth media:  
RPMI, DMEM, DMEM II, DMEM/Ham`s F12 and MEM-Earl`s complete growth media 
were supplemented with 10 % heat inactivated fetal calf serum (FCS). Low-serum ECGM 
medium contained 2 % FCS.  
 
Infection media:  
Infection medium for C. trachomatis infection (RPMI for Hela cells, FT cells and FT tissue 
culture, DMEM for End1 cells) was supplemented with 5 % FCS.  
 
Tab. 2.3: Cell culture buffers and reagents. 
Name Company 
Phosphate buffered saline (PBS)   Gibco-invitrogen, no. 14190-169 (without Ca, Mg) 
Trypsin/EDTA, 0.05 % Gibco-Invitrogen, no. 25300-096, 0.05 % trypsin  
Trypsin/EDTA, 0.25 % Gibco-Invitrogen, no. 25200-056, 0.25 % trypsin  
TripLE Express Invitrogen, no. 12605-010 
Trypsin inhibitor Sigma, no. T6414 
Accutase Sigma, no. A6964  
Collagenase Biochrom, no. C2-28 
HEPES Gibco-Invitrogen, no. 15630080 
L-glutamine Invitrogen, no. 25030-024  
Na-pyruvate Sigma, no. 8636  
Fetal calf serum (FCS) Biochrom, no. S0115  
HBSS (+Ca,Mg) Gibco-Invitrogen, no. 14025-076   
Gelatine Sigma, no.G1393 
Penicillin G Sigma, no. PENNA-1MU  
Streptomycin Sulfate Sigma, no. S6501 
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2.1.5 Chemicals and reagents 
If not stated otherwise, chemicals and reagents were bought from Roth, Sigma-Aldrich or 
Merck. 
 
Tab. 2.4: Additional chemicals and reagents. 
Chemical / reagent Company 
BSA Biomol, no. 01400 
DPX mountaint for histology  Fluka, no. 44581 
DRAQ 5 Alexis, no. BOS-889-001-R200 
Ganciclovir Calbiochem, no. 345700 
Hoechst Sigma, B2261 
Target retrieval solution Dako, no. S1699 
TritonX-100 Calbiochem, no. 648 466 
 
2.1.6 Buffers and solutions 
Tab. 2.5: Composition of buffers and solutions. 
Buffer / solution Composition 
Blocking / permea-
bilisation solution  
0.1 % TritionX-100 and 0.2 % BSA in PBS  
(for staining of cells)  
IFF blocking buffer  PBS + 1% BSA + 2% FCS, filter through 0.2 µm filter  
(for staining of tissue)  
2x HBS 50mM HEPES 
280mM NaCl  
1,5mM Na2HPO4  
adjust pH to 7.00 (± 0.05) with NaOH, exakt! Sterile filter (0.22 µm), store 
at 4 °C or -20 °C  
Mowiol 2.4 g Mowiol 40-88 
6 g Glycerin 
6 ml H2O; swell overnight 
12 ml 0.2 M Tris pH 8,5 
stir and heat to 60°C, centrifuge at 4000 min-1, aliquot 
PBS 0.2 g KCl 
0.2 g KH2PO4 
8 g NaCl 
2.16 g Na2HPO4 
ad 1 l H2O 
PFA (para-form-
aldehyde)  
40 g PFA (for 8 % stock) dissolved by heating in warm 400 ml PBS 
(turbid solution), use NaOH to clarify  
ad 500 ml PBS, adjust pH to 7.5, stock aliquots -20ºC  
SPG-buffer 75 g Sucrose 
0.52 g KH2PO4 
1.22 g Na2HPO4  
0.72 g L-glutamic acid  
ad 1 l distilled H2O, adjust to pH 7.4, sterile-filter, stored at 4°C 
LB-medium 10 g Bacto-Trypton (Difco) 
5 g yeast extracts (Difco)  
10 g NaCl  
ad 1 l H2O, pH 7.5  
100 μg ampicillin per ml media for bacterial selection  
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2.1.7 Antibodies 
Tab. 2.6: Primary antibodies. Antibodies (including labelled primary antibodies) used for 
immunofluorescence staining of cells or tissue sections. 
Antibody Species Company Dilution 
anti-acetylated tubulin  mouse Sigma, no. T7451  1: 100 (tissue) 
anti-ß-catenin rabbit Sigma, no. C2206 1: 50 (tissue) 
anti-ß-catenin  rabbit Abcam, no. 2365 1: 50 (tissue)  
anti-C. trachomatis  goat AbD Serotec, no. 1990-0804 1:25-1: 50 
(tissue) 
anti-C. trachomatis L2 
MOMP 
mouse University of Washington, no. KK12 1:5000 (cells) 
anti-cytokeratin-8 mouse Santa Cruz, sc-8020 1:100 (cells) 
1:100 (tissue) 
anti-E-cadherin rabbit  Cell Signaling, #3195  1:80 (cells) 
anti E-cadherin  mouse BD Transduction Laboratories, no. 
610181 
1:200 (tissue)  
anti-EpCAM mouse Cell Signaling, no. 2929 1:80 (cells) 
anti-chlamydial HtrA rabbit selfmade (Dr. Mirjana Kessler) 1:400 (cells) 
anti-cleaved caspase 3  rabbit Cell Signaling, no. 9664 1: 100 (tissue)  
anti-LPS  rabbit Milan, no. D183.1903  1:70 (cells) 
1:150 (tissue) 
anti-N-cadherin  rabbit Abcam, ab18203 1:80 (cells)  
anti-occludin  mouse Invitrogen, no. 33-1500 1:100 (tissue) 
anti-Oct4 mouse Sigma, no. P0082   1:133 (cells) 
anti-PECAM-1 mouse R&D Systems, no. BBA7 1:50 (cells) 
M30 CytoDeath (anti-  
cleaved cytokeratin-18)  
mouse Peviva, no. 10700 1:100 (cells)  
1:100 (tissue)  
FITC-anti-CD44 mouse BD Pharmingen, no. 555478 1:150  (cells) 
Alexa488-anti-Gfp  mouse Santa Cruz, sc-9996 1:50 (cells) 
 
Tab. 2.7: Secondary antibodies. Fluorescently labelled secondary antibodies used for 
immunofluorescence stainings. Dilution 1:200 for all applications. 
Antibody Company 
Alexa 488- anti-mouse Molecular Probes  
Cy2-, Cy5- anti-mouse  Jackson Immuno Research 
Cy3-, Cy5- anti-rabbit  Jackson Immuno Research 
Cy2-, Cy3- anti-goat  Jackson Immuno Research 
 
2.1.8 Primers 
Tab. 2.8: Primers for RT-PCR. Primers used for oncogene detection via RT-PCR.  
Target gene Primer  Sequence  
HTERT forward ACGGCGACATGGAGAACAA 
 reverse CACTGTCTTCCGCAAGTTCAC 
SV40T forward CAGGCATAGAGTGTCTGC 
 reverse CAACAGCCTGTTGGCATATG 
BMI1 forward TTGGAGACCAGCAAGTATTGTC 
 reverse CGGGTGAGCTGCATAAAAATCT 
GAPDH forward GGTATCGTGGAAGGACTCATGAC 
 reverse ATGCCAGTGAGCTTCCCGTTCAG 
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Tab. 2.9: Primers for qPCR virus titration. Primers bind to indicated positions in plasmid 
pHRgfpLOX; the binding region sequence is identical in plasmids pLOX-TERT-iresTK, pLOX-Ttag-
iresTK, pLOX-CWBmi1 and pLOX-CW-CRE.  
Target position Primer  Sequence  
position 1428-1446  forward GGCTATTGAGGCGCAACAG 
position 1576 - 1555 reverse CAGTGGTGCAAATGAGTTTTCC 
 
2.1.9 Plasmids 
The plasmids pHRgfpLox, pLOX-TERT-iresTK, pLOX-Ttag-iresTK, pLOX-CWBmi1, 
pLOX-CW-CRE and psPAX2 were constructed by the group of Didier Trono 
(http://tronolab.epfl.ch/) and kindly provided by the group via Addgene (www.addgene.org, 
providing plasmid maps). The plasmid pCI-VSVG was a gift from Luk Van Parijs.  
 
Tab. 2.10: Lentiviral plasmids. Names and descriptions of plasmids used to produce lentiviruses 
in this study.  
Plasmid name Gene product(s) Description and reference 
pHRgfpLox eGFP eGfp gene, CMV promoter, lox-site in 3' LTR; 
Addgene plasmid 12264, Salmon, et al. (2000), 
strain collection # H3600 
pLOX-TERT-iresTK hTERT,  
HSV-1 TK  
hTERT and HSV-1 thymidine kinase (TK) 
genes, CMV promoter, lox-site in 3' LTR;  
Addgene plasmid 12245, Salmon, et al. (2000), 
strain collection # H3601 
pLOX-Ttag-iresTK SV40T,  
HSV-1 TK  
SV40T and HSV-1 thymidine kinase (TK) genes, 
CMV promoter, lox-site in 3' LTR; 
Addgene plasmid 12246, Salmon, et al. (2000), 
strain collection # H3602 
pLOX-CWBmi1 Bmi1 murine gene for Bmi1, CMV promoter, lox-site in 
3' LTR;  
Addgene plasmid 12240, Salmon, et al. (2000), 
strain collection # H3603 
pLOX-CW-CRE Cre nls-Cre gene (Cre-recombinase fused to nuclear 
localization signal), CMV promoter, lox-site in 3' 
LTR; 
Addgene plasmid 12238, Cudré-Mauroux, et al. 
(2003), strain collection # H3604 
pCI-VSVG VSV-G envelope gene for viral envelope glycoprotein from 
Vesicular Stomatitis Virus; 
Addgene plasmid 1733, gift from Luk Van Parijs 
to the group, strain collection # L373  
psPAX2 viral enzymes and 
structural proteins 
genes for viral enzymes and additional 
structural proteins;  
Addgene plasmid 12260, Didier Trono 
laboratory, strain collection # L142  
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2.1.10 Equipment 
The laboratory was equipped at modern laboratory standards.  
Tab. 2.11: Additional equipment.  
Equipment / material Company 
Phase contrast microscope Olympus 
Epifluorescence microscope Leica DMR 
Laser scanning confocal microscope TCS SP-1 Leica 
Transmission electron microscope Leo 906E Zeiss 
ABIprism, RT-PCR cycler Applied Biosystems  
FACS Calibur BD 
cellZscope cell monitoring system nanoAnalytics 
filter inserts BD Falcon 
Cell culture flasks, dishes, multi-well plates   TPP 
Cell culture 48-well plates Corning 
 
2.1.11 Kits 
EndoFree Plasmid Midi / Maxi kits (Qiagen), for plasmid purification from bacteria stocks;  
DNeasy Blood & Tissue Kit (Qiagen), for genomic DNA isolation;  
RNeasy kit (Qiagen), for RNA isolation;   
Quantitect SYBR Green RT-PCR kit (Qiagen), for quantitative RT-PCR and qPCR  
 
2.1.12 Software and databases 
ACT-1 vers.2 (fluorescence microscopy), Leica Confocal Software (confocal microscopy), 
Adobe Photoshop CS3 (image editing), FCS Express V3 (FACS analysis), SDS 2.2.0 
(RT-PCR analysis), cellZscope (cell polarization monitoring), Microsoft PowerPoint 
(graphic design), Microsoft Word (text), Microsoft Excel (table calculation), NCBI 
homepage http://www.ncbi.nlm.nih.gov/ (literature database, BLAST sequence 
alignment), EndNote (bibliography management)  
 
2.2 Cell culture and tissue preparation 
2.2.1 Preparation of primary human fallopian tube (FT) cells 
Primary human fallopian tube cells were either prepared via explants or digests.  
The tissue was stored in a closed clean container, transported on ice to the lab within 2-3 
h after surgery and rapidly processed. The tissue was placed in a sterile petri dish and 
continuously rinsed with PBS to remove all visible evidence of blood and to wash. Care 
was taken to remove connective tissue. For preparation of explants, the lumen of the tube 
was exposed by cutting it open longitudinally. The mucosal folds were dissected off by 
naked eye in a sterile environment, placed in a separate dish containing growth medium 
MEM-Earl`s + 10 % FCS + penicillin/streptomycin (Pen/Strep) and further cut into small 
pieces. The pieces were placed in 48well, 24well or 12well dishes in growth medium with 
10 % or 40 % FCS supplemented with Pen/Strep. Small volumes of medium were used to 
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ensure tissue pieces could attach to well bottom surfaces. Samples were incubated in a 
humidified atmosphere at 5 % CO2 and 37 °C. On the next day or when most pieces had 
adhered, medium was filled up to the standard volume used per well. Latest 3 days after 
preparation all cultures were kept in normal growth medium (10 % FCS) for usually 1-2 
weeks until immortalization or subculture. Explants were removed after 3-4 days, or latest 
when outgrown directly surrounding cells were near confluent. This method was adapted 
from Saridogan, et al. (1997) Human Repr., 12 (7), 1500-1507.  
 
When cells were prepared using enzymatic digest, tissue was transported and washed as 
described above. Then the fallopian tube was perfused with 0.5 % collagenase in HBSS 
for 10 min. After incubation, the mucosal folds were cut off, placed in an Eppendorf 
reaction tube and incubated in 0.25 % trypsin/EDTA at 37 °C for 30 min while 
continuously shaking. The samples were centrifuged at 50 g (in an Eppendorf centrifuge) 
for 3 min. The pelleted cells were resuspended in growth medium with Pen/Strep and 
seeded into multi-well plates. This method was adapted from Ando, et al. (2000) Human 
Repr., 15 (7), 1597-1603.  
 
In another protocol using enzymatic digest the following procedure was performed. The 
tissue was transported and washed as described above. After removal of surrounding 
tissue, the fallopian tube was minced extensively using a scalpel. Minced tissue was 
placed in a 15 ml Falcon tube and incubated in 5 ml pure TripLE Express enzyme at 37 
°C in a water bath for 30 min. Afterwards the supernatant containing loosened cells was 
collected without disturbing the rest of the tissue. 7 ml DMEM/Ham`s F12 + 10 % FCS + 
Pen/Strep was added. Cells were pelleted by centrifugation with 400g (ca. 1500 rpm in a 
Falcon tube centrifuge) for 5 min. Supernatant was discarded. The cells were 
resuspended in fresh media and seeded in 25 cm² flask. This method was described by 
Jazedje, et al. (2009) J Transl Med., 7(46) doi:10.1186/1479-5876-7-46.  
 
2.2.2 Preparation of primary human FT tissue for tissue culture 
The tissue was stored in a closed clean container, transported to the lab and rapidly 
processed. The tissue was placed in a sterile petri dish and continuously rinsed with PBS 
to remove all visible evidence of blood and to wash, at least twice. Care was taken to 
remove connective tissue. Then tissue pieces of about 0.5 cm length were obtained by 
transverse sections and placed into 4-6 cm dishes in growth medium without antibiotics, 
as pieces were usually used for infection studies. 
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2.2.3 Preparation of primary human umbilical vein endothelial cells (HUVEC) 
The umbilical cord was placed in a large sterile Petri dish. A metal buttoned cannula was 
inserted into the vein and fixed with a clamp. The vein was rinsed two times with pre-
warmed 37 °C HBSS. 10 ml pre-warmed 0.5 % collagenase in HBSS were used to 
remove remnants of HBSS and after clamping of the other end used to fill the vein 
completely. The cord was incubated 15 – 30 min at 37 °C in the Petri dish rapped in a 
sterile plastic bag in a humidified incubator with 5 % CO2. After incubation, the lower 
clamp was taken off, the collagenase solution collected in a petri dish and the vein was 
rinsed two times with 20 ml HBSS each. Wash flow through was collected together with 
collagenase solution in a 50 ml Falcon tube and centrifuged 5 min with 1200 rpm. Cells 
were resuspended in growth medium ECBM containing Pen/Strep and seeded into a 75 
cm² flask coated with 0.5 % gelatine. The cells were incubated in a humidified incubator 
with 5 % CO2 and 37 °C. After 1 h, cells were rinsed two times with HBSS and fresh 
growth medium containing antibiotics was added.  
 
2.2.4 Cell culture propagation 
Cell culture work was performed under sterile conditions. Cells were routinely grown in 
growth medium (see chapters 2.1.2 and 2.1.4) in culture flasks in a humidified incubator 
at 5 % CO2 and 37 °C. Culture vessels for HUVEC cells were coated with 0.5 % gelatine 
in PBS for 1h at RT and then washed with PBS. Cells were splitted before reaching 
complete confluence. Cells were washed with RT PBS and then 1 ml trypsin pre-warmed 
at 37 °C (for Hela, End1, HFF-1 and HUVEC cells) or accutase (for FT cells) was added 
per 75 cm² flask. Cells were incubated in the humidified incubator until the cells detached 
(at RT for HUVEC). Growth medium with 10 % FCS was added to neutralize trypsin 
activity. In case of HUVEC cells grown in low-serum medium, 1 ml trypsin-inhibitor was 
added directly to detached cells, PBS was added to wash and the cells were pelleted for 
5 min at 800-1000 rpm in a Falcon tube centrifuge. Pellets were resuspended in growth 
medium. Diluted cells were splitted into new flasks for further culture and incubated as 
described above.  
The volumes typically used were: 12 ml medium per 75 cm² flask, 6-7 ml per 25 cm² flask, 
2 ml per sixwell, 1 ml per 12well, 0.5 ml per 24 well and 0.25 – 0.5 ml per 48 well.  
 
2.2.5 Isolation of cell clones 
In order to obtain single cells for clonal expansion, mixed cell cultures were treated with 
cloning rings or subjected to FACS single cell sorting. Cloning rings were fixed with sterile 
melted agarose around single colonies in cultures with very low confluence. Cells within 
rings were treated with trypsin as used in cell culture propagation and transferred to a 
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new culture well. For FACS single cell sorting, samples were prepared as described for 
determination of virus titer and infection rate via FACS (see 2.3.3). In addition, cells were 
stained with the red fluorescent membrane dye FM 4-64 (Invitrogen) at 0.1 µl per 1 ml 
media. Cell sorting was performed by co-workers of the flow cytometry core facility at the 
institute.  
 
2.3 Working with lentiviruses 
2.3.1 Notes on the method of reversible immortalization 
A scheme sumarizing the strategy for reversible immortalization is displayed in Fig. 3.4 
and a summary of the method is provided here. For details of lentiviral plasmids see 
above (chapter 2.1.9), for lentiviral integration please refer to the introduction.  
For production of recombinant lentivector (LV) particles, three plasmids are co-transfected 
into producer 293T cells. The plasmids encode either the target protein (oncoprotein 
hTERT, SV40T or Bmi1; or recombinase Cre), the viral envelope protein (Vesicular 
Stomatitis Virus Glycoprotein, VSV-G) or the viral structural proteins and enzymes. 
Produced LV particles are released into the cell supernatant. Recombinant viruses are 
harvested with the cell supernatant. For immortalization, primary cells are infected with 
recombinant LV particles carrying the oncogenes. The target gene sequences integrate 
into the genome of the infected cells and are flanked by lox-sites after integration. 
Excision of oncogenes is mediated by the recombinase Cre and designated as re-
mortalization. To achieve excision, immortalized cells are superinfected with recombinant 
LV particles carrying a self-excisable Cre recombinase construct. The gene integrates 
into the genome as well. Expressed Cre recombinase recognizes the lox-sites and 
excises the integrated oncogenes. As the gene encoding the recombinase itself is flanked 
by lox-sites, too, also this sequence is excised after sufficient production of recombinase. 
To select re-mortalized cells, the viral thymidine kinase (TK) suicide gene is encoded on 
the hTERT and SV40T immortalizing plasmids in addition to the oncogen for negative 
selection of immortalized cells.  
 
2.3.2 Generation of recombinant lentivector particles 
Lentiviruses were produced in 293T cells via calciumchloride transfection of lentiviral 
plasmids. 2x106 293T cells were seeded in a 10cm dish in 10ml DMEM + 10 % FCS + 
2mM L-glutamine without antibiotics. On the next day, the cells were simultaneously 
transfected with 20 µg target plasmid (coding for Gfp, an oncoprotein, or Cre 
recombinase), 6 µg envelope plasmid (coding for VSV-G) and 15 µg packaging plasmid 
(plasmid psPAX2). The DNA was diluted in H2O ad 250 µl, and 250µl CaCl2 (1M, RT) was 
added. During continous vortexing, the DNA/CaCl2  mixture was added slowly dropwise to 
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500µl 2x HBS (RT) and incubated for 30 min at RT. 1 ml transfection solution was 
pipetted dropwise on the cells in one dish. The dish was gently agitated to mix. On the 
next morning, cells were washed with warm PBS (37 °C) and 10 ml fresh medium were 
added carefully. One day later, the supernatant (i.e. medium containing lentivector 
particles) was collected, and 8 ml fresh medium was added to the cells. The supernatant 
was centrifuged at 2000 rpm 4°C for 7min to remove cell debris and stored at 4 °C over 
night. On the next day, the supernatant was collected from cells, centrifuged at 2000 rpm 
4°C for 7min and clear supernatants from day1 and day2 were pooled. The solution 
containing lentiviruses was filtered through 0.45 µm pore filter. Small aliquots were stored 
at -80°C.  
 
2.3.3 Determination of virus titer / infection rate via FACS 
This procedure was applied to titrate viruses encoding Gfp. Hela cells (1.5x105 ) were 
seeded in six-well plates in 2 ml medium per well. On the next day, medium was changed 
in the afternoon and 1 ml fresh medium was added per well. The polybrene stock (Sigma, 
10 mg/ml) was diluted with PBS to 1 mg/ml working solution, of which 1ml was added per 
ml medium. Generally, six samples were prepared per titration assay: cells untreated, 
treated only with polybrene, or infected with 1 µl, 10 µl, 100 µl or 1000 µl of virus 
containing supernatant. On the next morning, the medium was removed, cells were 
washed with pre-warmed PBS (37 °C) and 2 ml fresh medium was added per six-well. 
Cells were harvested three or four days post infection, harvested with trypsin as usual, 
washed with PBS and centrifuged (1000 rpm in Falcon, 5-7 min). Pelleted cells were 
resuspended in and fixed with 2 % PFA for 20 min at RT. After PBS wash and addition of 
fresh PBS (approx. 500 µl), cells were analyzed. When cells were in culture for at least 4 
days post infection, there was no free virus and cells could be analyzed without fixation. 
For analysis of living cells, trypsinized cells were resuspended in 500 µl 4 % FCS in PBS. 
In case of living cells, propidium iodid was added to discriminate dead cells. Propidium 
iodide stains DNA in dead cells due to their permeable cell membrane. Samples were 
vortexed very shortly.  
Cells were analyzed in a FACS Calibur (BD) for Gfp expression in channels FL-1 versus 
FL-2. Data were analyzed using the software FCS Express and the percentage of Gfp 
expressing (i.e. infected) cells was measured by placing a gate discriminating between 
Gfp-negative and Gfp-positive cells. Untreated non-infected cells were used as negative 
control. The histograms display cells after exclusion of cell debris by size and of dead 
cells by propidium iodide staining.  
In a typical titration experiment, only dilutions yielding to 2-20% GFP positive cells were 
considered for titer calculations (below 2%: chance of unreliable results, above 20%: 
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chance for each positive target cell to be transduced twice significantly increases, 
resulting in underestimation of the number of transducing particles).  
The virus titer in cell transducing units (ctu) was calculated using the following formula:  
ctu / ml = number of target cells x (% of infected cells/100) / volume of supernatant (in ml)  
 
2.3.4 Determination of virus titer via quantitative PCR 
In order to assure functionality and determine efficiency of the LV packaging system, the 
obtained LV particles were titrated by quantitative real time PCR (qPCR) in comparison to 
LV particles encoding Gfp instead of an oncoprotein in the same plasmid background. In 
qPCR, the number of lentivector constructs stably integrated into the target cells is 
measured. The Gfp-encoding LV particles were also titrated via FACS analysis (see 
above), the standard titration protocol in the group, to obtain comparable values.  
A standard curve was generated for absolute quantification of viral integration. For this 
purpose, Hela cells were infected with the Gfp-encoding lentivector particles used in this 
study to obtain cells with a defined number of integrations (ideally 1). Cells were analyzed 
in FACS analysis (as described above) and cells were sorted in the core facility flow 
cytometry in the institute. Gfp-positive Hela cells were obtained that carried in average 
0.9 viral integrations per cell. Genomic DNA was prepared (see chapter 2.7.2) from these 
cells and used for quantitative PCR (see chapter 2.7.5) with primers amplifying a part of 
the gag-gene/packaging signal present on all target gene-plasmids of this system. The 
standard curve was calculated with Excel software displaying copy number versus delta 
Ct-value obtained in qPCR.  
For titration, Hela cells were infected with the lentivector particles as described above. 
Genomic DNA was prepared and qPCR was performed (see below). The standard curve 
was used to calculate integration numbers from delta Ct-values obtained in qPCR.  
The titer in cell transducing units (ctu) was calculated using the following formula:  
ctu / ml = number of target cells x number of copy per cell of the sample / volume of 
supernatant (in ml)  
As qPCR titers were higher than FACS titres, both titres were compared for the Gfp-
encoding lentivector particles and the multiplicity factor was determined, by which both 
titers differed. For comparibility, titers of all other lentivector particles were calculated 
accordingly to match the Gfp-construct FACS titer.  
 
2.3.5 Infection with lentivirus (immortalization, re-mortalization) 
Cells were seeded the day before infection in the evening or primary isolates were used 
on the day of infection. Directly before infecting cells, the medium was exchanged and 
fresh medium was added (half the volume used for normal culture: 1 ml per six-well, 500 
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µl per 12-well, 250 µl per 24-well). 10 µl polybrene (1 mg/ml diluted in PBS) was added 
per ml medium (final concentration 10µg/ml). Virus containing supernatant was added 
according to multiplicity of infection (MOI). On the next morning, medium was removed, 
cells were washed once with pre-warmed PBS (37 °C), and fresh medium was added (2 
ml per six-well, accordingly for smaller wells) and cells were further incubated.  
For oncogene excision (re-mortalization), cells were infected with lentivector particles 
encoding the recombinase Cre. Various MOIs were tested with TMNK-1 control cells. For 
negative selection of cells with non-excised constructs, cells were treated with 1 µM 
ganciclovir starting 3 days post infection for 10 days (as used by Salmon, et al., 2000). 
Ganciclovir is a nucleoside analogon phosphorylated by the viral HSV-1 TK. The resulting 
nucleotides are toxic as their incorporation during DNA replication leads to a block thereof 
and eventually to cell death (Salmon, et al., 2000; Caruso, 1996).  
During infection with Cre-encoding virus (re-mortalization) of TMNK-1, cells were sub-
cultured during the course of the experiment as follows: sample MOI1 three times, 
sample MOI5 twice, non-infected sample four times.  
The HUVEC samples were analyzed with SYTOX dead cell stain (Invitrogen) at the end 
of the Cre experiment following manufacturer’s protocol, with analysis in a 
spectrophotometer plate reader. Living cells are impermeable to this nucleic acid stain, 
which therefore specifically stains dead cells. 
 
2.4 Working with Chlamydia 
2.4.1 Chlamydia trachomatis stock preparation 
Hela cells were cultivated in a 75 cm² flask and infected with C. trachomatis at approx. 
MOI2 (serovar L2) or 50 µl aliquot from old stock (serovar D) by putting the bacteria into 
infection medium on the cells. Two hours post infection, medium was exchanged. Cells 
were incubated for 48h for serovar L2, 72h for serovar D in a humidified cell incubator at 
35 °C. Cells were then scraped into the culture medium, transferred into 50 ml Falcon 
tube filled with 7.5 ml sterile glass beads (1-1.5 mm2) and vortexed for 3 min (2500 rpm). 
The chlamydial suspension was transferred to a new tube and used to inoculated Hela 
cells in 10x 150 cm² flasks with each 200 µl directly into the old medium. The medium 
was exchanged two hours post infection for infection medium. Cells were incubated for 
48h for serovar L2, 72h for serovar D in a humidified cell incubator at 35 °C. 
Cycloheximid was added, if cells tended to overgrow. To harvest, medium was reduced to 
10 ml in each flask. Cells were scraped into the medium, transferred into 50 ml Falcon 
tubes filled with 7.5 ml sterile glass beads (1-1.5 mm2), max. 30 ml per tube, and vortexed 
for 3 min (2500 rpm). The chlamydial suspension was transferred to new Falcon tubes, 
and centrifuged at 2000 rpm for 5 min at 4°C in a Haermle centrifuge. The supernatant 
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was transferred to SS34 tubes and centrifuged at 18.000x g in the Sorval centrifuge at 
4°C for 30 min. The chlamydial pellet was resuspended in 10 ml SPG buffer, transferred 
to a Falcon tube, and resuspended in a syringe 5x with G20 needle and 3x with a smaller 
G23/26 needle. 50 µl aliquots were stored at -80 °C.  
 
2.4.2 Determination of C. trachomatis stock titre 
Hela cells were seeded in DMEM with 10 % FCS, L-glutamine and Na-pyruvat, thereby 
cells from a 75 cm² flask were distributed 1:4 to a complete 24-well plate. On the next 
day, cells should be 80-90 % confluent, not more. C. trachomatis was diluted in infection 
medium containing only 5 % FCS as follows: 1:500, 1:1000, 1:2000, 1:5000, 1:10.000, 
1:20.000; infections were performed in duplicates (two wells per dilution), with each 250 
µl. Medium was exchanged two hours post infection. Samples were incubated for 24h in 
a humidified cell incubator at 35 °C.  
On the next day, chlamydial inclusions were counted under the phase contrast 
microscope using the 40x objective. Alternatively, the Hela cells were seeded on 
coverslips in 12wells in the beginning, used for immunofluorescence staining for 
Chlamydia and inclusions were counted from pictures acquired with the epifluorescence 
mircroscope. For the latter procedure, the medium was removed, the cells fixed with 350 
– 500 µl ice cold methanol per well for 10 min at RT and wash twice with 1xPBS. For 
uniform staining of chlamydial inclusions it was advisable to store the plate in 70 % 
ethanol 500 µl per well at 4°C overnight. Sampled were blocked with 300 µl of 0.2 % BSA 
in 1x PBS for 30 min at RT. Blocking solution was removed and 300 µl primary antibody 
dilution was added per well (anti-MOMP for L2) in 0,2% BSA in 1xPBS. Samples were 
incubated for one hour at RT and washed twice with 1xPBS. Hoechst was diluted 
1:10.000 in 0,2% BSA in 1xPBS and the secondary antibody was added 1:100. 300 µl of 
the solution was added per well. The plate was incubated for one hour in the dark, and 
then washed twice with 1xPBS. 500 µl fresh 1xPBS was added per well and the 
coverslips removed and mounted on object slides in Mowiol. Slides were stored at 4 °C.  
The samples were counted from the dilution, at which 30 – 60 inclusions were visible per 
optic field. Per well 10 random optic fields were counted, with 5 crosswise and 5 
lengthwise. Duplicates gave 20 values and the average was used for calculations. The 
titer was calculated as follows, expressed in inclusion forming units (ifu):  
ifu / ml  =  Ø * 2975,2 * dilution factor * 4 
 
2.4.3 Infection of cells with C. trachomatis 
Infection was generally performed in half the amount of medium used for cell culture 
propagation, and with infection medium containing only 5 % FCS. Chlamydial stock 
 - 42 - 
Materials and methods 
solution was freshly thawed from -80 °C. Cells were infected by directly adding 
chlamydiae to the infection medium. Samples were incubated in a humidified cell 
incubator at 35 °C.  
 
2.4.4 Infection of tissue with C. trachomatis 
Tissue samples were infected on the day of dissection with C. trachomatis serovar D or 
L2 with 5*10^6 ifu in RPMI medium + 5% FCS and incubated at 35°C 5% CO2 in a 
humidified incubator. To detect bacterial progeny, which was able to re-infect cells, 
supernatants were collected after usual incubation time and applied to Hela cells. Cell 
samples were infected as described above.  
 
2.5 Cell biological methods 
2.5.1 Immunofluorescence staining of cells 
Medium was removed from cells grown on coverslips, cells were washed once carefully 
with PBS, and fixed in 2 – 4 % PFA for 20 – 30 min at RT. Samples were rinsed two times 
with PBS and either stored in fresh PBS at 4 °C until staining or used fresh. After 
additional 10 min wash, samples were blocked and permeabilised in 0.2 % BSA in PBT 
(PBS + 0.1 % Triton X-100) for 30 min in the dark. The first antibody was diluted in 0.2 % 
BSA in PBS or PBT and ca. 30 µl per sample were incubated for 1 – 1.5 h at RT in a wet 
chamber to prevent samples from drying. Cells were washed three times 5 min with PBS 
on a shaker. The fluorescently labelled secondary antibody and a DNA staining dye 
(Hoechst for epifluorescence microscopy or Draq5 for confocal microscopy, both diluted 
ca. 1:1000) were diluted in 0.2 % BSA in PBS or PBT and ca. 30 µl per sample were 
incubated for 1 h at RT in a wet chamber in the dark. From here on, samples were kept in 
the dark. Cells were washed three times 10 min with PBS on a shaker, rinsed once 
shortly in distilled water to remove salt crystals and mounted in Mowiol on object slides. 
Dried samples were stored at 4 °C. Images were acquired with an epifluorescence 
microscope using ACT-1 software.  
 
2.5.2 Polarization of cells 
4*104 cells per insert were seeded on PET membrane filter inserts (BD Falcon® 353103, 
1.0 µm pore size) for 12-wells. Cells were grown for two weeks in MEM-Earl’s growth 
medium with penicillin and streptomycin. In continuous simultaneous measurements of all 
wells, trans-epithelial electrical resistance (TEER) was determined with the automated 
computer-controlled cell monitoring system cellZscope (nanoAnalytics, Germany) using 
the cellZscope software (nanoAnalytics). In each well, TEER was measured sequentially 
once per hour.  
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2.5.3 Transmission electron microscopy 
For fine structural analysis, cell-layers on filters were fixed with 2.5% glutaraldehyde, 
postfixed with 0.5% osmium-tetroxide, contrasted with 0.1% tannic acid (all from 
Polysciences) and with 2% uranyl-acetate (Serva), dehydrated in a graded ascending 
ethanol series, and embedded in Polybed (Polysciences). Filters were first polymerized 
with a thin film of resin, cut to size, stacked and re-embedded in resin. After 
polymerization, specimens were cut at 60 nm and contrasted with 3% lead citrate (Merck, 
prepared after Reynolds, 1963). Specimens were analyzed in a Leo 906E transmission 
electron microscope (Zeiss, Oberkochen, Germany) equipped with a sidemounted digital 
camera (Morada, SIS-Olympus, Münster, Germany). After fixation with glutaraldehyde, 
the sample preparation and transmission electron microscopy were performed by the co-
workers of the microscopy core facility at the institute.  
 
2.5.4 Karyotype analysis 
Karyotype analysis was performed in cooperation by Dr. Marc Trimborn from the Institute 
for Medical Genetics, Campus Virchow-Klinikum, at Charité University Hospital, Berlin, 
Germany. For chromosome preparation, colcemid was added to cell cultures 1h prior to 
the preparation. Cells were trypsinized, centrifuged, and the pellet resuspended. Samples 
were filled up with 5 ml of prewarmed 0.4 % KCl solution (37°C) (hypotonic salt solution) 
and incubated for 10 min at 37 °C in a water bath. Samples were centrifuged, approx. 4 
ml of the supernatant discarded and the pellet resuspended in the residual volume. The 
cells were fixed with 1 ml ice-cold fixative (methanol/acetic acid 3:1) dropwise and slowly, 
resuspended carefully and another 4 ml were added. Samples were centrifuged, 
resuspended in 5 ml fresh ice-cold fixative, and this step was repeated once. Most of the 
supernatant was discarded and samples resuspended. For slide preparation, glass slides 
were cleaned with ethanol. One or two drops of the suspension were dropped on a slide 
and let to disperse. Slides were dried under a lamp in wet atmosphere above water bath. 
Chromosomes need to be free from cytoplasm.  
Samples of chromosome spreads were incubated with trypsin followed by staining with 
Giemsa-solution, leading to GTG-banding of chromosomes. For banding, slides were 
incubated over night at 60 °C. On the next day, 2.5 ml trypsin (2.5%) were thawed and 
diluted with 22.5 ml 0.9% NaCl to the final concentration 0.25%. Samples were 
trypsinized at RT for 20s to minutes, optimized intervals needed to be determined for 
every preparation. Slides were carefully rinsed with tap water. For staining, slides were 
incubated for approx. 14 min with 5 % Giemsa in phospate buffer (pH 6,88); again, 
optimized incubation times were determined daily. Staining was checked under the 
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microscope and prolonged if necessary. Pictures were acquired and chromosomes 
ordered according to their consecutive numbers to obtain karyograms.  
 
2.6 Histological methods 
2.6.1 Paraffin embedding and microtome sections 
Tissue was washed with PBS, fixed in 4 % PFA for 16-24h, washed twice with PBS and 
stored in PBS at 4 °C until embedding.  
Tissue was dehydrated via alcohol series and perfused with paraffin in a Shandon 
Citadell 1000 rondell, with the following steps, each 1h incubation: 60 % ethanol, 70 % 
ethanol, 80 % ethanol, 90 % ethanol, 2x 96 % ethanol, 2x isopropanol, 2x acetone, 2x 
paraffin for each 2h. Tissue stayed in liquid paraffin until embedding. Tissue was 
embedded in paraffin blocks using a Microm Paraffin Console and cut with a Microm 
Paraffin Rotation Microtome. Prepared sections on object slides were incubated over 
night at 37 °C before use.  
 
2.6.2 Hematoxillin-eosin staining 
For deparaffinisation, paraffin samples were incubated two times 15 min in xylol, two 
times 5 min in absolute ethanol, 3  min in 90 % ethanol, 3 min in 70 % ethanol, 5 min in 
50 % ethanol and 5 min in bidest water. Samples were incubated in hematoxillin for 5 
min, then rinsed under streaming water for 10 min, and in 0.5 % eosin for 2 min. Slides 
were quickly washed in bidest water and 70 % ethanol, then incubated in 90 % ethanol 
for 3 min, two times in absolute ethanol for each 5 min, and two times in xylol for each 15 
min. The samples were covered with DPX mountaint for histology.  
 
2.6.3 Immunofluorescence staining of formalin-fixed paraffin-embedded (FFPE) 
tissue 
Before dewaxing and antigen retrieval of paraffin tissue sections Dako target retrieval 
solution was heated to 95 °C in a glass container in a water bath. Sample slides were 
placed in a glass slide holder, incubated two times 5 – 10 min in xylene with agitation at 
regular intervals, 2x (10 – 20 sec in 100 % ethanol), 10 – 20 sec in 90 % ethanol, 10 – 20 
sec in 70 % ethanol, 10 – 20 sec in 50 % ethanol followed by two washes in water. Then 
the slide holder was transferred into pre-heated target retrieval solution and incubated for 
30 min in the water bath, then 20 min at RT and 5 min under running water.  
For immunofluorescence labelling, the slides were removed from running water and 
wiped around the section. 100 µl PBS was added on the section to prevent it from drying 
out. An ImmEdge pen was used to make rings around the sections. The slide was shaken 
to remove excess PBS and 100 µl of blocking solution / IFF = immunofluorescence buffer 
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(PBS + 1% BSA + 2% FCS, filtered through 0.2 µm filter) was added on the section. The 
slides were placed in a moist chamber to prevent drying. All following steps were carried 
out at RT, the volumes were 20 – 40 µl depending on the size of the sections. The first 
antibody diluted in IFF was incubated 90 min. After washing three times 5 min with PBS, 
the fluorescently labelled secondary antibodies (1:200) and Draq5 (1:800) were diluted in 
IFF and incubated for 60 min in the dark. Samples were washed three times 5 min with 
PBS and 1x with destilled water. For mounting, Mowiol was dropped on the sections on 
object slides and cover slips were put above. Dried samples were stored at 4 °C in the 
dark. This method was described by Robertson, et al. (2008), BMC Cell Biology, 9:13. 
Confocal images were acquired with Leica TCS SP-1 microscope using Leica Confocal 
Software.  
 
2.7 Working with nucleic acids 
2.7.1 DNA plasmid purification 
Plasmids were obtained each transfected in Escherichia coli laboratory strain Stbl3 and 
purified from bacterial cultures grown in LB-medium + ampicillin at 37 °C. The EndoFree 
Plasmid Midi / Maxi kits (Qiagen) were used following the manufacturer’s protocol to 
purify plasmids. DNA concentrations were determined with a spectrophotometer (ND-
1000, Nanodrop, Wilmington, USA).  
 
2.7.2 Genomic DNA purification 
DNA was isolated using DNeasy Blood & Tissue Kit (Qiagen) following the manufacturer’s 
protocol. The DNA was eluted in prewarmed (56 °C) ultra-pure water.  
 
2.7.3 RNA purification 
RNA was isolated using RNeasy kit (Qiagen) following the manufacturer’s protocol using 
the spin technology. Approx. 1*106 cells were pelleted by centrifucation, resuspended in 
300-350 µl lysis buffer RLT and used directly or stored at -20°C. Cells were homogenised 
using a QiaShredder-column and RNA was purified using the RNeasy spin column as 
described in the protocol. RNA concentrations were determined with a spectrophotometer 
(ND-1000, Nanodrop, Wilmington, USA).  
 
2.7.4 Real time RT-PCR 
Real time RT-PCR was performed using Quantitect SYBR Green RT-PCR kit (Qiagen) in 
a one step reaction combining reverse transcription (RT) and polymerase chain reaction 
(PCR) on cDNA. Reactions performed in 25 µl contained 100 ng RNA (in 10 µl), 12.5 µl 
SYBR Green mix, 0.25 µl RT-mix and 0.4 µM per primer and nuclease-free water ad 25 
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µl. Reactions were analyzed in 96-well plates in an ABIprism cycler (Applied Biosystems). 
The following program was used: 30 min 50°C, 15 min 95 °C, 45 cycles of 20 sec 
94°C/40 sec 60°C/40 sec 72°C, then melting curve determination with 15 sec 95 °C, 15 
sec 60 °C, 15 sec 95 °C. Reactions for GAPDH were performed for every RNA sample 
and used as internal controls. Analysis was performed using SDS 2.2.2 software and 
graphs were generated using Excel table calculation software.  
 
2.7.5 Quantitative PCR 
Quantitative PCR (qPCR) on genomic DNA (to determine viral titers, see above) was 
performed without reverse transcription (RT-mix substituted with nuclease-free water) and 
using 5 ng and 50 ng DNA per reaction (for titration standard curve) or 35-160 ng DNA 
(for titration); otherwise, the same protocol as above was followed.  
Results 
3 Results 
The results of this study are divided topically into two parts. The first part addresses 
immortalization of human primary cells, with focus on cells from fallopian tubes, a natural 
site of infection for Chlamydia (part 3.1). In the second part, the chlamydial infection is 
analyzed in a newly established human fallopian tube ex vivo tissue culture to gain insight 
into the host-pathogen-interactions in an “in vivo-like” situation (part 3.2).  
 
3.1 Part 1: Immortalization of primary human cells to generate a new infection 
model 
Cancer cell lines and immortalized cells are well established model systems to study the 
processes of pathogen-host-interaction during infection. However, these cells have 
indefinite life span and lack contact inhibition. Therefore, they differ substantially from the 
pathogen’s primary host cells. In the case of cancer cell lines, which may have been 
cultivated in laboratories for decades, the changes resulting from transformation are 
usually unknown, especially the number of affected genes and their impact. However, 
primary cells, which better mimic the natural in vivo situation of host cells, often are 
difficult to acquire and enter senescence rapidly. This complicates the direct and routine 
work with primary cells.  
Therefore, we aimed to establish new infection models by using primary human 
endothelial and epithelial cells for reversible immortalization. This process would allow the 
generation of a stable stock supply and the possibility to revert cells later back to a 
“primary-like” phenotype.  
 
3.1.1 Isolation and cultivation of primary human epithelial and endothelial cells 
As a first step, primary human fallopian tube epithelial cells and endothelial cells from the 
human umbilical cord had to be isolated directly from primary tissue. Therefore, 
establishment of the preparation of fallopian tube tissue and the isolation and culture of 
fallopian tube cells were a major part of this work.  
Healthy human fallopian tubes were obtained from the Clinics of Obstetrics and 
Gynecology, Campus Virchow-Klinikum and Charité Mitte, at Charité University Hospital, 
Berlin, Germany, when tissues were removed for medical reasons. Material transfer and 
scientific usage were approved by the ethics commission of the Charité University 
Hospital and were carried out with given consent of patients. Varying tissue parts were 
obtained, ranging from the beginning of the tube next to the ovary (infundibulum with 
fimbrial segment) to the end near the uterus (isthmic segment). In each case, it depended 
on the performed surgery which tissue part was obtained. Tissues were usually dissected 
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within 2-3 h after surgery. The surrounding tissue was removed carefully to obtain the free 
tube (Fig. 3.1A). Afterwards, the fallopian tube was opened longitudinally to expose the 
inner mucosal folds (Fig. 3.1B). The mucosal folds line the lumen of the tube, appear 
brownish-yellowish and contain the single-layer simple epithelium.  
For the preparation of primary fallopian tube (FT) cells, different isolation strategies were 
tested. The most effective approach was carefully taking small tissue explants of the inner 
mucosal folds into culture. Primary cells grew from the rim of the tissue into the medium, 
where explants had contact with the bottom of culture vessels (Fig. 3.1C). Cells which 
were loosened during the isolation process adhered to the vessels and formed colonies 
of primary cells (Fig. 3.1D). In a second approach, cells were isolated by mechanical 
shearing and subsequent enzymatic digestion of small tissue pieces. Coating of culture 
vessels with collagen or gelatine did not improve the outcome of both strategies. A third 
protocol for the isolation of cells from FT tissue combined mincing the whole tube with 
subsequent digestion. The protocol was introduced only recently into this work and 
yielded mixed cultures of primary cells.  
 
 
Fig. 3.1: Fallopian tube tissue and cell preparation. A) Four cm long part of a human fallopian 
tube (FT) after removal of surrounding tissue. B) Tissue was opened longitudinally to expose the 
lumen with inner mucosal folds, which appeared brownish-yellowish (arrow) and contained the 
simple columnar epithelium. C) Primary cells growing out of a FT tissue explant (tissue, appearing 
white) four days after preparation. D) Isolated cell island of FT primary cells four days after 
preparation.  
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The obtained primary FT cell populations were investigated for the presence of epithelial 
cells within the isolates. EpCAM (epithelial cell adhesion molecule) is an adhesion marker 
and ubiquitously expressed in differentiated epithelia within the genital tract. EpCAM was 
expressed throughout the cytoplasm in an isolated primary epithelial cell within a mixed 
primary cell population (Fig. 3.2 top). In End1 control cells, an epithelial cell line, EpCAM 
localized at cell contacts. Cytokeratin-8 (CK-8) is a cytoskeleton component present in all 
epithelial cells in simple epithelium, including FT epithelium. A fraction of primary FT cells 
was positive for CK-8, which was localized throughout the cytoplasm comparable to End1 
cells (Fig. 3.2 bottom). This analysis confirmed the presence of epithelial cells in the 
isolated primary FT cell populations. The precondition for immortalization is the isolation 
and culture of primary cells. This task was successfully completed, as epithelial cells were 
detected in mixed populations.  
In contrast to fallopian tube cells, a well-functioning protocol was available for the 
isolation and separation of primary endothelial cells from the human umbilical vein from 
surrounding tissue. Nearly pure cell populations could be obtained with this protocol.  
 
 
Fig. 3.2: Primary fallopian tube cell populations contain cells of epithelial origin expressing 
EpCAM and cytokeratin-8. Immunofluorescence analysis of isolated primary fallopian tube (FT) 
cell populations and End1 epithelial cell line for epithelial markers EpCAM (top) and cytokeratin-8 
(CK-8, bottom). Top: EpCAM (green) was detected in an isolated primary epithelial cell (left, arrow) 
and at cell contacts in confluent End1 cells (right). Bottom: Cytokeratin-8 (CK-8; green) was 
localized in the cytoplasm in both primary epithelial cells (left, arrows mark examples) and End1 
cells (right). DNA was stained with Hoechst (blue).  
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Therefore, human umbilical vein endothelial cells (HUVEC) were used to establish single 
steps of the complex process of reversible immortalization. For preparation of primary 
endothelial cells, human umbilical cords were obtained shortly after childbirth from clinics 
of Obstetrics and Gynecology, Campus Virchow-Klinikum and Campus Charité Mitte, at 
Charité University Hospital, Berlin, Germany. After removal of blood from the vein, 
endothelial cells were isolated by enzymatic digestion. Flow through after incubation 
contained the endothelial cells.  
To verify the isolation of primary endothelial cells from the human umbilical vein, cells 
were tested for the expression of the endothelial marker platelet/endothelial cell adhesion 
molecule-1 (PECAM-1). PECAM-1 was expressed at cell-cell-contacts and thus identified 
HUVEC (Fig. 3.3).  
 
 
Fig. 3.3: Primary cells of human umbilical cord isolates are positive for PECAM-1. 
Immunofluorescence staining of primary isolated cells from the human umbilical vein for the 
endothelial marker PECAM-1 (green) to verify endothelial origin. Cells were positive for PECAM-1, 
which was localized at cell-cell-contacts. DNA was stained with Hoechst (blue).  
 
3.1.2 Reversible immortalization: Testing the system with Hela and TMNK-1 
control cells 
In order to generate reversibly immortalized primary human cells as a new infection 
model, the effects of three different oncogenes were analyzed in this study. Depending on 
the activity of the respective oncoprotein, cellular immortalization will lead to different 
phenotypic changes within the cells. Oncogenic mechanisms include senescence bypass 
by elongation of telomeres (by hTERT) as well as inhibition of tumor suppressors. The 
latter can take place through protein-interactions (by SV40T) or on transcriptional level 
(by Bmi1). The oncoproteins’ characteristics are summarized in table 3.1. They have 
been used for the intended immortalization of various epithelial cells before (see 
introduction, chapter 1.5.1 ff.). In the following study expression of single oncogenes as 
well as combination of two oncogenes were tested to immortalize primary human cells.  
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Tab. 3.1: Characteristics of the oncoproteins used in this work. For details and references, 
see chapter 1.5.1 ff. in the introduction.  
Oncoprotein Full name Origin Function 
hTERT Human telomerase reverse transcriptase human 
- catalytic subunit of human telomerase 
- elongation of telomeric repeats at end of 
chromosomes to counteract senescence 
SV40T Simian Virus 40  large T antigen viral 
- inactivation of retinoblastoma proteins, 
which leads to activation of transcription 
factors and entry into S phase of cell cycle 
- inactivation of p53 tumor suppressor  
- protein necessary for the viral DNA 
replication and transcription  
Bmi1 B lymphoma Mo-MLV insertion region 1 
mouse 
(human 
homolog 
exists) 
- transcriptional repressor  
- repression of the ink4a-locus with the 
tumor suppressors p16 and p19Arf 
(human homolog: p14Arf)  
- a polycomb ring finger protein, required 
for self-renewal of adult stem cells  
 
For oncogene transfer into primary cells, a lentiviral based system was implemented with 
gene delivery through virus like particles – a process also called viral transduction. The 
lentiviral system used in this work is derived from Human Immunodeficiency Virus 1 (HIV-
1). Lentiviruses are able to infect dividing as well as non-dividing cells and therefore are 
highly suitable for infection of primary cells, which do not always grow in culture. 
Delivered genes are integrated into the host genome, which enables long-term and stable 
expression.  
Fig. 3.4 gives an overview over the strategy for reversible immortalization via lentiviral 
gene transfer. Recombinant lentivector particles (LV particles), which encode one of the 
immortalizing oncoproteins hTERT, SV40T or Bmi1, were used for gene transfer into the 
human target cells.  
For production of LV particles (Fig. 3.4A), three plasmids are co-transfected into producer 
cells, e.g. 293T (human embryonic kidney cells). The plasmids encode the viral 
packaging system, the oncoprotein and the envelope protein. The envelope protein from 
Vesicular Stomatitis Virus (VSV) is used due to its high stability and broad tissue tropism. 
The other structural and enzymatic components of the LV particles are derived from HIV-
1. The viral components are expressed in the producer cells and assemble to LV particles 
carrying the oncogene. The oncogene-construct itself is the only genetic material that will 
be incorporated into the LV particles. Therefore, no genetic information coding for genes 
from HIV or VSV are transferred. LV particles are released into the cell supernatant 
through budding from the cytoplasmic membrane.  
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Fig. 3.4: Strategy for the reversible immortalization via lentiviral gene transfer. Scheme of 
reversible immortalization via lentiviral gene transfer. A) For production of recombinant lentivector 
(LV) particles, three plasmids are co-transfected into 293T producer cells. The plasmids contain 
the target gene (encoding for oncoprotein hTERT, SV40T or Bmi1 or for recombinase Cre), the 
gene for the viral envelope protein (Vesicular Stomatitis Virus Glycoprotein, VSV-G) and the viral 
structural and enzymatic genes. Produced LV particles are released into the cell supernatant. B) 
For immortalization, primary cells are infected with recombinant LV particles carrying the 
oncogenes. These target genes are flanked by lox-sites after integration into the cell’s genome. 
Re-mortalization (excision of oncogenes) is mediated by the recombinase Cre. Therefore, 
immortalized cells are superinfected with LV particles encoding Cre. After integration, expressed 
Cre recombinase recognizes the lox-sites and excises the integrated genes. To select re-
mortalized cells, the viral thymidine kinase (TK) suicide gene is present on the immortalizing 
plasmids in addition to the oncogen for negative selection of immortalized cells. For details, see 
text and materials and methods.  
 
For immortalization, primary cells are infected with the generated LV particles (Fig. 3.4B). 
After infection, the oncogenes integrate into the genome of primary cells and are 
expressed under the control of an active viral promoter. After integration, the oncogenes 
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are flanked by lox-sites at both ends. Excision of oncogenes, i.e. re-mortalization, is 
mediated by infection of immortalized cells with LV particles encoding the recombinase 
Cre. This enzyme recognizes the lox-sites and excises the oncogenes between the two 
lox-sequences. As the gene encoding the recombinase is flanked by lox-sites, too, this 
sequence is excised as well.  
For selection of re-mortalized cells with excised constructs, the viral thymidine kinase 
(TK) suicide gene from Herpes Simplex Virus type 1 (HSV-1) is used. Cells which still 
carry the constructs after Cre treatment die upon addition of the substrate analogon 
ganciclovir to the medium. HSV-1 TK is encoded additionally on the immortalizing 
constructs with hTERT and SV40T genes.  
 
The LV particles carrying either one of the oncogenes or the recombinase gene were 
produced as explained in Fig. 3.4A. To confirm that produced LV particles were infective 
in cell culture and to get an estimation of infection rates, standard cell lines were infected 
with the Gfp-encoding LV particles. Hela229 cells (human epithelial cervix carcinoma 
cells) and End1 cells (human epithelial endocervical cells) were infected with a multiplicity 
of infection (MOI) 1 (Fig. 3.5A). Infection was verified by immunofluorescence analysis 
with staining for Gfp. Approximately ¼ of the cells were Gfp-positive. The Gfp-positive 
infected cells were detected in both cell lines throughout samples. This confirmed both 
successful production of LV particles and efficient infection.  
For quantification of the infection rate, Hela229 cells were infected with the same Gfp-
encoding LV particles. Infected cells were analyzed for the Gfp-positive population in 
comparison to non-infected cells 5 days post infection (p.i.) (Fig. 3.5B). An infection rate 
of approximately 50% was observed in the Hela229 cells infected at MOI1. These 
analyses show that Gfp-encoding LV particles infected standard cell lines efficiently. The 
corresponding oncogene-carrying LV particles therefore were used for the immortalization 
of primary cells.  
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Fig. 3.5: Recombinant Gfp-encoding LV particles infect cell lines efficiently. A) Verification of 
infection by immunofluorescence analysis. Hela229 and End1 cells were infected with Gfp-
encoding LV particles with a multiplicity of infection (MOI) 1 and analyzed 3 days post infection 
(p.i.). Samples were stained for Gfp (green) and with Hoechst (DNA, blue). Gfp-positive infected 
cells were detected in both cell lines throughout samples. B) Quantification of infection rate by 
FACS flow cytometry analysis. Hela229 cells infected with Gfp-encoding LV particles were 
analyzed for the Gfp-positive population in comparison to non-infected cells 5 days p.i.. An 
infection rate of approx. 50% was observed in Hela229 cells infected at MOI1. In the histogram, 
cell counts are plotted against fluorescence intensity measured in the FL-1 channel. The red bar 
designates the Gfp-positive cell population.  
 
The system of reversible immortalization using lentiviral gene transfer was tested in a 
standardized cell line, in which the method was known to work. This cell line, TMNK-1, is 
derived from human liver endothelial cells through immortalization with hTERT and 
SV40T via retroviral gene transfer (Matsumura, et al., 2004). One of the immortalizing 
constructs used by Matsumura and colleagues additionally encodes Gfp. The 
immortalizing constructs are both flanked by lox-sites and can be excised by Cre-
recombinase. Oncogene excision had been shown using a purified Cre-fusion protein 
(Matsumura, et al., 2004). We altered the method by using lentiviral delivery of the Cre 
recombinase gene. Thus, TMNK-1 cells were optimal control cells to study re-
mortalization using the lentiviral system.  
To test the efficiency of oncogene excision (re-mortalization) in the lentivector system, 
TMNK-1 cells were infected with LV particles encoding the Cre-recombinase (Fig. 3.6A).  
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Fig. 3.6: Quantification of oncogene excision (re-mortalization) and analysis of cell 
phenotype after oncogene excision in control cell line TMNK-1. A) Oncogene excision (re-
mortalization) via Cre-encoding LV particles is efficient in the control cell line TMNK-1. The cells 
were infected with LV particles encoding the Cre-recombinase using different MOI to test efficiency 
of oncogene excision. Samples were analyzed in flow cytometry 6 days p.i. for the Gfp-positive 
population, which decreased with increasing MOI. The bar designates the Gfp-positive cell 
population. Cell counts were plotted against fluorescence intensity. B) MOI-dependant survival of 
TMNK-1 control cells infected with Cre-encoding LV particles (LV Cre). TMNK-1 cells continuously 
grow after Cre-mediated excision of oncogenes. Cells infected with MOI 1 showed higher survival 
rate than cells infected with MOI 5. The cells were infected with LV Cre and analyzed 6 and 13 
days p.i..  
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Successful gene excision by Cre-recombinase will remove oncogene constructs including 
GFP from TMNK-1 cells, and therefore will reduce the fraction of Gfp-positive cells. 
Samples were analyzed six days p.i.. The Gfp-positive population decreased with 
increasing MOI of Cre-encoding LV particles. Using MOI 0.25, approximately 78 % Gfp- 
positive cells remained. MOI 1 and MOI 5 led to approx. 34 % and 2 % Gfp-positive cells 
left, respectively. These results demonstrated efficient gene excision by Cre-recombinase.  
For evaluation of viability and cell phenotype after oncogene excision, TMNK-1 cells were 
infected with Cre-encoding LV particles (Fig. 3.6B). Cells were analyzed 6 and 13 days 
p.i.. After re-mortalization, both MOI 1 and MOI 5 infected samples showed diminished 
cell numbers compared to non-infected cells 6 days p.i.. However, only few cells died 
after infection with MOI 1 compared to non-infected cells. Surviving cells recovered fast. 
At MOI1, no significant increase in cell death or negative impact on cell growth was 
detected. In contrast, levels of cell death were increased after infection with MOI 5 and 
remaining cells grew slower. These samples recovered confluence only with time delay. 
Therefore, TMNK-1 cells in general grow continuously after Cre-mediated excision of 
oncogenes. According to cell recovery, MOI 1 as well as MOI 5 can be used, but MOI5 
has a negative effect on cell survival. Infection with Cre-encoding lentiviruses with MOI 1 
led to 2/3 of the cells having excised constructs while a high survival rate was maintained. 
 
3.1.3 Immortalization of primary endothelial cells (HUVEC) using viral gene 
transfer and characterization of immortalized cells 
Recombinant Gfp-encoding LV particles could be shown to infect standard cell lines 
efficiently (see Fig. 3.5). These LV particles were produced using the same plasmid 
background as the oncogene-carrying LV particles needed for immortalization. The next 
step was to test the infection efficiency in primary cells.  
Primary HUVEC (human umbilical vein endothelial cells) were infected with Gfp-encoding 
LV particles and the infection rate was quantified. For this purpose, samples were 
analyzed for the Gfp-positive population 5 days p.i. (Fig. 3.7). The primary HUVEC were 
infected with MOI 1.6. An infection rate of approximately 61 % was observed. This 
experiment showed efficient infection of primary cells by the recombinant Gfp-encoding 
LV particles. The result is comparable to the infection rate in Hela229 cells (see Fig. 3.5) 
with 50 % infected cells using MOI 1.  
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Fig. 3.7: Recombinant Gfp-encoding LV particles infect primary HUVEC efficiently. 
Quantification of infection rate by FACS analysis. Primary HUVEC infected with Gfp-encoding LV 
particles were analyzed for the Gfp-positive population in comparison to non-infected cells 5 days 
p.i.. An infection rate of approx. 61 % was observed in primary HUVEC infected with MOI 1.6. The 
histogram displays cell count against fluorescence intensity. The red bar designates the Gfp-
positive cell population.  
 
 
The next aim was to generate immortalized HUVEC by using the oncoproteins hTERT, 
SV40T and Bmi1 to analyze the effects of these oncoproteins on primary cells. All three 
oncoproteins were used individually as well as in combination of two each. Primary 
HUVEC were infected in parallel with LV particles carrying the different oncogenes with 
approximately MOI 1 and grown continuously. Four months after infection with LV 
particles, pictures were taken to visualise different growth characteristics. Cells 
expressing hTERT + SV40T were rounder and more regular shaped compared to all 
other samples (Fig. 3.8). Among the cells transduced with one of the oncogenes 
individually, only SV40T expressing cells continued proliferating beyond passage 29. 
Thus, hTERT or Bmi1 alone were not sufficient for immortalization. However, comparing 
SV40T expressing cells with double-transduced cells could indicate incomplete 
immortalization, as SV40T expressing cells grew less steadily and more cells were 
enlarged or died. Four samples of transduced cells survived: HUVEC immortalized with 
hTERT + SV40T, hTERT + Bmi1, SV40T + Bmi1 and SV40T alone. The cells were 
cultivated up to p. 50 before original continuous culture was stopped. 
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Fig. 3.8: Differences in cell viability and phenotype of immortalized HUVEC due to 
combination of oncogenes. Phase contrast pictures of transduced HUVEC four months post 
transduction. Primary HUVEC cells were infected with LV particles carrying different oncogenes as 
indicated and grown in parallel continuously. Pictures were acquired on the same day and passage 
numbers (p.) are indicated to visualise different growth characteristics. A) HUVEC immortalized 
with hTERT + SV40T grew steadily and had a round phenotype. B) HUVEC with hTERT + Bmi1 
grew continuously, they exhibited longer and more irregular cell shapes. C) HUVEC with SV40T + 
Bmi1 grew steadily. Many cells appeared round with long cell shapes in between. D) HUVEC with 
hTERT alone had lowest survival rates. Cells had stopped growing in p. 19 and died completely 
after additional step of subculture. E) HUVEC with SV40T alone grew continuously. Cells showed 
mixed phenotypes with long as well as irregular cell shapes. F) HUVEC with Bmi1 alone had 
diminished survival rates. Enlarged irregular cells were observed, which died after additional step 
of subculture.  
 
The successfully growing transduced HUVEC were considered to be immortalized. Next, 
gene expression of the oncogenes was verified in HUVEC immortalized with two of the 
oncogenes. The oncogene expression according to the inserted constructs could be 
verified in all three HUVEC samples transduced with two oncogenes (Fig. 3.9). Primary 
HUVEC did not express HTERT, SV40T or BMI1. HTERT was expressed in all HUVEC 
transduced with the hTERT construct (Fig. 3.9A). HUVEC immortalized with hTERT + 
SV40T showed 1.6-fold higher HTERT expression level than HUVEC immortalized with 
hTERT + Bmi1. All HUVEC carrying the SV40T construct showed expression of SV40T 
(Fig. 3.9B). HUVEC immortalized with hTERT + SV40T showed a 3.6-fold lower 
expression level than HUVEC immortalized with SV40T plus Bmi1. Both HUVEC 
immortalized with Bmi1 construct expressed BMI1 (Fig. 3.9C). However, BMI1 expression 
was 16.5-fold lower in HUVEC immortalized with hTERT + Bmi1 compared to HUVEC 
immortalized with SV40T + Bmi1.  
Notably, HUVEC immortalized with SV40T + Bmi1 showed highest expression of both 
transduced oncogenes SV40T and BMI1 among all HUVEC. TMNK-1 cells served as  
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Fig. 3.9: Verification of oncogene expression in immortalized HUVEC by real time RT-PCR. 
Quantitative real time RT-PCR was performed to determine the expression of oncogenes on 
mRNA level in immortalized HUVEC cells compared to primary HUVEC cells, TMNK-1 cells and 
Hela229 cells. Relative expression values were normalized to primary HUVEC (sample 1). hT: 
hTERT; SV: SV40T; Bmi: Bmi1. A) Relative expression of HTERT. HTERT was expressed in all 
HUVEC transduced with the hTERT construct (samples 2, 3) and in TMNK-1 cells. B) Relative 
expression of SV40T. All HUVEC carrying the SV40T construct (samples 2, 4) and TMNK-1 cells 
showed expression of SV40T. C) Relative expression of BMI1. HUVEC carrying Bmi1 construct 
expressed BMI1 (samples 3, 4). In other cells, only basal BMI1 expression was detected.  
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positive control and expressed HTERT as well as SV40T as expected (see above). 
Hela229 cancer cells expressed HTERT at very low levels (64-fold lower compared to 
TMNK-1 HTERT expression). As oncogene expression was verified for the respective 
genes, the immortalization of primary HUVEC was successful. 
 
After immortalization of primary cells, characterization of obtained cells was necessary to 
verify endothelial origin and to exclude changes of endothelial phenotype. Therefore, the 
four surviving immortalized HUVEC samples were analyzed for expression of the 
endothelial marker platelet/endothelial cell adhesion molecule (PECAM-1) (Fig. 3.10). All 
cell samples were positive for PECAM-1, which localized at cell-cell-contacts, and thus all 
cells could be confirmed as endothelial cells. The localization of PECAM-1 corresponds to 
the one in primary HUVEC (compare Fig. 3.3). 
 
 
 
Fig. 3.10: Immortalized HUVEC express endothelial marker PECAM-1. Immunofluorescence 
staining of immortalized HUVEC cells for the endothelial marker PECAM-1 (green) to verify 
endothelial origin. DNA was stained with Hoechst (blue). Oncoproteins used for immortalization 
are indicated. Immortalized cells were positive for PECAM-1, which localized at cell-cell-contacts 
between confluent cells. Absence of PECAM-1 signal in some cells can be explained by lack of 
confluence.  
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3.1.4 Excision of oncogenes using Cre recombinase 
Cells carrying constructs for reversible immortalization can be reverted back to a 
“primary-like” phenotype by cutting the oncogenes out of the genome. Such re-mortalized 
cells need to be healthy and ideally growing actively, to be suitable for subsequent 
experiments. In the system applied in this study, selection of re-mortalized cells with 
excised oncogene constructs is obtained by negative selection of cells which still carry 
the oncogenes. This is achieved through Herpes Simplex Virus type 1 thymidine kinase 
(HSV-1 TK) (compare Fig. 3.4), which is encoded on hTERT and SV40T constructs. HSV-
1 TK is a suicide gene, because the kinase renders the cells sensitive to ganciclovir, 
which eventually leads to cell death (Salmon, et al., 2000; Caruso, 1996). To exclude 
general toxicity, primary HUVEC used in this study were treated with ganciclovir. The cells 
were not affected, as their growth characteristics did not change during the observed time 
period.  
In order to test oncogene excision, verify the excision and check cell condition afterwards, 
immortalized HUVEC were infected with Cre-encoding LV particles (LV Cre) to excise the 
oncogenes. The same MOI was used that had been efficient in TMNK-1 cells while a high 
survival rate had been maintained. As controls, samples not infected with LV Cre were 
kept in parallel. All cells were treated with ganciclovir to kill cells with non-excised 
constructs. Cells not infected with LV Cre were expected to die upon addition of 
ganciclovir. In LV Cre infected samples, all cells with successful and efficient oncogene 
excision would survive. At 13 days p.i., all samples infected with Cre-encoding LV 
particles and treated with ganciclovir exhibited enlarged cells and were reduced in cell 
numbers (Fig. 3.11A). Growth arrest occurred in all samples. Non-infected cells treated 
with ganciclovir died completely in three of four samples. This indicates that oncogene 
constructs were excised in the respective LV Cre infected cells. Only non-infected 
HUVEC carrying hTERT + Bmi1 were less sensitive to ganciclovir. As control, Fig. 3.11B 
shows untreated HUVEC without ganciclovir immortalized with hTERT + SV40T for 
comparison. These cells continued normal growth in contrast to the ganciclovir treated re-
mortalized HUVEC, which arrested growth.  
To elucidate possible reasons for the growth arrest of HUVEC after Cre treatment, the 
samples were stained at the end of the Cre experiment for dead cells. In this preliminary 
staining experiment, the Cre-treated HUVEC samples did not have elevated levels of cell 
death compared to untreated samples. This finding indicated that growth arrested cells 
did not undergo cell death above basal level after excision of oncogenes.  
The conclusion of this experiment is that re-mortalization of immortalized HUVEC is 
principally possible, as oncogene excision was achieved. However, re-mortalized cells 
arrested growth, which might indicate diminished cell fitness. Follow-up experiments  
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Fig. 3.11: Verification of oncogene excision by ganciclovir treatment in immortalized 
HUVEC. A) Immortalized HUVEC cells (respective oncoproteins indicated) were infected with Cre-
encoding LV particles (LV Cre) at MOI 1 to excise the oncogenes. Cells were analyzed 13 days 
p.i.. Three days after infection with LV Cre, the cells had been treated with 1 µM ganciclovir for 10 
days to kill cells with non-excised constructs. All samples infected with Cre-encoding LV particles 
and treated with ganciclovir (left) showed enlarged cells and reduced cell numbers. Growth arrest 
occurred. Oncogene constructs were excised in these cells, as non-infected cells treated with 
ganciclovir (right) died. B) Untreated HUVEC immortalized with hTERT + SV40T for comparison. 
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studying host-pathogen interactions can take several days. Therefore it is questionable 
whether the system of reversible immortalization can be used, as re-mortalized HUVEC 
arrested cell growth already during the reversion process. 
 
3.1.5 Immortalization of primary fallopian tube cells using viral gene transfer 
The recombinant oncogene-carrying LV particles had been shown to successfully 
immortalize primary HUVEC. These LV particles were now used to generate immortalized 
cell lines from fallopian tubes, which are a natural site of infection for genital tract 
pathogens, to study host-pathogen-interactions.  
Single oncoproteins (hTERT, SV40T or Bmi1) were used initially to immortilize primary FT 
cells, but none of the samples grew continuously and no stably transduced cell lines with 
only one oncogene could be obtained. Therefore, combinations of two of the oncoproteins 
hTERT, SV40T and Bmi1 were used as in the previous experiments, where these 
combinations had been successful in the immortalization of primary HUVEC.  
Primary fallopian tube cells showed signs of cellular stress after LV particle infection. Fig. 
3.12 shows primary FT cells 3 days post LV particle infection, i.e. oncogene transduction. 
The transduced cells showed stress fibres and vacuoles. More stressed cells with stress 
fibres and accumulated vacuoles were observed in samples transduced with hTERT- + 
Bmi1-encoding LV compared to combinations with SV40T.  
Initially, epithelial cells should be selected of mixed primary populations before lentiviral 
infection; however, this approach was not followed up, as the cells mostly died after 
subculture. Due to the reduced growth potential of primary cultures, infection was 
performed directly in primary isolates in average 1 week after isolation. Cell numbers of 
starting samples were usually rather low, in the range of only few hundred cells per  
 
 
Fig. 3.12: Cellular stress phenotypes in primary fallopian tube culture after lentiviral 
infection. Phase contrast pictures of primary fallopian tube cells 3 days post viral infection 
(oncogene transduction). Combinations of used constructs are indicated. Cells partially showed 
stress fibres (examples marked by arrow) and vacuoles (examples marked by asterisk). Cells 
transduced with hTERT- plus Bmi1-constructs developed stress fibres and vacuoles more often. 
 - 64 - 
Results 
sixwell. Cells had not reached complete confluence when used for oncogene 
transduction. In total, primary isolates of 18 tissue pieces (derived from 12 different 
patients) were used in 10 independent immortalization experiments. 
Immortalized samples consisting of mixed populations were cloned by using cloning rings 
or FACS single cell sorting. All obtained FT cell clones, which were continuously growing, 
were immortalized with SV40T and Bmi1. Cells within transduced samples were growing 
and expanding only if SV40T was present.  
Gene expression of the transduced oncogene constructs was analyzed in the best 
characterized ones of the obtained clonal FT cell lines (named FT-01 to FT-06; compare 
chapter 3.1.6) to control immortalization. mRNA levels were compared to three different 
samples of primary FT cells, which were derived from three different donors (Fig. 3.13). 
Primary FT cells did not express any of the three oncogenes HTERT, SV40T or BMI1. 
The immortalized FT cell lines did not express HTERT, too, as expected (Fig. 3.13A). All 
FT cell lines expressed SV40T, but expression levels differed (Fig. 3.13B). FT-01, FT-04 
and FT-06 cell lines showed strong SV40T expression. The FT cell lines FT-02, FT-03 
and FT-05 expressed SV40T at approximately 4.6-fold lower levels when average values 
of high-and low-expressing samples were compared.  
Unexpectedly, BMI1 expression levels were lower in FT cells compared to HUVEC (see 
above) although the same LV particles were used for immortalization. FT-01, FT-04 and 
FT-06 expressed BMI1 (Fig. 3.13C). FT-02, FT-03 and FT-05 cells only showed the same 
basal activity as primary FT cells. Notably, only FT cell lines with high SV40T expression 
(namely FT-01, FT-04 and FT-06) showed BMI1 expression. TMNK-1 control cells 
expressed HTERT and SV40T as expected (see chapter 3.1.2). Hela229 cancer cells 
expressed HTERT at a low level compared to TMNK-1. Both TMNK-1 and Hela cells had 
low BMI1 expression when normalized to primary FT cells. The analysis revealed that 
levels of oncogene expression differed between the obtained FT cells. Expression of both 
SV40T and BMI1 was verified in cell lines FT-01, FT-04 and FT-06 as expected according 
to the transduced constructs.  
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Fig. 3.13: Verification of oncogene expression in immortalized FT cells by real time RT-PCR. 
Quantitative real time RT-PCR was performed to determine the expression of oncogenes on 
mRNA level in FT cells immortalized with SV40T and Bmi1 compared to primary FT cells, TMNK-1 
and Hela229 cells. Graphs were normalized to primary FT cells (sample 1). A) Relative expression 
of HTERT. Neither primary FT cells (samples 1-3) nor FT cells immortalized with SV40T and Bmi1 
(samples 4-9) expressed HTERT. B) Relative expression of SV40T. Primary FT cells (samples 1-
3) did not express SV40T. All FT cell lines immortalized with SV40T and Bmi1 (samples 4-9) 
expressed SV40T. C) Relative expression of BMI1. BMI1 was expressed (at least 2-fold compared 
to primary cells) in FT cell lines FT-01, FT-04 and FT-06 (samples 4, 7 and 9, respectively).  
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3.1.6 Characterization of immortalized fallopian tube cells 
During this work, 21 continuously growing clonal FT cell lines were generated in total, all 
immortalized with SV40T and Bmi1. Six of these, namely cell lines FT-01 to FT-06, were 
maintained and observed for a longer period of time. Oncogene expression was verified 
in these cells (see Fig. 3.13). Two of the clonal lines (FT-01, FT-02) had been obtained by 
using cloning rings. They both originated from the same donor tissue. The other four 
clonal FT cell lines had been selected by flow cytometry single cell sorting. Among these, 
FT-03, FT-04 and FT-05 cells were derived from the same patient sample. FT-06 
originated from a third independent donor tissue. For characterization of immortalized FT 
cells, these six cell clones were analyzed in more detail in the following studies.  
Comparison of continuous cell cultures revealed differences in shape and growth pattern 
(Fig. 3.14). FT-01, FT-02 and FT-06 cells appeared rounded and grew tightly confluent. 
FT-02 cells were larger than most of the other cells. FT-02 and FT-06 had the most 
regular growth pattern. FT-03, FT-04 and FT-05 cells had a longer shape. FT-03 and FT-
04 cells grew with gaps between cells. FT-05 cells were able to grow tightly confluent as 
well.  
 
 
Fig. 3.14: Growth pattern of clonal immortalized FT cell lines. Phase contrast pictures of clonal 
immortalized FT cell lines immortalized with SV40T and Bmi1. FT-01, FT-02 and FT-06 cells were 
rounded and grew tightly confluent. FT-03, FT-04 and FT-05 cells showed a longer shape. FT-03 
and FT-04 cells grew with gaps (asterisks) between cells. Clones were obtained by cloning rings 
(FT-01 and FT-02) or by flow cytometry single cell sort (FT-03, FT-04, FT-05 and FT-06). Cells 
originated from three different patient samples. Patient 1: FT-01 and FT-02; patient 2: FT-03, FT-04 
and FT-05; patient 3: FT-06. 
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The next step was to analyze whether the immortalized cells were able to establish apico-
basal cell polarity, as it is observed in polarized epithelial layers. Therefore, FT cell lines 
were grown on permeable filter supports, which stimulate cells to polarize. Cells were 
cultivated for approximately two weeks and then analyzed by electron microscopy (EM) 
(Fig. 3.15). Polarized columnar epithelium, as it is present in FT mucosal folds, is 
characterized by apico-basal cell polarity, which is maintained by the adhesion belt and 
functional tight junctions. EM analysis of FT cells revealed multiple cell layers with mainly 
horizontal orientation of nuclei (Fig. 3.15A). Notably, none of the cell clones showed 
apico-basal polarity. The number of cell layers and cell forms differed between the cell 
lines. Flattened disc-like shapes were observed in most samples (FT-01 – FT-04). Of 
these, FT-01 cells were most flattened and had grown with the highest number of layers 
on top of each other. Dead cells were observed in the more loosely connected FT-01, FT-
03 and FT-04 cells. Rounder cell shapes were found in FT-06 and FT-05 cells. Microvilli 
were observed at the apical side of cells in the top layer of FT-06 cells, and in lower 
numbers at FT-02 cells. FT-06 cells appeared most tightly connected of all samples. 
However, no tight junctions were observed. In conclusion, overall FT cell lines did not 
show characteristics of polarized epithelial cells.  
Notably, among all samples FT-06 cells had the most consistent growth pattern and 
orientation of cell layers. Closely neighboured cells, which more adhered to each other, 
were observed in this cell line with nuclei partially in apico-basal orientation (Fig. 3.15B). 
In addition, these cells were among the FT clones with highest oncogene expression (see 
above). In T84 control cells, apico-basal polarity was observed, as characterized by 
vertical nuclei, microvilli and tight junctions (Fig. 3.15C).  
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Fig. 3.15: Ultrastructural analysis of FT cell lines reveals differences in cell shape. Cells 
were grown on permeable filter supports for approximately two weeks to induce cell polarization 
and then processed for electron microscopy. A) FT cells immortalized with SV40T and Bmi1. 
Notably, none of the cell clones showed apico-basal polarity. Nuclei of cells were oriented 
horizontally in many cells. No tight junctions or clear adherens juntions were observed. In all 
samples, multi-layering of cells was observed. The cell lines differed among each other concerning 
form and number of layers. Most cells had flattened disc-like shapes (FT-01 to FT-04). Of these, 
FT-01 cells were most flattened and had grown with the highest number of layers on top of each 
other. Dead cells were observed in the more loosely connected FT-01, FT-03 and FT-04 cells 
(asterisks). FT-06 and FT-05 cells were rounder. FT-06 cells appeared most tightly connected of all 
samples. Microvilli were detected at the apical side of cells in the top layer of FT-06 cells (arrows), 
and to less extent in FT-02 cells (arrow). FT cell lines did not exhibit characteristics of polarized 
epithelial cells. B) Closely neighboured FT-06 cells with close cell contacts (arrowheads) and 
some nuclei in apico-basal orientation were observed. C) Positive control: T84 cells showed apico-
basal polarization expected for epithelial cells with vertically oriented nuclei, microvilli (arrows) and 
tight junctions (arrowheads). Picture of T84 cells kindly provided by Claudia Lange. 
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The immortalization of the FT cells was achieved via oncoproteins, some of which are 
known to be often associated with chromosomal changes, especially SV40T (Ray, et al., 
1992). In order to analyze, whether immortalization caused large genomic 
rearrangements, the chromosomal integrity was tested in the FT cell lines. Therefore, 
karyotype analysis was performed for the generated cell lines.  
All analyzed FT cell lines had abnormal karyotypes with chromosomal changes of both 
number and structure compared to the normal human diploid chromosome set of 46 
chromosomes (Fig. 3.16). FT-06 and FT-03 cells both showed a hypodiploid karyotype 
with less than 46 chromosomes (Fig. 3.16A). The karyograms revealed missing 
chromosomes as well as marker chromosomes. Marker chromosomes are structurally 
abnormal chromosomes, whose origin cannot be identified. The karyotype of FT-06 cells 
was closest to the normal human female karyotype of 22 chromosome pairs plus 2 X-
chromosomes among all cells analyzed. In FT-03 cells ring chromosomes and dicentric 
chromosomes were found among the marker chromosomes. Dicentric chromosomes are 
abnormal chromosomes with two centromeres. FT-02 and FT-01 cells both had a 
polyploid karyotype with triple as well as quadruple chromosomes resulting in high 
chromosome numbers (Fig. 3.16B). In addition, multiple marker chromosomes were 
observed. Of these two samples, only FT-02 cells showed single chromosomes, for which 
the corresponding second copy could not be identified. In some cases, identifiable 
chromosomes carried changes in form of elongations, e.g. the first chromosome 9 in FT-
02 cells and the third chromosome 12 in FT-01 cells (Fig. 3.16B) as well as the second 
chromosome 12 in FT-06 cells (Fig 3.16A).  
The results confirmed chromosomal changes in the immortalized FT cell lines, 
presumably induced through SV40T. Unfortunately, within the scope of this study 
immortalization of FT cells was achieved only in the presence of SV40T, as other 
oncogenes proved to be insufficient for immortalization (see above). 
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Fig. 3.16: Extensive chromosomal changes are revealed in FT cell lines by karyotype analysis. 
Karyograms of FT cell lines immortalized with SV40T and Bmi1. All analyzed FT cell lines had 
abnormal karyotypes. A) FT-06 and FT-03 cells showed a hypodiploid karyotype with missing 
chromosomes as well as marker chromosomes (mar; top right in each karyogram). The karyotype 
of FT-06 cells (left) was closest to the normal human female karyotype. FT-03 cells (right) showed 
ring chromosomes (ring) and dicentric chromosomes (dic), which are abnormal chromosomes with 
two centromeres, among marker chromosomes. B) FT-02 and FT-01 cells had a polyploid 
karyotype with multiple marker chromosomes as well as triple and quadruple chromosomes. Only 
FT-02 cells (left) showed single chromosomes.  
 
Since immortalization was performed in original isolates consisting of mixed cultures, the 
origin of generated cell lines needed to be confirmed by the analysis of expression of cell 
type specific markers. In the following, FT-06 cells are shown as a typical example. These 
cells appeared least changed of all analyzed FT cell lines in their morphology and 
karyotype and were among the cells with highest oncogene expression.  
FT cell lines were compared to the epithelial cell line End1 to investigate whether FT cells 
were of epithelial origin (Fig. 3.17). Confluent cells were stained for three epithelial 
markers: epithelial cell adhesion molecule (EpCAM), E-cadherin and cytokeratin-8. FT-06 
cells, which are shown as example, did not express the adhesion molecule EpCAM, 
whereas in End1 cells EpCAM was widely expressed and localized mainly to the cell 
borders (Fig. 3.17, top). Cadherins are a component of adherens juntions and E-cadherin 
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is the subtype found in epithelial cells. However, E-cadherin was only found at cell-cell-
contacts of End1 cells, but not in FT-06 cells (Fig. 3.17, middle). Cytokeratin-8 is a 
cytoskeleton component in epithelial cells derived from simple columnar epithelium, as it 
is present in fallopian tubes and endocervix. FT-06 cells did not express cytokeratin-8. 
End1 cells, which are derived from the endocervix, expressed cytokeratin-8 throughout 
the cytoplasm (Fig. 3.17, bottom). This analysis revealed that the generated FT cell lines 
did not originate from epithelial tissue.  
 
 
Fig. 3.17: Immortalized clonal FT cell lines do not express epithelial markers. 
Immunofluorescence analysis of immortalized fallopian tube cell line FT-06 carrying SV40T and 
Bmi1 and epithelial cell line End1 for epithelial markers. Top: Cells were stained for the epithelial 
cell adhesion molecule (EpCAM; green). FT-06 cells did not express EpCAM. In End1 cells, 
EpCAM was localized at cell borders. Middle: Staining for E-cadherin (E-Cadh, red). FT-06 cells 
did not express E-cadherin. In End1 cells, E-cadherin was detected at cell-cell-contacts. Bottom: 
Cells were stained for cytokeratin-8 (CK-8, green). FT-06 cells did not express cytokeratin-8. In 
End1 cells, cytokeratin-8 was localized in the cytoplasm. DNA was stained with Hoechst (blue).  
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To further explore from which cell type the generated FT cell lines originated, samples 
were analyzed for the endothelial marker platelet/endothelial cell adhesion molecule 1 
(PECAM-1). Confluent fallopian tube FT-06 cells, which are shown as example, did not 
express PECAM-1 (Fig. 3.18). In contrast, PECAM-1 was localized at cell-cell-contacts in 
primary endothelial HUVEC. Note that primary HUVEC were not confluent. This 
experiment led to the conclusion that the obtained FT cell lines were not endothelial cells.  
 
 
Fig. 3.18: Immortalized clonal FT cell lines are not from endothelial origin. 
Immunofluorescence staining of immortalized fallopian tube cell line FT-06 and primary HUVEC 
endothelial cells for PECAM-1 (green). FT-06 cells did not express the endothelial marker PECAM-
1. Primary HUVEC expressed PECAM-1 at cell-cell-contacts between confluent cells. Absence of 
staining in other HUVEC can be explained by lack of confluence. DNA was stained with Hoechst 
(blue).  
 
Because the generated FT cell lines turned out to be neither epithelial nor endothelial, 
other possible cell types were investigated. It is known that multipotent adult 
mesenchymal stem cells are found in the human fallopian tube and can be isolated from 
this tissue (Jazedje, et al., 2009). Thus, possible cell types included mesenchymal cells 
and stem cells, which express markers as CD44, Oct4 and N-cadherin. CD44 is a marker 
of mesenchymal stem cells and multipotent adult stem cells. The transcription factor Oct4 
belongs to the key regulators of stem cell pluripotency. Neural cadherin (N-cadherin) is 
generally regarded as mesenchymal marker and is also a marker of undifferentiated 
mesenchymal stem cells.   
To investigate expression of these cell type markers, FT cells were analyzed for 
expression of CD44 and Oct4 (Fig. 3.19). FT-06 cells are shown as example. CD44 was 
expressed in FT-06 cells at cell-borders. In addition, it was detected weakly in the 
cytoplasm of most cells and stronger in spots in some cells. Oct4 was observed in a 
patchy nuclear pattern. In addition, cells were analyzed for expression of N-cadherin. N-
cadherin was expressed in FT-06 cells and localized in spots and short stretches at cell-
cell-contacts (Fig. 3.19). Thus, FT-06 cells expressed both CD44 and Oct4 stem cell 
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markers as well as the mesenchymal marker N-Cadherin, and therefore exhibited 
properties of undifferentiated mesenchymal stem cell-like cells.  
 
Fig. 3.19: Stem cell markers CD44 and Oct4 as well as N-cadherin are expressed in clonal 
FT cell line. Immunofluorescence staining of immortalized fallopian tube cell line FT-06 for CD44 
(green, left), Oct4 (green, middle) or N-cadherin (N-Cadh; red). FT-06 cells expressed the stem 
cell marker CD44, which was detected in the cytoplasm and at cell-borders. The stem cell marker 
Oct4 was detected in the nucleus of FT-06 cells. N-cadherin was found in FT-06 cells in spots at 
cell-cell-contacts. DNA was stained with Hoechst (blue).  
 
All cell systems analyzed so far were intended to be used for investigating pathogen-host-
interactions. The human pathogenic bacterium Chlamydia trachomatis causes urogenital 
infections and naturally can infect the human fallopian tube. Therefore, Chlamydia 
infection was studied in the six best analyzed FT cell lines (FT-01 to FT-06). These cells 
had all been immortalized with the same combination of oncogenes (SV40T + Bmi1). 
Cells were infected with C. trachomatis serovar L2, a standard laboratory strain (Fig. 
3.20). C. trachomatis infected all of the immortalized human fallopian tube cell lines. 
Chlamydial inclusions were detected throughout samples; these are the vacuoles in 
which bacterial replication takes place. Interestingly, C. trachomatis growth differed 
between the FT cell lines as judged by the size of the chlamydial inclusions (Fig. 3.20). 
The growth difference was consistent with the tissue source. FT-01 and FT-02 cells 
showed larger inclusions. These cells were both derived from donor tissue #1. The cell 
lines FT-03, FT-04 and FT-05 were derived from donor tissue #2. FT-03 and FT-04 cells 
carried few large inclusions as well as medium-sized inclusions. In FT-05 cells, medium-
sized as well as small inclusions were found. The FT-06 cell line was derived form donor 
tissue #3 and mainly small inclusions were observed, with only some medium-sized ones. 
The analysis showed that all tested FT cell lines were readily infected by C. trachomatis 
and indicated that infection differed between the investigated FT cell lines; this seemed to 
be related to patient samples.  
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Fig. 3.20: Chlamydial inclusions differ in size between human FT cell lines. Immortalized FT 
cell lines were infected with Chlamydia trachomatis serovar L2 with MOI 3-4 for 24h. 
Immunofluorescence staining was performed for the chlamydial protease HtrA (red). DNA was 
stained with Hoechst (blue). C. trachomatis readily infected the immortalized human fallopian tube 
cell lines. Chlamydial inclusions were detected in all FT cells. FT-01 and FT-02, both derived from 
patient #1, showed larger inclusions. FT-03, FT-04 and FT-05 were derived from patient #2. FT-03 
and FT-04 carried few large inclusions as well as medium-sized inclusions. In FT-05 cells medium 
and small inclusions were observed. FT-06 cell line derived form patient #3 showed mainly small 
inclusions with some medium-sized ones.  
 
3.2 Part 2: Human fallopian tube ex vivo tissue culture as infection model for 
Chlamydia trachomatis 
Urogenital and gastrointestinal pathogens first encounter the epithelial layer of target 
organs when entering their hosts. So far cell lines and primary cells were well established 
models to analyze these pathogen-host-interactions. However, pathogens do not only 
interact with and induce changes in single cell types. In cell culture systems the target 
cells are isolated. Therefore, they do not represent the in vivo situation present in the 
living host, where the cells are integrated into complex tissue structures. Structural 
interaction between neighbouring cells plays an important role for polarization and barrier 
function of epithelial cells, and various cell types build and interact within the tissue. 
Pathogens also often modify cellular mechanisms, which are directly dependant on or 
regulated by tissue homeostasis, e.g. cell cycle and apoptosis, apico-basal transport, 
adhesion and inflammation. Thus, pathogens can induce changes that have an impact on 
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the entire tissue. As consequence, these cellular mechanisms are difficult to be analyzed 
in cell culture.  
In order to circumvent the limitations of single-cell type-cultures, we were interested to 
establish an ex vivo tissue culture model of human fallopian tubes to analyze the complex 
interactions of the human pathogenic bacterium Chlamydia trachomatis with host cells of 
the female genital tract. With this model, the chlamydial infection can be studied directly 
in the tissue context, as it occurs in vivo 1. 
 
3.2.1 Establishment of human fallopian tube ex vivo tissue culture 
For the establishment of tissue culture, healthy human fallopian tubes (FT) were obtained 
from the department of Obstetrics and Gynecology, Campus Virchow-Klinikum, at Charité 
University Hospital, Berlin, Germany, with given consent of patients. Samples were 
prepared as described above (see chapter 3.1.1), without removal of epithelium or 
digestion treatment. Pieces of FT tissue were cultured for 1-5 days.  
In order to analyze the complex thick tissue, microtome sectioning was necessary to 
obtain samples thin enough for analysis. In order to check whether the tissue was intact 
after processing and the procedure was suitable, tissue sections were analyzed 
microscopically. Stained thin sections revealed many complete mucosal folds protruding 
into the lumen of the tube (Fig. 3.21A). Two layers of muscle comprise the tubal wall.  
 
 
Fig. 3.21: Histology of human fallopian tube. Hematoxillin-eosin staining of human FT. A) 
Overview of cross-section of human FT tissue. The mucosal folds (MF, arrows) protruded into the 
lumen of the tube. Two layers of muscle (M) comprise the tubal wall. B) Enlargement of mucosal 
fold. The mucosa consists of the single-layer epithelium (E, arrow) and the lamina propria 
mucosae (LP) underneath, which is loose connective tissue. The mucosa was largely intact after 
culture and embedding procedures.  
                                                
1 This project was performed in cooperation with Dr. Mirjana Kessler, my direct supervisor. Predominantly, Dr. 
Kessler coordinated the project and helped with experimental design, I performed experiments and analyzed 
the data.  
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Higher magnification of a mucosal fold revealed that the mucosa was largely intact after 
culture and embedding procedures (Fig. 3.21B). The mucosa consists of the single-layer 
epithelium and the lamina propria mucosae underneath, which is loose connective tissue. 
Thus, the general tissue architecture was preserved in processed cross-sections showing 
that applied protocols were suitable for analysis. 
Next, we wanted to analyze whether FT tissue stayed viable in ex vivo culture. For 
detailed analysis of molecular markers on a subcellular level, an optimised 
immunofluorescence staining protocol for paraffin-embedded tissue was applied on thin 
cross-sections, and samples were analyzed with high resolution confocal microscopy.  
To determine functional integrity of the epithelium in the tissue culture, localization of 
molecular markers was analyzed. Preservation of the apico-basal axis is a major 
determinant of homeostasis of epithelial layers. E-cadherin is a transmembrane 
component of adherens junctions, thereby mediating cell-cell-adhesion. Beta-catenin is 
involved in connecting E-cadherin to the actin cytoskeleton. Occludin is a component of 
tight junctions, which are needed for epithelial barrier tightness and only are fully 
established in polarized epithelium. All three markers showed the localization expected in 
polarized epithelium. E-cadherin formed clear bands at the lateral cell membrane of 
epithelial cells at cell borders (Fig. 3.22A). Beta-catenin was observed at lateral cell 
membranes in epithelial tissue (Fig. 3.22B). In addition, occludin could be stained in small 
spots at the top end of lateral cell membranes (Fig. 3.22B). These data revealed that the 
ex vivo tissue culture was optimal, as the epithelium maintained its polarity and was 
viable for the time of culture. Further structural components of FT epithelium are 
cytokeratin-8, a cytoskeleton component of simple epithelia, and acetylated tubulin, which 
is present in cilia. Both markers were exclusively located in the epithelial layer as 
expected. Cytokeratin-8 demonstrated preserved tissue structure of mucosal folds with 
intact epithelium (Fig. 3.22C). An intact single-layer epithelium with apico-basal 
orientation was observed together with the lamina propria. Acetylated tubulin enabled 
detection of cilia at the apical side of some cells facing the lumen of the tube (Fig. 3.22D). 
This staining allowed discriminating between ciliated cells and the non-ciliated secretory 
cells of the epithelium. These observations revealed structural integrity of the epithelium 
after ex vivo tissue culture. Overall experiments revealed that tissue was in general viable 
for the tested period of 3-5 days in culture.  
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Fig. 3.22: Tissue structure, polarity and viability are preserved in culture. 
Immunofluorescence analysis of tissue cross-sections. Tissue cultured for 24h. Pictures display 
mucosal folds (as in Fig. 3.21B). A) Staining for E-cadherin (green), and DNA (Draq5, blue). E-
cadherin formed clear bands between cells in the area of the lateral cell membrane and cell 
borders. B) Staining for occludin (green) and β-catenin (blue). Distinct spots of occludin were 
observed at the upper part of lateral membranes facing the lumen (L). C) Staining for cytokeratin-8 
(green) and DNA (Draq5, blue) revealed preserved tissue structure of mucosal folds after tissue 
culture, embedding and staining. D) Staining for acetylated tubulin (green). Ciliated cells could be 
discriminated from non-ciliated secretory cells; β-catenin stained in blue.  
 
3.2.2 Chlamydia trachomatis successfully infects human fallopian tubes ex vivo 
Human fallopian tube tissue was used to study the infection of the human pathogenic 
bacteria Chlamydia trachomatis, which are a cause of sexually transmitted diseases. To 
check whether C. trachomatis could successfully infect the tissue, fallopian tubes were 
infected with bacteria and cultured ex vivo (Fig. 3.23A). Chlamydial inclusions, i.e. the 
vacuoles in which the bacteria replicate, were observed in the tissue 24h post infection 
(p.i.). The epithelial layer stayed intact, as polarization and cytokeratin expression of 
epithelial cells were preserved. The degree of infection varied locally within the tissue as 
well as between samples. Chlamydial serovars D and L2 both infected the tissue. For 
discriminating whether the bacteria replicated and differentiated inside the tissue or only 
invaded the epithelium, bacteria were collected from infected tissue. Therefore, medium 
supernatant from tissue, which had been infected for 3 days, was transferred onto 
Hela229 cells (Fig. 3.23B). After three days, prominent chlamydial inclusions were 
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observed in the cells. The presence of chlamydial inclusions demonstrated that the 
bacteria successfully infected the FT tissue, replicated inside the tissue and differentiated 
to form infectious progeny. Thus, bacteria were able to establish a replicative niche inside 
the tissue and complete their developmental cycle. 
 
 
Fig. 3.23: Chlamydia trachomatis infects fallopian tube tissue in culture and completes 
bacterial developmental cycle. A) Human FT tissue was infected with C. trachomatis serovar D 
for 24h. Samples were analyzed in immunofluorescence staining for bacterial LPS (red) and 
cytokeratin-8 (green); DNA was stained with Draq5 (blue). C. trachomatis was able to infect the 
epithelium of tissue in culture, as bacterial inclusions (red) were observed. The degree of infection 
varied locally within the tissue as well as between samples. B) Medium supernatant from infected 
tissue, which had been infected for 3 days, was transferred onto Hela229 cells. 3 days p.i., large 
chlamydial inclusions (arrows) were observed in infected cells.  
 
3.2.3 C. trachomatis infection leads to destruction of epithelium in late stages of 
infection cycle 
In order to analyze the course of C. trachomatis infection in the tissue over time, we 
checked whether changes in the infected ex vivo tissue culture occurred. Therefore, FT 
tissue was infected with C. trachomatis serovar D for a time course. Samples were 
analyzed for the adherens junctions’ component E-cadherin and C. trachomatis (Fig. 
3.24A). In non-infected tissue, apico-basally polarized epithelium with the characteristic 
lateral localization of E-cadherin was observed. In early chlamydial infection, here 
analyzed 24h p.i., the E-cadherin staining pattern did not differ significantly from non-  
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Fig. 3.24: Disruption of epithelium and loss of adhesion occur in late stages of Chlamydia 
infection. A) Human fallopian tube tissue was infected with C. trachomatis (Ctr) serovar D for 24h, 
48h or 72h or cultured non-infected. Immunofluorescence analysis was performed with staining for 
E-cadherin (green) and C. trachomatis (red), DNA was stained with Draq5 (blue). In non-infected 
tissue, columnar epithelial cells were observed with intact lateral bands of E-cadherin. In early 
chlamydial infection, i.e. 24h p.i., the infected epithelium stayed intact. Both chlamydial inclusions 
and clear lateral E-cadherin staining were observed. 48h p.i., epithelial cells started to loose apico-
basal polarity. In some cells, E-cadherin was found dislocated apically (asterisks). In late stages of 
chlamydial infection, 72h p.i., cell adhesion was lost and the epithelium was disrupted. Cells lost 
shape of polarized columnar cells. B) Tissue treated with EGTA (5 mM) for 48h was stained for E-
cadherin (green) with immunofluorescence. Treatment with EGTA led to loss of apicobasal polarity, 
as E-cadherin was dislocated to the apical side (asterisks). 
 
infected tissue, as was observed before (compare Fig. 3.23), with chlamydial inclusions 
inside epithelial cells. However, later in infection, significant changes in phenotype were 
detected within C. trachomatis infected mucosa; here analyzed 48h p.i.. The degree and 
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speed of induced rearrangements in epithelium depended on the infection rate in 
individual tissues. In some cells, the otherwise laterally located cell-adhesion marker E-
cadherin was also found redistributed to the apical membrane. In late stages of 
chlamydial infection, 72h p.i., cells had lost the shape of polarized epithelium and were 
flattened. E-cadherin was lost in some cells, in others observed diagonally to the axis of 
the epithelial layer. Cell adhesion was lost and the epithelium was disrupted. Notably, 
within infected epithelium loss of polarity and adhesion was not restricted only to inclusion 
containing cells. Non infected cells in the neighbourhood also showed phenotypes 
consistent with loss of epithelial tissue architecture.  
A similar phenotype was observed upon treatment of tissue with EGTA. EGTA is a 
chelating agent binding the Ca2+ ions required for cadherin-mediated cell-cell-contacts, 
and thus is a known inhibitor of adhesion. EGTA treatment led to dislocation of E-
cadherin, which was also observed apically, showing loss of apico-basal polarity and the 
defined adhesion belt (Fig. 3.24B). This phenotype resembled the one in late chlamydial 
infection and thus indicated the latter to be caused by loss of adhesion. In conclusion, 
results showed that C. trachomatis disrupts epithelial integrity. This finding demonstrates 
the profound effect that C. trachomatis exerts on the homeostasis of epithelial mucosa in 
the fallopian tube by altering distribution of molecular markers in infected as well as non-
infected cells. 
 
3.2.4 C. trachomatis serovar D induces apoptosis 
Chlamydia trachomatis is known to block apoptosis in cell culture. In the literature, many 
reports describe the inhibition of apoptosis by C. trachomatis. However, most of the 
studies used C. trachomatis serovar L2. This is a widely preferred laboratory strain, which 
causes rare lymphogranuloma venereum disease but is not a causative agent of sterility. 
In contrast, the C. trachomatis serovar D is prevalent in patients with urogenital infections, 
which can ascend to the upper genital tract including fallopian tubes.  
For comparison of both strains, human FT tissue was infected with C. trachomatis 
serovar D or L2. Samples were analyzed for the apoptosis-marker cleaved cytokeratin-18 
(Fig. 3.25). No apoptotic cells were observed in non-infected tissue cultured for 24h, and 
only few apoptotic cells after 72h. The infection with C. trachomatis serovar D induced 
apoptosis already 24h p.i.. Elevated levels of apoptosis were observed 72h p.i.. The 
apoptotic cells were observed in a wide area of the epithelial region. In contrast, no 
apoptotic cells were detected after infection with C. trachomatis serovar L2 for 24h. Only 
few apoptotic cells were observed 72h p.i. with numbers comparable to the basal level in 
non-infected tissue. Thus, infection with C. trachomatis serovar D – but not L2 – indeed 
caused apoptosis in FT tissue samples.  
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Fig. 3.25: Infection with C. trachomatis serovar D causes apoptosis throughout tissue. 
Immunofluorescence analysis of human fallopian tube tissue. Samples were infected with C. 
trachomatis serovar D (Ctr D) or L2 (Ctr L2) and analyzed 24h p.i. (left) or 72h p.i. (right) in 
comparison to non-infected tissue. Tissue microtome sections were stained for the apoptosis-
marker cleaved cytokeratin-18 (green) and LPS (red), DNA stained with Draq5 (blue). Non-infected 
tissue did not contain apoptotic cells 24h p.i. and only few apoptotic cells 72h p.i.. Infection with Ctr 
D led to apoptotic cells already 24h p.i. and elevated level of apoptosis 72h p.i.. Apoptotic cells 
were observed in a wide area of the epithelial region. In contrast, no apoptotic cells were observed 
in tissue infected with Ctr L2 at 24h p.i., and only few apoptotic cells 72h p.i. comparable to the 
basal level of non-infected cells.  
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Fig. 3.26: Infection with C. trachomatis serovar D leads to activation of caspase-3. 
Immunofluorescence analysis of infected human fallopian tube tissue. Samples were infected with 
C. trachomatis serovar D (Ctr D) and analyzed 24h or 48h p.i., as indicated, in comparison to non-
infected cells. Tissue sections were stained for the apoptosis-marker cleaved caspase-3 (red), for 
C. trachomatis (green), and E-cadherin (blue) to visualize the epithelium. Non-infected tissue did 
not stain either for the apoptosis-marker or bacteria. Infection with Ctr D induced cleavage of 
caspase-3. Cleaved caspase-3 was observed in tissue 24h (middle) and 48h (right) p.i..  
 
To further verify induction of apoptosis by C. trachomatis serovar D, infected tissue was 
analyzed for an additional apoptosis marker, caspase-3. This is an effector enzyme of the 
apoptosis pathway. This protein is active in its cleaved form. Therefore, tissue was 
infected with C. trachomatis serovar D and analyzed for the presence of the cleaved 
caspase-3 (Fig. 3.26). In non-infected tissue, no caspase-3 was observed. The infection 
with C. trachomatis serovar D caused cleavage of caspase-3. 24h p.i. and 48h p.i. 
Chlamydia as well as cleaved caspase-3 were detected. The experiment led to the 
conclusion that C. trachomatis serovar D infection indeed induced apoptosis.  
 
To confirm the phenotype of apoptosis induction, experiments were conducted in cell 
culture. Cell culture models raise more possibilities for manipulation of cells and for 
controls. As a positive control for the induction of apoptosis, the apoptosis-inducer 
staurosporin was included. Hela05 cells were infected with C. trachomatis serovar D or 
L2 or treated with staurosporin. After 24h, non-infected cells showed normal cell shape 
and viability of completely untreated cells (Fig. 3.27). In cells treated with staurosporin 
signs of apoptosis were observed as expected: cells with formation of apoptotic vesicles 
and cell shrinkage. In samples infected with C. trachomatis serovar D increased levels of 
cell death were observed, cells were elongated and accumulated vesicles. In contrast, 
cells infected with C. trachomatis serovar L2 did not reveal any signs of apoptosis but 
normal cell shape with typical inclusions.  
In addition, these samples were analyzed for cleaved cytokeratin-18 (CK-18) (Fig. 3.28). 
No signal was detected in non-infected cells for cleaved CK-18, as expected. In cells 
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treated with the apoptosis-inducer staurosporin a strong signal for cleaved CK-18 was 
observed in small dots. Infection with C. trachomatis serovar D led to staining of cleaved 
CK-18, too, in a pattern comparable to staurosporin-treated cells. In contrast, when cells 
were infected with C. trachomatis serovar L2, bacterial inclusions were detected but no 
signal for cleaved CK-18. Because staining of the apoptosis-marker CK-18 occurred in 
the same arrangement as in the positive control, the experiment confirmed the finding of 
apoptosis-induction by C. trachomatis serovar D in the cell culture model.  
 
 
 
Fig. 3.27: Increased cell death is observed in cell cultures after infection with C. trachomatis 
serovar D. Phase contrast pictures. Hela05 cells were infected with C. trachomatis serovar D (Ctr 
D) or L2 (Ctr L2) with MOI 3 or treated with the apoptosis-inducer staurosporin (SSP) at 1 µM. 24h 
p.i., non-infected Hela05 cells, which were completely untreated, had normal cell shape and 
viability. SSP-treated cells showed signs of apoptosis, e.g. apoptotic vesicles and cell shrinkage 
(arrowheads). After infection with Ctr D, cell death increased. Cells were elongated and 
accumulated vesicles (arrowheads). Examples of chlamydial inclusions are marked by asterisks. 
In contrast, cells infected with Ctr L2 did not show any signs of apoptosis but normal cell shape 
with typical inclusions (asterisk).  
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Fig. 3.28: Apoptosis induction by C. trachomatis serovar D is confirmed in cell culture. 
Immunofluorescence analysis. Hela05 cells were infected with C. trachomatis serovar D (Ctr D) or 
L2 (Ctr L2) with MOI 3, or treated with the apoptosis-inducer staurosporin (SSP, positive control) 1 
µM for 24h. Samples were stained for apoptosis-marker cleaved cytokeratin-18 (cleaved CK-18; 
green) and bacterial LPS (red), DNA stained with Hoechst (blue). Non-infected cells did not stain 
for cleaved CK-18. SSP-treated cells showed strong staining of cleaved CK-18 in small dots. 
Infection with Ctr D led to cleaved CK-18-staining, too, as sign of apoptosis. In contrast, cells 
infected with Ctr L2 were negative for cleaved CK-18.  
Discussion 
4 Discussion 
Cell culture systems have long been used to study the interaction between pathogens 
and their living host cells. These model systems usually involve cancer-derived cell lines 
or immortalized cells lines of a single cell type, and due to their reduced complexity they 
are convenient for the analysis of single factors in pathogen-host interactions. However, 
these cells do not represent the condition of primary cells, as they e.g. possess infinite life 
span and often lack contact inhibition of growth. Additionally, in cancer-derived cell lines, 
the extent of changes resulting from carcinogenic transformation is unknown, especially 
the number of affected genes and their impact. Therefore, primary cells are used to 
exclude possible effects of these undefined changes. The major problems of primary cells 
are, however, that their proliferation capacity is usually limited and acquisition may be 
difficult. This complicates the direct and routine work with primary cells. In addition, all of 
these model systems differ from the infection situation in vivo, where multiple cell types 
interact and the cells are embedded in the complex tissue structure. Especially the barrier 
function of epithelial cells requires polarization and structural interaction between 
neighbouring cells, which are not present in normal cell culture systems.  
Therefore, new primary tissue based model systems are needed to better mimic this 
complex situation. In this study two approaches were taken to circumvent the limitations 
of traditionally used cell culture systems. The aim of this study was to establish new 
models on the basis of (1) isolated reversibly immortalized human primary cells, and (2) 
intact human ex vivo tissue culture to analyze infections with the human pathogenic 
bacterium Chlamydia trachomatis. Human fallopian tubes were used for both studies, as 
Chlamydia trachomatis urogenital infections cause inflammation of fallopian tubes, and 
may lead to pelvic inflammatory disease or tissue scarring followed by occlusion of the 
tubes. The detailed mechanisms of pathogenesis are still not completely understood. 
Therefore, it is important to resolve the interaction between chlamydial pathogens and 
their hosts further.  
 
4.1 Immortalization of human primary cells 
Primary human umbilical vein endothelial cells (HUVEC) and primary human fallopian 
tube (FT) cells were successfully immortalized in this study. Expression of the transduced 
immortalizing oncogenes could be detected within the cells. Later on, the immortalized 
HUVEC were subjected to re-mortalization, i.e. the excision of oncogenes, and 
immortalizing constructs were shown to be excised efficiently; however, cells arrested 
growth. The analysis of the immortalized FT cells revealed expression of markers present 
in undifferentiated cell types, such as stem cells, and acquired chromosomal changes.  
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4.1.1 Isolation of human primary endothelial HUVEC and FT epithelial cells 
In this study, protocols for the isolation and culture of human primary fallopian tube cells 
were established in our group, which were adapted from different published protocols. 
Various differing methods and descriptions can be found in literature for isolation of FT 
cells from human and animal tissue, including (1) mechanical disruption and enzymatic 
digestion, (2) uncoated and coated culture vessels as well as (3) serum-containing and 
serum-free media (Levanon, et al., 2010; Okada, et al., 2005; Ando, et al., 2000; 
Saridogan, et al., 1997; Takeuchi, et al., 1991; Henriksen, et al., 1990).  
As no uniform procedure was provided in the literature, different isolation strategies were 
tested in this study (mainly adapted from Ando, et al., 2000; Saridogan, et al., 1997). The 
most successful approach included mild mechanical disruption by carefully taking small 
pieces of tissue of the inner mucosal folds. Culture of these explants resulted in 
outgrowth of primary cells from the tissue rim. Various protocols based on enzymatic 
digestion were tested, too, using different digestion enzymes and incubation times, and 
yielded differently successful results. All of these protocols are described for the isolation 
of epithelial cells, but all will lead to mixed populations of primary cells, not to pure 
cultures.  
In order to optimize further parameters, coating of culture vessels with collagen and 
gelatine was performed as described in other protocols. However, coating did not improve 
the procedures, therefore the isolation protocols mainly adapted here use uncoated 
culture vessels. Additionally, published protocols include various media, containing serum 
or no serum, defined growth hormones or total gland extracts with mixed hormones. In 
this study, usually medium containing fetal calf serum was used, as done for routine cell 
culture and as described in the adapted protocols for FT epithelial cells and assisted 
reproduction techniques. Neither addition of epidermal growth factor (EGF) to the 
medium, nor usage of serum-free media containing either extracts from bovine pituitary 
gland or defined supplements, generally enhanced cell yield and survival in this study.  
In total, primary material derived from 26 different patients, each time including one to two 
tubal segments, were subjected to isolation protocols during my studies. Epithelial cells 
could be isolated from the human FT, as cells within mixed primary isolates were positive 
for the epithelial cytoskeleton protein cytokeratin-8 or the epithelial cell adhesion 
molecule EpCAM. Taken together, primary cells could be successfully isolated and 
cultured with the established protocols, and mixed populations included FT epithelial 
cells.  
As the single-layer FT epithelium is very thin and the underlying lamina propria contains 
fibroblasts, a main problem encountered during epithelial cell isolation is separation from 
fibroblasts. Keratinocyte serum-free medium (K-SFM) is optimized for keratinocytes and 
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cervical epithelial cells and is developed to suppress fibroblast growth 
(http://tools.invitrogen.com/content/sfs/brochures/332-032442_SFMBrochure.pdf). In this 
study, application of K-SFM did not change the obtained primary cultures compared to the 
other media used. This indicates that the obtained primary isolates did not contain large 
fractions of fibroblasts. 
The usage of laser microdissection is described in the literature as another method to 
separate the epithelial cell layer from surrounding tissue (Lotz, et al., 2006). However, the 
procedure was performed with thin sections of snap-frozen intestinal tissue. Thus, the 
protocol would not be suitable to recover and culture cells, as the tissue is not alive any 
more.   
With the protocol for isolation of primary HUVEC, which was available before and 
routinely used in the laboratory, apparently nearly pure cell populations were obtained. 
However, endothelial origin of primary cells was not tested before. Therefore, in this study 
isolated primary HUVEC were stained by immunofluorescence for the endothelial marker 
platelet/endothelial cell adhesion molecule-1 (PECAM-1; CD31). Primary HUVEC were 
positive for PECAM-1, confirming endothelial cell origin and assumed purity of isolates.  
 
4.1.2 Successful oncogene excision in TMNK-1 cells 
In order to establish an infection model with reversibly immortalized human cells, the pre-
conditions for this method were tested at the beginning of this study. This included 
assessment of the technical aspects of reversion by oncogene excision. The 
recombinase Cre was used for oncogene excision, as it was already shown in 1996 that 
Cre is able to excise efficiently the constructs introduced into the host cell’s genome, 
while the recombinase FLP is not (Westerman and Leboulch, 1996). The present study 
demonstrated efficient gene excision (re-mortalization) in the control cell line TMNK-1 by 
lentivirally transduced Cre-recombinase verifying the general functionality of the used 
system. TMNK-1 cells carry hTERT- and SV40T-constructs flanked by lox-sites, which 
can be excised by Cre-recombinase (Matsumura, et al., 2004). Efficient gene excision 
was demonstrated in FACS analysis leading to excised constructs in 66 % of cells to over 
95 % at high MOI. Cell viability of re-mortalized cells was preserved after the procedure, 
as seen in growing cell culture.  
Thus, the result of this study - the efficient Cre-mediated gene excision in TMNK-1 cells -, 
is consistent with the finding of Matsumura, et al. (2004), who used a different method of 
transferring Cre. Purified Cre-fusion proteins were directly transfected into immortalized 
cells in their experiments and yielded up to 60 % cells with excised constructs in a dose-
dependent manner. In their study, reverted TMNK-1 cells slowly lost proliferative 
capability, which was monitored until three weeks after beginning of Cre treatment. In the 
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present study, growth of reverted cells slowed down, but cells were still able to grow 
confluent. Cells were monitored until 13 days after beginning of Cre treatment. Thus, re-
mortalization was feasible and the procedure worked in our hands with the altered 
protocol including lentiviral transduction of Cre. 
Besides the direct transfection of purified Cre-fusion proteins into the target cells 
(Matsumura, et al., 2004), various methods including the usage of viral vectors are 
described for gene transfer.  Due to different widely used viral vectors, different protocols 
for Cre-mediated excision of oncogenes are described in literature, including adenoviral 
vectors (Salmon, et al., 2000) or lentiviral vectors (Nguyen, et al., 2005; Cudré-Mauroux, 
et al., 2003).  
 
4.1.3 Immortalization and oncogene excision in the endothelial model system 
Successful immortalization was achieved in HUVEC with combinations of each two of the 
oncoproteins hTERT, SV40T and Bmi1 resulting in unlimited cell growth. Cells were 
monitored up to passage 50. Cell lines were also obtained with SV40T alone. Oncogene 
expression was confirmed by real time RT-PCR and the immortalized cells retained 
endothelial phenotype, as they still expressed the endothelial marker PECAM-1. In 
contrast to the immortalized HUVEC, HUVEC transduced with only hTERT- or Bmi1-
construct did not grow continuously, growth was arrested and cells finally died. Thus, it 
was concluded that hTERT or Bmi1 alone were not sufficient for immortalization and the 
cells entered senescence. Insufficiency of hTERT or Bmi1 alone for immortalization was 
observed by Cudré-Mauroux, et al. (2003) as well. Taken together, the successful 
immortalization of primary HUVEC in this study using lentiviral gene transfer showed that 
the system can be applied for the immortalization of primary cells.   
PECAM-1 was shown to be a stable endothelial marker in this study, which is in 
agreement with other groups who reported maintenance of PECAM-1 expression. 
Oostingh, et al. (2007) compared primary HUVEC and human dermal microvascular 
endothelial cells with four immortalized endothelial cell lines from brain, placenta or 
dermis, and reported loss of two endothelial adhesion molecules (E-selectin and VCAM-
1) in the immortalized cells. At the same time, PECAM-1 (CD31) was still expressed in all 
but brain immortalized endothelial cells and expression was comparable to the primary 
cells. Stability of endothelial marker expression including PECAM-1 was also reported for 
hTERT- and SV40T-immortalized HUVEC after over 100 population doublings (Tentori, et 
al., 2005) and HUVEC immortalized with human papillomavirus 16 E6/E7 in 
approximately passage 30 (Fontijn, et al., 1995). Additionally, a reversibly immortalized 
HUVEC cell line was achieved by Noguchi, et al. (2002) via retroviral transfer of SV40T, 
and cells retained expression of endothelial markers.  
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In contrast, van Leeuwen, et al. (2000) reported loss of endothelial markers such as 
PECAM-1 and von Willebrand factor in HUVEC immortalized with SV40T. PECAM-1 
expression declined with continuous cell growth (measured in cell passages 13-31) and 
was not detected in cells at high passages (measured up to passage 89). In the present 
study, cells were observed for a shorter time period up to passage 50. Therefore, 
changes in marker expression in later cultures can not be excluded.  
 
For re-mortalization, oncogene excision via the recombinase Cre was achieved in 
immortalized HUVEC in this study following the protocol successfully tested with TMNK-1 
control cells. However, soon after Cre treatment the reverted HUVEC arrested growth 
completely. The reasons for this permanent growth arrest were so far unclear as the 
principal usability of lentivirally transduced Cre-recombinase was shown in this study for 
TMNK-1 cells (see above) and efficient Cre-transduction was also reported by other 
groups using retroviruses or adenoviruses (Kowolik, et al., 2004; Salmon, et al., 2000). It 
was expected that the re-mortalized HUVEC would rather behave like the Cre-treated 
TMNK-1 cells in this study, which slowed down the cell growth but did not completely 
arrest it. Therefore the observed complete growth arrest of the re-mortalized HUVEC was 
unexpected.  
In contrast to our study, Noguchi, et al. (2002) were able to perform successful reversion 
(i.e. re-mortalization) of immortalized HUVEC to a pre-transduced state, in which cells did 
not enter senescence directly. Their study differs from our methods, as the authors used 
adenovirus-mediated transfer of the recombinase Cre with MOI 5. Reverted cells were 
selected by using the antibiotic G418, as reverted cells in their system expressed the 
neomycin resistance gene. In addition, growth characteristics after oncogene excision 
were influenced by the time span the cells had been cultured. Cells with lower population 
doublings maintained cell proliferation after reversion. 
Although Noguchi, et al. (2002) state that the immortalized endothelial cells can be 
reverted without any problems, Cre-induced growth arrest was reported by other groups.  
When the TMNK-1 cell line was originally published, a slow loss of cell proliferation after 
re-mortalization was reported (Matsumura, et al., 2004). A Cre-induced growth arrest was 
also observed by Salmon, et al. (2000) in liver endothelial cells already two to four days 
after Cre-treatment. The authors concluded that cell division of the immortalized cell line 
still strictly depended on the presence of the immortalizing genes. Other studies also 
reported growth arrest of cells after addition of Cre recombinase to reversibly 
immortalized cells (Narushima, et al., 2005; Cudré-Mauroux, et al., 2003; Kobayashi, et 
al., 2000). In our study, the cells seem to be still dependent on the oncogenes as well.  
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Notably, in this study HUVEC immortalized with hTERT + Bmi1 partially survived 
treatment with ganciclovir. One possibility is that the cells were less sensitive to 
ganciclovir than the other immortalized HUVEC, and that Cre-mediated oncogene 
excision was not efficient in HUVEC with hTERT + Bmi1. Alternatively, primary cells might 
be present in between immortalized cells. Primary HUVEC were shown not to be affected 
by ganciclovir. However, it is not likely that primary cells were still present in these long-
term cultures.  
Silver and Livingston (2001) showed that continuous expression of Cre-recombinase led 
to decreased growth, cytotoxicity and chromosomal aberrations in the transduced cells. 
These negative effects were avoided by using a self-excisable Cre-construct, which is 
flanked by lox-sites. Thus, the amount and duration of Cre expression were limited. As a 
self-excisable Cre-construct was used in the present study, this cytotoxicity effect could 
be excluded.  
Despite several studies describing successful and feasible re-mortalization of cells in 
culture, there are only few reports about direct applications of reversibly immortalized cell 
lines after reversion back to a pre-transduced state. Kobayashi, et al. (2000) transplanted 
reverted human hepatocytes into rats and successfully prevented acute liver failure. 
Transplantation of reverted insulin-producing hepatocytes into pigs and of human 
pancreatic β-cells into mice resulted in control of diabetis (Narushima, et al., 2005; Okitsu, 
et al., 2004).  
 
4.1.4 Primary human fallopian tube cells were successfully immortalized 
For the isolation of primary human fallopian tube cells, tissues from 26 different patients 
were obtained, each time including one to two tubal segments. In total, mixed primary cell 
populations of 18 FT tissue pieces (derived from 12 different patients) could be used in 10 
independent immortalization experiments. Combinations of the oncoproteins hTERT, 
SV40T and Bmi1 as well as single oncoproteins were used. FT cells showed stress 
vacuoles and fibres after transduction with oncogenes. The mixed primary cell 
populations used for immortalization contained epithelial cells, but were not pure cultures. 
As pure isolation of epithelial cells was difficult, clonal expansion was performed via flow 
cytometry single cell sort or cloning rings. In most cases, single cells did not grow and 
died, when cells were singled to obtain clones. The survival rate did not increase when 
culture vessels were coated. Altogether, 21 FT cell clones were obtained. The transduced 
primary cells had proliferated only in the presence of SV40T, and all obtained FT cell 
clones were immortalized with SV40T and Bmi1. Oncogene expression was verified in FT 
cell clones.  
 - 91 - 
Discussion 
The oncoprotein hTERT alone was not sufficient for immortalization (as was 
demonstrated in this study already with HUVEC). It remains unclear why no FT cells 
immortalized with hTERT plus SV40T or Bmi1 were obtained in the present study. A 
defective hTERT construct can be excluded, as functionality of the hTERT construct was 
shown in HUVEC (by detection of HTERT expression and cell immortalization via hTERT 
in combination with SV40T or Bmi1). Immortalization of human fallopian tube epithelial 
cells was achieved by other groups using HPV16 E6/E7, TERT plus SV40T or SV40T 
alone (Lee, et al., 2010; Lee, et al., 2001; Ando, et al., 2000). Until now, there are no 
reports of reversibly immortalized human fallopian tube epithelial cells.   
 
Reversible immortalization was implemented into this study to have an option to revert 
the cells back to a primary-like state. When immortalized cells were reverted, it was 
assumed that they adjusted growth properties to the ones of primary cells. In the initial 
experiments, reversion of TMNK-1 cells could be shown to work efficiently, and cells 
retained a lower proliferation capacity. However, experiments with immortalized HUVEC 
in this study and reports by other groups showed that in many cases reverted cells 
stopped growth very soon after Cre-treatment (see above). Based on the findings from 
these experiments it was concluded that cells can be re-mortalized but undergo cell cycle 
arrest. The procedure of Cre-treatment and selection of reverted cells takes up to two 
weeks. Therefore, the cells had no proliferation potential any more by the time they could 
be applied to other experiments. The major problem here is that these follow-up studies 
themselves can take several days or longer.  
Strikingly, García-Escudero, et al. (2010) reported that only ensheathing glia cells 
reversibly immortalized with Bmi1 and hTERT still proliferated after re-mortalization, when 
they compared different combinations of SV40T, hTERT and Bmi1. None of the other 
cells could revert back to this primary cell replicative state.  
In addition, it is known from literature that epigenetic changes can occur after introduction 
of oncogenes. In case of Bmi1, histone modifications are influenced. Bmi1 is involved in 
gene silencing by histone H3 methylation (Agherbi, et al., 2009; Bracken, et al., 2007). 
Additionally, Bmi1-dependent histone 2A ubiquitylation was described (Kallin, et al., 
2009).   
Due to all these reasons, re-mortalization could not be extensively studied in the FT cell 
lines.  
 
All 21 FT cell clones generated in this study were analyzed for the expression of at least 
one or all three epithelial markers (EpCAM, E-cadherin, and cytokeratin-8). None of the 
cell lines expressed epithelial markers and thus the cells were not regarded as epithelial 
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cells. In addition, all cells tested were negative for the endothelial marker PECAM-1, so 
endothelial origin of immortalized cells was excluded. In the literature the epithelial cells 
were distinguished from fibroblasts by many authors via their cell shapes (Ando, et al., 
2000; Saridogan, et al., 1997; Takeuchi, et al., 1991; Henriksen, et al., 1990). They 
described the primary epithelial cells in FT isolates as irregular, polygonal and slightly 
elongated. In this study, the obtained FT clones differed in their cell shape. While some 
grew irregularly round and tightly confluent, others were elongated and more spindle-like. 
When the cells were grown on permeable filter supports to induce polarized growth, the 
trans-epithelial electric resistance (TEER) increased, albeit absolute values were low. A 
rising TEER usually indicates closure of gaps between the cells and thus between both 
sides of the filter, indicating barrier formation by tight junctions. However, EM analysis 
revealed that no FT cell line was single-layered or polarized with an apico-basal axis 
including tight junctions and apico-basally oriented nuclei. The cells did not show 
properties of polarized epithelial or endothelial cells. The low rise in TEER values might 
have been caused by blockage of filter pores by multiple cell layers.  
 
4.1.5 Immortalized FT cells express stem cell markers 
Interestingly, in this study immortalized FT cells were shown to express the stem cell 
markers CD44 and Oct4 as well as the mesenchymal and stem cell marker N-cadherin. 
CD44 is a glycoprotein localized on cell surfaces, which is involved in cell-cell-adhesion 
and cell migration (Aruffo, et al., 1990; Stoolman, 1989). In addition, CD44 is a marker of 
mesenchymal stem cells and multipotent adult stem cells. For example, CD44 is 
expressed in prostate epithelial stem cells and breast stem cells (Jazedje, et al., 2009; 
Zuba-Surma, et al., 2009; Zenzmaier, et al., 2008; Mani, et al., 2008). As it is known that 
CD44 is expressed in human fallopian tube stem cells (Jazedje, et al., 2009), the cells 
isolated in this study could indeed be stem cells.  
The transcription factor Oct4, also known as POU5F1, is one of the key regulators of 
stem cell pluripotency and is required to keep embryonic stem cells in their 
undifferentiated state. The transcription factor is described not to be active in normal 
somatic cells (Nichols, et al., 1998; Pei, 2009; Marikawa, et al., 2005). However, Oct4 
expression was reported in very small embryonic-like stem cells and ovarian cancer stem 
cells (Zuba-Surma, et al., 2009; Peng, et al., 2010). Thus, the observed Oct4-positive FT 
cells from this study have a stem cell-like phenotype.  
N-cadherin (neural cadherin or cadherin 2) is expressed in neural and non-neural cells 
such as myocardiac cells and hematopoietic progenitor cells (Takeichi, 2007; Wein, et al., 
2010; Hatta, et al., 1987). N-cadherin is also a marker of undifferentiated mesenchymal 
stem cells, which can differentiate to form cells of bone, fat tissue and muscle (Shin, et 
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al., 2000; Mbalaviele, et al., 2006). It is known that multipotent adult mesenchymal stem 
cells are found in the human FT. These cells can undergo differentiation to bone, fat, 
cartilage, and muscle cells (Jazedje, et al., 2009). The last authors did not analyze N-
cadherin expression, but these reports support the conclusion that maybe stem cell-like 
FT cells were isolated in this study. The epithelial cells might have been too sensitive and 
maybe did not grow long enough to obtain clonal cultures, so that stem cell-like cells 
expanded.  
In addition to the expression of CD44, Oct4 and N-cadherin in stem cells, their expression 
is also described in other cell types. For instance, CD44 is observed in cancer-initiating 
cells that play a role in tumor formation and Oct4 is detected in stem-cell-like cells found 
in epithelial ovarian cancer (Marhaba, et al., 2008; Peng, et al., 2010). N-Cadherin is 
often generally regarded as mesenchymal marker.  
Loss of epithelial markers and gain of mesenchymal and stem cell properties are 
characteristics known from epithelial to mesenchymal transition (EMT). EMT is a process 
in which epithelial cells convert to a mesenchymal phenotype, and it is involved e.g. in 
embryonic development, tumor invasion and metastasis. EMT is characterized by loss of 
E-cadherin with shift to N-cadherin and expression of vimentin. In addition, EMT is 
connected to stem cell properties such as promoted cell survival and expression of CD44 
or Oct4 (Thiery, et al., 2009; Mani, et al., 2008). EMT could have influenced cell marker 
expression of the isolated and immortalized FT cells. Apart from the possibility that 
original stem cells were isolated and transduced in this study, it is thus conceivable as 
well that epithelial cells were isolated, which then lost the epithelial phenotype.  
It is also known from literature that markers present in primary cells can get lost in cell 
culture. Comer, et al. (1998) reported that epithelial FT cells adopted an immature 
secretory-like phenotype in vitro. This was reversible, as hormones could stimulate cells 
to differentiate and form cilia again. The degree of marker loss may vary.  
The studies discussed here allow two alternative interpretations of the presented results: 
(1) an undifferentiated stem cell-like cell type was isolated and immortalized in this study; 
or (2) epithelial cells were isolated but lost their specific markers in in vitro culture and 
maybe went through EMT.  
 
4.1.6 Immortalized fallopian tube cells acquired chromosomal changes 
All FT cell lines obtained in this study were immortalized with the oncoproteins SV40T 
and Bmi1. Karyotype analysis revealed abnormal chromosomes in the analyzed FT cell 
lines. The chromosomal changes were partially extensive, including fusion chromosomes, 
missing chromosomes and structurally aberrant chromosomes, whose origin could not be 
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identified. The latter formed ring structures, contained two centromeres or consisted of 
fused chromosomes or only small chromosome parts.  
SV40T has been used to immortalize many different cell types. Among these are 
numerous human epithelial and endothelial cells as well as other cells types, e.g. 
hepatocytes (Qiu, et al., 2006; Nguyen, et al., 2005; Kowolik et al, 2004; Maruyama, et 
al., 2004; Matsumura, et al., 2004; Garbe, et al., 1999). SV40T is very efficient for the 
induction of proliferation and immortalization of primary cells. However, in some studies 
the chromosomes of immortalized cells were analyzed. In these studies, SV40T led to 
chromosomal aberrations and partly to strong phenotypic changes in the SV40T-
expressing cells (García-Escudero, et al., 2010; Cudré-Mauroux, et al., 2003).  
It has long been known from literature that introduction of SV40T can induce 
chromosomal changes in the target cells. Ray, et al. (1992) systematically investigated 
SV40T-expressing cells in different stages. Soon after introduction of SV40T the cells 
showed distinct alterations of both chromosome number and structure, indicating 
chromosome breaks. Aneuploidy, i.e. an abnormal number of chromosomes, was found in 
nearly all cells. Analysis of the cells in later stages revealed that the SV40T induced 
effects were not transient but ongoing. The most frequent structural abnormalities 
detected were dicentric chromosomes. In contrast, few ring chromosomes and acentric 
fragments were observed. The SV40T-expressing cells showed chromosomal instability, 
as chromosome numbers varied in cultures and also changed over time. Hein, et al. 
(2009) reported induction of tetraploidy by SV40T.  
SV40T binds to and thereby inactivates the cellular retinoblastoma (Rb) proteins. This 
leads to activation of transcription factors, e.g. E2F, followed by entry of host cells into the 
DNA replication phase. SV40T also inactivates the tumor suppressor p53 (Levine, 2009). 
In addition, SV40T alone was shown to be enough to induce the DNA damage response 
observed in SV40 infections. It disrupts genome integrity mechanisms by binding to Bub1, 
which functions in the mitotic spindle checkpoint. Mutated Bub1 was shown to induce 
aneuploidy and cancer. The elicited DNA damage response is activated via the binding of 
SV40T to Bub1. SV40T interaction with Bub1 might thus disturb the checkpoint and lead 
to aneuploidy (Cheng, et al., 2009; Hein, et al., 2009). These mechanisms could 
contribute to the observed aneuploidy in the immortalized FT cells. Additionally, it was 
reported that SV40T can bind to the MRN complex, which itself binds to double-stranded 
DNA breaks and usually recruits repair factors of the DNA damage response. SV40T 
binding to MRN can circumvent the DNA damage signalling (Cheng, et al., 2009) and 
thus may result in unrepaired DNA double strand breaks. The latter could explain the loss 
or fusion of chromosome parts, leading to the aberrant marker chromosomes observed in 
this study.  
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Cantalupo, et al. (2009) compared gene expression patterns of two different mouse cell 
types expressing SV40T and observed cell type specific gene regulation by SV40T in 
addition to the changes occurring in both cell types. This suggested that the outcome of 
SV40T action depends on the cell type as well.  
It was shown that alterations in DNA methylation are associated with SV40T-induced 
carcinogenesis in a mouse model and that a de novo DNA methyltransferase contributes 
to transformation of cells in culture. Increased DNA methylation and downregulated gene 
expression were observed for some tumor suppressors (Soejima, et al., 2003; Komatsu, 
et al., 2000).  
Some studies directly compared the effect of the three oncoproteins hTERT, SV40T and 
Bmi1 on chromosome structure in the same cellular background (García-Escudero, et al., 
2010; Cudré-Mauroux, et al., 2003). In contrast to SV40T, hTERT and Bmi1 were 
described to maintain the normal karyotype of immortalized cells usually without 
chromosomal aberrations. Therefore, it is assumed that Bmi1 did not contribute to the 
chromosomal changes observed in the present study in cells immortalized with SV40T 
and Bmi1.  
 
One possibility to circumvent karyotype changes in immortalized cells might be using 
alternative oncogenes. Mechanisms for the inactivation of p53 and Rb were also 
developed by other viruses than SV40. For example, the E6 and E7 proteins from human 
papilloma viruses (HPVs) high-risk strains are used for the immortalization of human 
primary epithelial cells (Dimri, et al., 2005; Fichorova, et al., 1997). E7 can interact with 
the retinoblastoma protein family. E6 targets the p53 tumor suppressor for degradation 
and leads to activation of the hTERT promoter and thus to telomerase activity (Moody 
and Laimins, 2010; Wise-Draper and Wells, 2008).  
The HPV16 E6/E7 proteins are described to maintain chromosomal stability in some 
reports, while they seem connected to chromosomal changes in others. Fontijn, et al. 
(1995) reported that HUVEC immortalized with HPV16 E6/E7 retained a diploid 
karyotype. Deng, et al. (2008) achieved immortalization of human cervical epithelial cells 
with HPV16 E6/E7 with only minor structural chromosomal instability in two cell lines, 
while in a third cell line extensive chromosomal aberrations were observed. The 
successive accumulation of genomic alterations in E6/E7 immortalized cells was reported 
as well (Carmean, et al., 2007).  
 
4.2 Analysis of chlamydial infection in human fallopian tube tissue culture 
Ex vivo tissue culture of the human fallopian tube (FT) was successfully established and 
tissue was viable for 3-5 days in culture. This is the first study providing high resolution 
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subcellular immunofluorescence analysis of formalin-fixed paraffin embedded human 
fallopian tube by optimised confocal imaging.  
In this study, the new tissue culture model was used to analyze the infection of Chlamydia 
trachomatis. The bacteria were shown to infect epithelial cells within fallopian tube tissue 
and to complete the replication cycle in tissue culture, as infectious C. trachomatis were 
recovered from medium of infected tissue. In the second half of the chlamydial infection 
cycle, the infection was demonstrated to disrupt the epithelium and to induce loss of cell 
adhesion. Furthermore, differences could be highlighted in this study between the C. 
trachomatis serovars D and L2. The serovar D was found to induce apoptosis in infected 
and non-infected cells in fallopian tube tissue and also in cell culture. In contrast, the 
serovar L2 did not induce apoptosis, as is known from literature.  
 
4.2.1 Successful fallopian tube tissue culture and analysis by high resolution 
immunofluorescence confocal imaging 
This study provides for the first time subcellular analysis of formalin-fixed paraffin 
embedded (FFPE) human fallopian tube (FT) tissue using optimised multiple 
immuofluorescence staining and applies this model for the analysis of chlamydial 
infection. The immunofluorescence protocol for high resolution confocal microscopy of 
FFPE tissue was developed by Robertson and colleagues (2008) to circumvent 
limitations in conventional immunohistochemistry. So far, analysis of FFPE tissue was 
commonly performed with antibodies coupled to an enzyme, e.g. peroxidase, converting 
a chromogenic substrate to a precipitate. Therefore, usually combinations of enzymes to 
detect more than one protein did not yield high quality results and could not be used for 
colocalization studies. Another disadvantage of this kind of detection was less resolution 
due to the precipitate and analysis of whole sections of several micrometers thickness in 
light microscopy. In contrast to the use of enzyme coupled antibodies, 
immunofluorescence staining was performed in cryosections instead of FFPE material, 
but cryosections tended to preserve the tissue structure less (Robertson, et al., 2008). 
Preliminary experiments at the beginning of our study had shown that cryosections of 
human FT tissue were distorted and torn. Robertson and colleagues (2008) demonstrated 
their method with human kidney and breast tissue. We investigated healthy human FT 
tissue and analyzed chlamydial infection therein using this optimised method.  
Human fallopian tube tissue culture was established and shown to remain intact with 
preserved tissue structure, polarity and viability in this study. The tight junction marker 
occludin and the adherens junction proteins E-cadherin and β-catenin were expressed at 
cell junctions or laterally at cell contacts, respectively, as demonstrated by 
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immunofluorescence staining. Cilia were preserved in tissue culture at the apical side of 
ciliated cells as marked by acetylated tubulin.  
The human FT tissue stayed viable in culture in this study, adhesion and polarity markers 
were observed as expected. Levanon, et al. (2010) obtained similar results with human 
FT culture staining the adhesion proteins E-cadherin and EpCAM as well as acetylated 
tubulin in cilia at the apical side of epithelial cells by immunohistochemistry. Other groups 
observed intact undisrupted epithelial surfaces with microvilli and cilia on tightly packed 
cells by electron microscopy of untreated tissue in culture for 1-7 days (Baczynska, et al., 
2007; Hvid, et al., 2007; Cooper, et al., 1990).  
So far, other studies reporting C. trachomatis infection of human FT in culture performed 
electron microscopy and conventional immunohistochemistry analysis (Baczynska, et al., 
2007; Hvid, et al., 2007; Kelly, et al., 2001; Cooper, et al., 1990). Only a study by Dieterle, 
et al. (1998) used FFPE FT tissue from patients infected with C. trachomatis to perform 
immunofluorescence staining of chlamydial major outer-membrane protein (MOMP). 
However, the sample was only stained for MOMP and lacked any cellular markers to 
enable orientation within the tissue or to demonstrate multi-colour analysis. Furthermore, 
no different stages of chlamydial infection were shown. Thus, the present study is the first 
to demonstrate multi-channel immunofluorescence staining with detailed subcellular 
analysis of FFPE human FT tissue.  
 
4.2.2 Chlamydia trachomatis infects and reproduces within ex vivo fallopian tube 
tissue culture 
Human fallopian tube (FT) ex vivo tissue was infected by C. trachomatis in culture within 
this study. Chlamydial inclusions were detected exclusively in epithelial cells in the tissue 
at various time points of the chlamydial replication cycle. As supernatant from infected 
tissue gave rise to infection in cell culture, the replication cycle was completed by 
chlamydiae in the tissue and infectious progeny was released from the tissue.  
As in our study, infection of the epithelial layer with C. trachomatis had been observed 
before in human FT tissue culture (Hvid, et al., 2007; Cooper, et al., 1990; Hutchinson, et 
al., 1979) confirming this as a reliable infection model. The successful replication of 
chlamydiae within the human FT tissue in culture is consistent with the findings of 
Hutchinson, et al. (1979), who were able to recover the bacteria from infected tissues and 
medium. Thus, chlamydial infection of human FT tissue ex vivo as presented here is a 
valid model.  
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4.2.3 Disruption of epithelium and loss of cell adhesion during chlamydial 
infection 
In our study, infection of human fallopian tube (FT) tissue with C. trachomatis (serovars D 
and L2) induced disruption of the epithelial layer during later stages of the infection cycle. 
This was observed two to three days post infection depending on the amount of infection 
in individual tissues. Cell adhesion and columnar shape of polarized epithelial cells were 
lost.  
In the literature, various changes within epithelial layers infected with Chlamydia are 
described. Rapture of single infected cells was observed 72 h post infection (p.i.) with C. 
trachomatis by Cooper, et al. (1990) in human FT tissue; however, the cytoplasmic 
membrane contacts to neighbouring epithelial cells appeared intact. The raptured cells 
released elementary bodies at the end of the chlamydial replication cycle, but did not 
reflect the loss of adhesion and of polarized cell shape of all cells within the epithelium as 
observed in our study.  
Hvid, et al. (2007) reported destruction within the epithelial layer of human FT tissue after 
infection with C. trachomatis 5 days p.i.. Mainly ciliated cells lost association with the 
epithelial layer and rupture occurred in some secretory cells as observed by scanning 
electron microscopy of the apical side. In cross-sections the epithelial layer seemed 
partially flattened; however, the extent and possible change of adhesion proteins can not 
be evaluated from these data.  
Adhesion between neighbouring cells is mediated among others by adherens junctions, 
protein complexes that span the extracellular space between cells and are connected to 
the intracellular actin cytoskeleton. In polarized epithelial cells, as they are present in 
intact mucosa, these junctions completely encircle the cells to form the lateral adhesion 
belt and are important for maintaining tissue integrity. Transmembrane cadherin proteins 
connect the cells by homophilic interactions depending on Ca2+ (Meng and Takeichi, 
2009; Chitaev and Troyanovsky, 1998). The redistribution of E-cadherin to the apical side 
of epithelial cells in infected FT tissue observed in the present study suggested a loss of 
cell adhesion and apico-basal polarity triggered by the infection. EGTA, a chelating agent 
binding Ca2+ and thereby inhibiting E-cadherin-dependent cell adhesion (Chitaev and 
Troyanovsky, 1998), was used to test this hypothesis. In EGTA treated FT tissue, E-
cadherin was observed also at the apical side of cells, and the epithelial cells lost cell 
adhesion and columnar shape. This observation was consistent with the changes 
observed in chlamydial infection and thus indicated loss of epithelial cell adhesion in 
infected tissue in this study.  
Epithelial barrier function is maintained by tight junctions. These protein complexes 
separate apical from baso-lateral membranes, thus being characteristic of polarized cells, 
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and contain the integral membrane protein occludin (Furuse, 2010; Furuse, et al., 1993). 
In our study, delocalization of E-cadherin to apical membrane compartments not only 
suggested loss of cadherin-mediated cell adhesion, but also loss of apico-basal cell 
polarity. For confirmation, occludin localization was analyzed in FT tissue infected with C. 
trachomatis in our group (Kessler, et al., submitted). Subapical occludin as detected in 
non-infected tissues was lost after infection and delocalized. These results further support 
the findings presented here.  
The loss of adhesion and polarity observed in this study is apparently directly regulated 
by the pathogen. Apico-basal polarity and structure is crucial for epithelial function 
(Gibson and Perrimon, 2003). Their disturbance in C. trachomatis infection may 
contribute to pathology. Interestingly, similar phenotypes were reported from infections 
with other bacterial pathogens. A loss of E-cadherin and cytokeratin-18 was observed in 
intestinal epithelial cells after infection with Escherichia coli (Cane, et al., 2010). Guttman, 
et al. (2006) reported the disruption of tight junctions characterized by delocalization of 
several claudin-proteins in an in vivo mouse study of enterohaemorrhagic Escherichia coli 
(EHEC) and enteropathogenic E. coli (EPEC) infection. Helicobacter pylori, a stomach 
pathogen, secretes effector proteins into epithelial cells by a type IV secretion system. 
These effectors induce loss of cell adhesion in gastric epithelial cell culture. The 
mechanisms were shown to include disruption of adherens junctions and E-cadherin 
cleavage (Weydig, et al., 2007; Suzuki, et al., 2005). Campylobacter jejuni intestinal 
infection disrupted claudin-4 localization at tight junctions and led to loss of epithelial 
barrier function in newly hatched chicken (Lamb-Rosteski, et al., 2008). Additionally, there 
are viruses known to interfere with cell-cell contacts as well. The Ebola virus envelope 
glycoprotein was described to induce loss of cell adhesion with cell rounding and 
detachment in cell lines and primary cells. Levels of cell death did not increase and cells 
were able to re-adhere and divide after transient glycoprotein expression (Simmons, et 
al., 2002).  
 
4.2.4 Apoptosis is induced during infection with C. trachomatis serovar D but not 
serovar L2 
The Chlamydia trachomatis serovar D is associated with urogenital tract infections.  
Tissue culture infection by C.trachomatis was mainly analyzed using this strain in the 
present study. A widely used laboratory strain, serovar L2, was incorporated into this 
study to determine possible differences between the strains. In cell culture experiments, 
Chlamydia trachomatis has been widely described to inhibit apoptosis. Interestingly, we 
showed in this study that infection with C. trachomatis serovar D induced apoptosis. 
Apoptosis was not restricted to infected cells. Phenotypic changes in non-infected cells 
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could be significant for and contribute to the understanding of Chlamydia-induced 
pathology, as they suggest the existence of a paracrine signalling during acute infection 
and change in epithelial homeostasis. The induction of apoptosis was observed in tissue 
explants as well as in cell culture. The serovar L2 did not induce apoptosis, as expected 
from literature.  
So far, bacteria of the family Chlamydiaceae have been extensively described in literature 
to confer apoptosis resistance on their host cells. Reports include the human pathogenic 
species Chlamydophila pneumoniae and Chlamydia trachomatis (Böhme, et al., 2010; 
Greene, et al., 2004; Rajalingam, et al., 2001; Fan, et al., 1998). Inhibition of apoptosis is 
known from literature among others for the C. trachomatis serovar L2 (Böhme, et al., 
2010; Rajalingam, et al., 2006; Pirbhai, et al., 2006; Ying, et al., 2005; Fischer, et al., 
2004; Fan, et al., 1998).    
However, there are few reports about induction of apoptosis following infection with 
chlamydiae in a caspase-independent manner (Perfettini, et al., 2002; Ojcius, et al., 1998) 
or only recently described via caspase-8 (Vats, et al., 2010). These results are discussed 
controversially in the literature. Chlamydiae seem to possess the ability to both inhibit and 
induce apoptosis, as was already reviewed by Häcker, et al. (2006) and Byrne and Ojcius 
(2004). In contrast, some authors say the observed cell death was different from 
apoptosis due to lack of caspase activation in cells infected with C. trachomatis serovar 
L2 and the cleavage of host proteins by the chlamydial protease-like activity factor 
(CPAF) (Paschen, et al., 2008; Ying, et al., 2006).   
Attempting to clarify the controversy about reported inhibition and induction of apoptotic 
cell death by chlamydiae, Greene, et al. (2004) used 17 different chlamydial strains 
(including 14 C. trachomatis serovars) in comparison to analyze chlamydial effects on 
host cell apoptosis. The authors stated that no biologically significant apoptosis was 
observed during infection with any of the serovars, and that an anti- but not pro-apoptotic 
activity predominated in cultures infected with chlamydiae. Nevertheless, low levels of 
apoptotic Hela cells (< 5 %) were detected at early time points (24h, 30h) in mostly non-
infected cells in infections with many serovars. Additionally, two serovars caused 
apoptosis also in infected cells 24h p.i., including C. trachomatis serovar D. At this time 
point no apoptosis at all was detected in completely non-infected cultures. However, 
when apoptosis was induced with staurosporin 4h prior to the end of experiments, all 
serovars conferred apoptosis resistance on infected cells compared to non-infected cells 
in the same culture. This included serovar D.  
The observed differences might be due to different infection conditions. Greene, et al. 
(2004) did not specify the subtype of Hela cells, and used MOI 1 for infection with serovar 
D and infection medium containing 10 % FCS. We used higher MOI (MOI of 3) in cell 
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culture and only 5 % FCS resulting in better infections. However, resistance to an external 
apoptotic stimulus was not tested in this study. Likewise, Zhong, et al. (2006) included C. 
trachomatis serovars D and L2 in their studies of chlamydial infection in Hela cells using 
10 % FCS infection medium and an MOI of only 0.2. Both serovars L2 and D inhibited 
apoptosis when it was induced by treatment with staurosporin. Only infected cells were 
protected. Again, experimental differences might account for the varying observations.  
Indeed, chlamydiae seem to possess apoptosis inhibiting as well as inducing capacities. 
As active caspase-3 was detected in the present study, the observed form of cell death is 
considered to be apoptosis. Inhibition of apoptosis might be only exerted in the presence 
of pro-apoptotic stimuli and might be of greater importance in long-term infections.  
Other obligate intracellular bacteria were described to inhibit apoptosis. In case of the 
Gram-negative bacterium Rickettsia rickettsii activation of the transcription factor NFκB, 
which leads to expression of anti-apoptotic genes, is necessary for host cell survival 
(Clifton, et al., 1998). The facultative intracellular bacterium Shigella flexneri as well as 
enteropathogenic Escherichia coli (EPEC) were both described to inhibit apoptosis by a 
type III secretion system secreted factor (Hemrajani, et al., 2010; Faherty and Maurelli, 
2009).  
Some pathogens induce apoptosis in infected cells by a bacterial toxin. Listeria 
monocytogenes can invade and move inside host cells. It produces listeriolysin, which 
triggers apoptosis in dendritic cells and might inhibit immune responses (Guzmán, et al., 
1996). Shiga toxin expressed by Shigella dysenteriae can induce apoptosis in a variety of 
cells, including epithelial and lymphoid cells (Tresh, 2010). Induction of apoptosis was 
reported as well for the human stomach pathogen Helicobacter pylori, triggering 
apoptosis in gastric epithelial cells (Chu, et al., 2003).  
Thus, both apoptosis induction and inhibition are widely distributed among pathogenic 
bacteria. These mechanisms may lead to death of immune cells or access to further cell 
layers in case of apoptosis, or a prolonged infection inside cells when apoptosis is 
inhibited.  
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4.3 Perspective 
In this study, reversible immortalization was applied to human primary cells of the 
umbilical vein and the fallopian tube (FT). While the umbilical vein cells expressed an 
endothelial marker protein, immortalized FT cells expressed markers that are found in 
stem cells. Future experiments could further resolve the cell type of the generated 
immortalized FT cell lines, by investigating the occurrence of additional stem cell markers. 
The mesenchymal stem cell markers CD13 and CD73 (an aminopeptidase and a 
nucleotidase, respectively) were described for human FT stem cells, as well as the 
adhesion markers CD29 (integrin β1) and CD90 (cell surface glycoprotein Thy-1) 
(Jazedje, et al., 2009).  
In addition, it is interesting to see whether the immortalized cells retain anchorage-
dependent growth or were transformed and tumorigenic. Invasiveness of cells can be 
tested in vitro with an invasion assay. Cells are grown on a matrix consisting of basement 
membrane components and observed for cell invasion into the matrix. Alternatively, cells 
are grown on a coated porous membrane and the percentage of cells is determined that 
migrated through to the other side of the membrane. In vivo experiments are described in 
literature, too, to analyze tumorigenicity. The tumor forming potential of cells can be 
tested in animal experiments by injection of cells into nude mice and subsequent 
examination of tumors.  
This study also showed that the ex vivo tissue culture of human FT is a valid and reliable 
model system. It includes higher complexity compared to tissue culture models and 
comprises cells in their natural tissue context. In this system it is possible to analyze 
cellular events as well as the interplay between cells or between pathogen and host cell 
on a subcellular level and at the same time in an in vivo-like situation. 
Infection with Chlamydia trachomatis revealed damage of the epithelial layer in the FT 
tissue, during which epithelial cells lost polarity and adhesion. Further analysis is required 
to determine the molecular events following the disruption of the epithelial layer. The 
adherens protein E-cadherin was shown in this study to be delocalized after chlamydial 
infection. In addition to the structural function of full-length cadherins in adherens 
junctions, their extra- and intracellular cleavage fragments fulfil biological functions, too. It 
is known that the cytoplasmic fragment of E-cadherin is involved in intracellular signalling 
processes and localizes to the nucleus, where it can bind DNA. Additionally, E-cadherin 
cleavage increases the levels of soluble α- and β-catenin in the cytoplasm (Ferber, et al., 
2008; Marambaud, et al., 2002). Thus, E-cadherin structural changes and signalling as 
well as other proteins important for cell polarization might be influenced by or involved in 
the epithelial destruction.  
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Apoptosis inhibition has been widely described as a characteristic observed in chlamydial 
infections. In this study, differential behaviour was shown for a chlamydial strain that 
induced apoptosis. Molecular analysis is necessary to determine how components of the 
apoptosis pathway are differently influenced by chlamydial strains. Chlamydiae can 
prevent the permeabilization of mitochondria, which is a pro-apoptotic step, by interfering 
with upstream factors, e.g. inhibiting BH3-only proteins and stabilizing Bcl-2 family 
proteins. Chlamydiae can also prevent the activation of caspase-3, a key effector of 
apoptosis, by increasing the levels of inhibitory IAPs (Sharma and Rudel, 2009). An 
apoptosis-inducing chlamydial strain might interact with these factors in another way.  
There are restrictions of the tissue culture model system regarding possible 
manipulations. In cell culture systems, gene silencing has evolved as a useful tool to 
inhibit single factors and investigate their influence on cellular mechanisms, including 
pathogen-host-interactions. Today it is still not possible to generate targeted mutants of 
chlamydiae. Therefore, the host cell is the possible point of manipulations. However, cells 
in tissues are much more resistant to transfection of silencing constructs, such as 
siRNAs, due to the stable and complex integration of cells in tissues. Additionally, only the 
exterior cell layers of tissues will most likely be reached by silencing constructs. Future 
experiments will determine the possibility and efficiency of delivering silencing constructs 
into human FT tissue, e.g. by viral transfer with lenti- or adenoviruses or by transfection 
reagents designed for in vivo animal studies. Transfer of siRNA is investigated for other 
tissue (Forbes, et al., 2009). Gene silencing in tissue explants would provide a model 
system combining the qualities of in vivo-like experiments and cell culture usability.  
In conclusion, this is the first study investigating chlamydial infection processes in an ex 
vivo tissue model with detailed analysis on a subcellular level. In addition, this study 
presents immortalization and characterization of human FT cells and the strategy of 
reversible immortalization. Stable ex vivo tissue culture and successful reversible 
immortalization are useful models to provide insights into the infection processes of 
Chlamydia and of other pathogens, e.g. Neisseria. Thus they can contribute to the 
broader understanding of bacterial infections. 
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List of abbreviations 
List of abbreviations 
Bmi1  B lymphoma Moloney Murine Leukemia Virus insertion region 1 
CMV  Cytomegalovirus 
CPAF  chlamydial protease-like activity factor 
dic  dicentric chromosomes  
EB elementary body 
EGTA  ethylene glycol tetraacetic acid 
EM electron microscopy 
FCS  fetal calf serum  
FFPE formalin-fixed paraffin embedded (tissue) 
FT  fallopian tube(s)  
Gfp green fluorescent protein 
h  hour(s) 
HPV human papillomavirus  
HSV-1  Herpes Simplex Virus type 1  
hTERT  human telomerase reverse transcriptase  
HUVEC  human umbilical vein endothelial cells  
IAPs inhibitor of apoptosis proteins  
LV particles lentivector particles  
mar marker chromosomes 
min  minute(s)  
MOI  multiplicity of infection  
Pen Penicillin  
p.i.  post infection  
PID Pelvic inflammatory disease 
RB reticulate body 
ring ring chromosomes 
RT  room temperature  
RT-PCR real time reverse transcriptase-PCR 
STD sexually transmitted disease(s) 
Strep Streptomycin 
SV40T  Simian Virus 40 large tumor antigen  
TK  thymidine kinase  
TTSS  type III secretion system 
VSV-G  Vesicular Stomatitis Virus Glycoprotein  
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